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Abstract 
     Mitochondria and the endoplasmic reticulum (ER) are two organelles that critically 
contribute to apoptosis induction. It is established that they communicate and several factors 
for this have been identified. However, how cell death signals are transmitted from 
mitochondria to ER is unknown. During my PhD, I found that the mitochondrial fission 
protein Fis1 conveys an apoptosis signal from mitochondria to the ER by physically 
interacting with Bap31, which facilitates its cleavage into the pro-apoptotic p20Bap31 
fragment. Exogenous apoptosis inducers likewise use this signalling route and induce the 
procession of Bap31. 
     Initiator caspases are the apical apoptosis proteases that comprise protein-protein 
interaction domains in their N-terminal prodomains, which allow them to aggregate through 
adaptor proteins. Procaspase-8 is one of the most prominent initiator caspase; yet there are 
only two known procaspase-8-activating complexes identified to date: DISC and Hip1/Hippi 
complex. The cleavage of Bap31 is reported to be mediated by procaspase-8. I have found 
that procaspase-8 is recruited to the Fis1-Bap31 platform early during apoptosis. Apoptosis 
stimulation induces the dimerization of Bap31 and an in-depth dissection of this tripartite 
protein complex revealed that the association between procaspase-8 and the Fis1-Bap31 
complex is dependent on the vDED domain present in Bap31. 
     This signalling pathway emanating from Fis1 or caused by the application of exogenous 
apoptosis signals eventually results in calcium release from the ER leading to cytosolic 
calcium elevation. Additionally, production of the proapoptotic p20Bap31 fragment was 
found to be necessary for this event. The released calcium ions are subsequently taken up by 
mitochondria to induce mitochondrial dysfunction via the permeability transition pore 
thereby establishing a feedback loop from the ER that activates mitochondria for apoptosis 
execution. 
    Hence, the Fis1-Bap31 complex, which we named ARCosome, bridges two critical 
organelles for apoptosis signalling and serves as a novel platform to activate the initiator 
procaspase-8. 
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IAP : Inhibitor of Apoptosis Protein 
IBM : IAP Binding Motif 
iCAD : Inhibitor of Caspase-Activating DNase 
ICE : Interleukin-1β Converting Enzyme 
IKK : IκB Kinase 
IMM : Inner Mitochondrial Membrane 
IMS : Inter-Mitochondrial Membrane Space 
IP : Immunoprecipitation 
IP3R : Inositol 1,4,5-trisphosphate Receptor 
IRE : Inositol Requirement 
JC-1 : 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide 
JNK : c-Jun N-terminal Kinase 
Kd : Dissociation Constant 
Ku70 : Ku Autoantigen 70kDa 
LB-broth : Luria-Bertani broth 
LRR : Leucine-Rich Domain 
Mdivi-1 : Mitochondrial Division Inhibitor 1 
Mfn : Mitofusin 
MHC : Major Histocompatibility Complex 
MISC1 : Mitochondrial Morphology and Cristae Structure 
MitoPLD : Mitochondrial Phospholipase 
MLD : Myosin-like Domain 
MOMP : Mitochondrial Outer Membrane Permeabilisation 
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mRNA : Messenger RNA 
NACHT : Neuronal Apoptosis Inhibitory Protein, MHC class II Transcription Activator, 
Incompatibility Locus Protein from Podospora anserina, and Telomerase-
Associated Protein 
NAD : Nicotinamide Adenine Dinucleotide 
NAIP : Neuronal Apoptosis Inhibitory Protein 
NB 
domain 
: Nucleotide-Binding Domain 
NB-ARC : Nucleotide-Binding Apaf-1, R-gene, and Ced-4 
NDUS1 : NADH Dehydrogenase Ubiquinone Fe-S protein 1 
NFκB : Nuclear Factor-κB 
NLS : Nuclear Localisation Signal 
NMR : Nuclear Magnetic Resonance 
NT : Non-Treated 
Nur77 : Neural Orphan Nuclear Receptor 
OMM : Outer Mitochondrial Membrane 
Opa1 : Optic Atrophy 1 
PAGE : Polyacrylamide Gel Electrophoresis 
PAK2 : p20-Activated Kinase 2 
PARP : Poly ADP-Ribose Polymerase 
PBR : Peripheral Benzodiazepine Receptor 
PBS : Phosphate Buffered Saline 
PBS-T : PBS with 0.1% Tween 
PCR : Polymerase Chain Reaction 
PERK : PRKR-Like Endoplasmic Reticulum Kinase 
PI : Propidium Iodide 
PIDD : p53-induced Protein with a Death Domain 
PKB : Protein Kinase B 
Pol : Reverse Transcriptase 
PT : Permeability Transition 
PTP : Permeability Transition Pore 
PVDF : Polyvinylidene Fluoride 
RAIDD : RIP-Associated ICH-1/CED-3 Homologous Protein with Death Domain 
Rev : Reverse Transcriptase 
RING : Really Interesting New Gene 
RIP : Receptor Interaction Protein 
RNA : Ribonucleic Acid 
ROCK1 : Rho-Associated Coiled-Coil Containing Protein Kinase 1 
ROS : Reactive Oxygen Species 
RT : Room Temperature 
RyR : Ryanodine Receptor 
S.D. : Standard Deviation 
SC : Scramble 
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SDS : Sodium Dodecyl Sulfate 
SERCA : Sarcoplasmic/Endooplasmic Reticulum Calcium ATPase 
shRNA : Short Hairpin RNA 
siRNA : Short Interfering RNA 
Smac : Second Mitochondria Derived Activator of Caspase 
SNARE : Soluble NSF Attachment Protein Receptors 
SODD : Silencer of DD 
STS : Staurosporine 
TAE 
buffer 
: Tris-acetate-EDTA buffer 
tBid : Truncated Bid 
TBS : Tris Buffered Saline 
TBSS : TBS with 0.02% w/v saponine 
TE buffer : Tris-EDTA buffer 
TEMED : Tetramethylethylenediamine 
Tg : Thapsigargin 
TM : Transmembrane 
TMRE : tetramethylrhodamine ethyl ester 
TNF : Tumour Necrosis Factor 
TNF-R : TNF Receptor 
TPR : Tetratricopeptide Repeat 
TR3 : Thyroid Hormone Receptor 3 
TRADD : TNF-R1-associated Death Domain Protein 
TRAF2 : TNF Receptor-associated Factor 2 
TRAIL-R : TNF-related Apoptosis Inducing Ligand Receptor 
UPR : Unfolded Protein Response 
UV : Ultraviolet 
VDAC : Voltage-Dependent Anion Channel 
vDED : Variant of DED 
vMIA : Viral Mitochondria-Localized Inhibitor of Apoptosis 
VSVG : Vesicular Stomatitis Virus Glycoprotein 
WD 
repeats 
: Tryptophan-Aspartic Acid Dipeptide Repeats 
WT : Wild Type 
XBP : X-Box Protein 
YC : Yellow Cameleon 
YFP : Yellow Fluorescent Protein 
β-gal : β-galactosidase 
ΔΨm : Mitochondrial Electrochemical Protein Gradient 
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Introduction 
1. Major Forms of Cell Death: Apoptosis and Necrosis 
     Cell death is an essential strategy for the control of the dynamic balance to maintain tissue 
integrity in multicellular organisms. Two major, yet fundamentally different forms of cell 
death have been known: necrosis and apoptosis. 
1.1 Necrosis 
     The word necrosis originates in the ancient Greek “nekus”, whose literal translation is “a 
dead body.” This form of cell death is an accidental, passive process resulting in an early 
disruption of the plasma membrane and the progressive breakdown of cellular organelles 
accompanied by organelle swelling (oncosis) leading to the lysis of the cell and the leakage 
of cellular contents into the extracellular space, which provokes an inflammatory response 
(Fig. 1 A (Leist and Jaattela 2001)). Neighbouring cells also undergo necrosis upon lysis of a 
single cell thus necrotic cell death affects a group of cells. Cellular necrosis is caused by 
several external causes such as violent perturbation of the environment (extreme high or low 
temperatures for example), mechanical trauma, infections and poisons. Clinically, hypoxic 
cells or tissues that underwent ischaemic injury often present necrotic cell deaths. 
Additionally, venoms produced by certain animals or the infections by particular bacteria can 
cause rapid and severe necrosis such as Group A streptococcus causing necrotizing fasciitis.    
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1.2 Apoptosis 
     Apoptosis or programmed cell death (Lockshin and Williams 1965), in contrast to necrosis, 
requires the evolutionary conserved, tightly regulated activation of an energy-requiring 
intracellular machinery. The word apoptosis was coined by Currie and colleagues in 1972 
(Kerr et al 1972). The name also originates from the ancient Greek; the prefix apo- means 
“off, from, away” and -ptosis means “falling”. Apoptosis was first described as a series of 
morphological changes and these changes are still important hallmarks of apoptotic cell 
deaths (see below for details). Unlike necrotic cells, apoptosis can occur in a single cell 
without inciting an inflammatory response. Characteristics of apoptotic cells include cell 
shrinkage and organelle condensation (Fig. 1 B,C). The cellular contents of dying cells are 
packaged into membrane-enclosed fragments at a later stage during apoptosis termed 
“apoptotic bodies”, which are then recognised by neighbouring cells or macrophages and 
cleared by phagocytosis (Fig. 1 C).   
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     Apoptosis is an essential part of life for a multicellular organisms that plays important 
roles in development and tissue homeostasis (Prindull 1995). Many cells are produced in 
excess during development, which eventually undergo apoptosis and thereby contribute to a 
successful organogenesis and tissue formation (Meier et al 2000, Scavo et al 1998, Schittny et 
al 1998). Failure to undergo programmed cell death during development can cause birth 
defects, for example syndactyly in humans. Apoptosis is not only important during 
Fig. 1  
Necrotic and Apoptotic Cell Death 
(A) Necrotic cells undergo cell lysis and the contents of the intracellular organelles 
are released into the extracellular environment. 
(B) Late stage apoptotic cells form several membrane-enclosed vesicles as depicted 
by the presence of small vacuolar structures in the cytosol. 
(C) Apoptotic cells in tissues are engulfed by macrophages or by neighbouring cells 
for clearing. 
Figure was taken from thesis of Dr. Anne-Laure Mahul-Mellier 
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development but plays critical roles in adult organisms as well. Apoptosis maintains the 
homeostasis of adult organs and tissues, and this regulation is especially important for a 
multicellular long-lived organism. Additionally, apoptotic cell death eliminates cells that are 
a threat to the organisms, such as virally infected cells or cells with damaged DNA, thus 
supporting the host immune system (Green and Martin 1995, Liebermann et al 1995, Shibata 
et al 1994). Dysregulation of this homeostasis will lead to various diseases (Thompson 1995) 
and has been observed in various pathological and therapeutic settings (Reed 2002, 
Thompson 1995). Suppression of apoptosis is linked to cancer, atherosclerosis and 
autoimmune disorders. Other diseases are linked with an excess of apoptosis such as viral 
infection (eg AIDS), neurodegenerative disorders (eg Alzheimer’s disease or Parkinson’s 
disease), autoimmune disorders (eg multiple sclerosis), haematological disorders (eg 
myelodysplastic syndromes), and toxin-induced diseases (eg alcohol-induced hepatitis).  
     Apoptotic cells are characterized both by morphological and biochemical changes (Table 
1). Characteristic morphological features of apoptotic cells include cell shrinkage (Fig. 2 
A,B), chromatin condensation (nuclear pyknosis), membrane blebbing (Fig. 2 A), cell 
detachment (if adherent), production of apoptotic bodies (Fig. 2 B), and finally engulfment by 
macrophages or by neighbouring cells (Kerr et al 1972, Savill and Fadok 2000). In addition 
to these visible features, apoptotic cells are also attributed to undergo a series of biochemical 
changes (Table 1). It is often detected that the free cytoplasmic calcium concentration is 
increased during apoptosis (Fig. 3 A,B), which will activate certain apoptotic pathways. The 
mitochondrial membrane potential is often lost, which inhibits the production of ATP, and 
the rupture of the outer mitochondrial membrane induces the release of pro-apoptotic factors 
from the mitochondrial inter membrane space and creates reactive oxygen species. Most 
importantly, a family of cysteine-dependent aspartate-directed proteases (Caspases) are 
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activated (Fig. 3 A,C). This family of proteases target hundreds of cellular substrates (Martin 
and Green 1995) and the substrate cleavage creates many of the morphological features of 
apoptotic cells as well as several biochemical changes, such as DNA degradation (nuclear 
karyorhexis (Cohen et al 1994)).  Externalisation of the phosphatidylserine also characterizes 
apoptotic cells (Martin et al 1995b). 
Table 1    Characteristics of apoptotic cells 
Morphological Features Biochemical Features 
Cell shrinkage Free [Ca
2+
]c rise 
Chromatin condensation DNA degradation 
Nuclear fragmentation Caspase activation 
Membrane blebbing Loss of mitochondrial membrane potential 
Cell detachment Phosphatidylserine externalisation 
Production of apoptotic bodies  
Phagocytosis of cell corpses  
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Fig. 2 
Time Lapse Images of Cells Undergoing Apoptosis: Morphological Features 
(A) HeLa cells were stained with a mitochondrial dye (JC-1) and treated with doxorubicin (2μM) to 
induce apoptosis. Merged pictures of a bright field image and the JC-1 stained mitochondria are 
shown. At later time points (t=6h onwards), membrane blebbing and the shrinkage of cells can be 
observed. 
(B) HeLa cells were transfected with GFP and cells undergoing spontaneous apoptosis were 
captured. At first, cells present equal cytoplasmic staining whereas spherical structures start 
appearing when cells begin to die (second panel onwards). As apoptosis progresses, numerous such 
structures termed “apoptotic bodies” appear and at a later stage the cells round up and lose focal 
adhesion.  
Both images were taken using a Leica scanning confocal microscopy. 
 
B 
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Fig. 3 
Time Lapse Images of Cells Undergoing Apoptosis: Biochemical Features  
HeLa cells were transfected with the cytosolic calcium indicator YC3.6. Cells were subsequently 
treated with doxorubicin (2µM) and CaspaTag Caspase-3/7 sulforhodamine (a dye that only binds 
to activated caspase-3 or -7 and emits red fluorescence upon binding).  
(A) The top six panels show the time course of cytosolic calcium increase (as indicated by the 
increased green fluorescence) and the activation of caspase-3 or/and -7 (as indicated by the red 
fluorescence). 
(B,C) The bottom two figures show the cytosolic calcium elevation and the Caspase-3 or/and -7 
activation of a representative cell.  
A 
B C 
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1.3 Apoptosis in Nematodes and Mammals 
     Intensive efforts have been made to explore the molecular mechanisms of the signalling 
pathways for apoptosis initiation, mediation to execution. The first insights into apoptosis 
came from genetic studies on the nematode Caenorhabditis elegans (Brenner 1974, Ellis and 
Horvitz 1986, Ellis et al 1991, Liu and Hengartner 1999, Sulston 1976). The use of C. 
elegans as a model organism has proven to be highly useful for investigating how cell death 
is orchestrated during the development of this 1090-cell organism because the autonomous 
cell deaths of 131 somatic cells were found to happen in a lineage-specific manner and occur 
very precisely. Genetic studies of defined single-gene mutation have revealed several genes 
involved in the active process of apoptosis. Some of these genes are ced-3, ced-4, and ced-9. 
Those genes encode the proteins Ced-3, Ced-4 and Ced-9 (Cell death abnormal 3, 4 and 9) 
respectively, and they are the central regulators of apoptosis in C. elegans (Fig. 4). In healthy 
cells, the pro-apoptotic Ced-4 is kept inactive by its association with the anti-apoptotic Ced-9 
(Shaham and Horvitz 1996). However, under specific developmental cues, egl-1 gene is 
expressed and the binding of Egl-1 (egg-laying defective) antagonises the anti-apoptotic Ced-
9 thereby releasing the pro-apoptotic Ced-4 from the complex (Chen et al 2000). The released 
Ced-4 in turn activates protease Ced-3 for apoptosis induction (Yang et al 1998a).  
     Mammals, although their signalling pathways are more diverse and not necessarily always 
functionally equivalent, possess homologous genes as C. elegans that are involved in 
apoptosis (Table 2). Egl-1 is homologous to BH3-only proteins of Bcl-2 family members; the 
anti-apoptotic Ced-9 corresponds to anti-apoptotic Bcl-2 family members; the pro-apoptotic 
Ced-4 protein is homologous to the caspase adaptor protein Apaf-1; and Ced-3 is 
homologous to initiator caspases in mammals (Table 2). Complementation study showed that 
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mammalian anti-apoptotic Bcl-2 family members are functional in replacing Ced-9 in C. 
elegans confirming the evolutional conservation of the basic apoptosis pathway (Hengartner 
and Horvitz 1994, Vaux et al 1992). 
Table 2   Evolutionary conservation of cell death proteins between worms and mammals  
Function C. elegans Mammals 
BH3-only Bcl-2 family Egl-1 Bid, Bim, Puma, Noxa, etc 
Anti-apoptotic Bcl-2 family Ced-9 Bcl-2, Bcl-XL, etc 
Caspase Activator Ced-4 Apaf-1 
Initiator caspase Ced-3 Caspase-1, -2, -8, -9 
  
     Although there are mammalian counterparts of apoptotic proteins found in C. elegans, the 
mammalian apoptosis pathway is more complex (Fig. 4). The initial cell death signal is 
received by BH3-only family members of Bcl-2 proteins, such as Bid or Bim in the 
mitochondria-induced pathway of apoptosis (Egl-1 in C. elegans). They then either inhibit 
anti-apoptotic Bcl-2 family members such as Bcl-2 or Bcl-XL (Ced-9 in C. elegans), or 
activate pro-apoptotic Bcl-2 family members such as Bax or Bak (no homologous gene found 
in C. elegans). The pro-apoptotic Bcl-2 family members then activate adaptor proteins to 
form several platforms for cell death depending on the nature of the apoptotic stimuli 
received. This platform, the death inducing signalling complex or the apoptosome for 
example (see later section for more details), activates initiator caspases such as procaspase-8 
or -9 (Ced-3 in C. elegans). These activated initiator caspases in turn activate effector 
caspases such as procaspase-3 or -7 to execute apoptosis. 
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Fig. 4 
General Apoptosis Pathway in C. elegans and Mammals 
C. elegans pathway 
Ced-9 and Ced-4 heterodimerize in healthy cells. Upon reception of an apoptosis signal, 
Egl-1 dissociates the Ced-9/ Ced-4 complex by binding to Ced-9. Released Ced-4 
activates Ced-3 for apoptosis induction.  
Mammalian pathway 
The initial apoptotic signal is received by a BH3-only member of the Bcl-2 family 
proteins, which either inhibit anti-apoptotic members of Bcl-2 family or activate pro-
apoptotic Bcl-2 family members. Activated pro-apoptotic Bcl-2 family proteins then 
activate adaptor proteins to form an initiator caspase-activating platform. Activated 
initiator caspases in turn activate effector caspases for the execution of cell death. 
Figure is adapted from Jin and El-Deiry (Chong et al 2005). 
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2. Caspases: Central Initiators and Executioners of Apoptosis 
     A family of cysteine-dependent aspartate-specific proteases (Caspases) are the main 
initiators and executioners of apoptosis (Alnemri et al 1996, Martin and Green 1995). Their 
activation is one of the major hallmarks of apoptotic cell death. Caspases use a cysteine 
residue as the nucleophilic group for substrate binding and cleave a peptide bond C-terminal 
to an aspartate residue (Stennicke and Salvesen 1998). The study of caspases originated from 
the discovery of the cell death-inducing gene ced-3 in C. elegans, whose mammalian 
homologue is interleukin-1β converting enzyme (ICE or caspase-1 (Xue et al 1996, Yuan et 
al 1993)), which has 28% sequence identity with a complete conservation of the active 
pentapeptide sequence to Ced-3. ICE (caspase-1) was initially studied based on its 
involvement in the 31kDa cytokine pro-interleukin-1β cleavage to produce the 17kDa mature 
interleukin-1β (Cerretti et al 1992, Thornberry et al 1992) that mediates an inflammatory 
response. This protein, however, was later found to be sufficient for the induction of 
apoptosis in mammalian cells (Stennicke and Salvesen 2000, Yuan et al 1993). A number of 
caspases were subsequently discovered. 
2.1 Classification of Caspases 
     Numerous caspases have been identified in mammals and they can be classified depending 
on their sequence similarities, functions, structures, and substrate preferences. The 
phylogenetic tree of the fourteen mammalian caspases is shown in figure 5.  
     Although the family of these proteases function as central initiators and executioners of 
apoptosis, some of them (Caspase-1, -4, -5, -13, -14 and murine caspase-11, -12) are involved 
in the procession of pro-inflammatory cytokines and in mediating the inflammatory responses. 
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The rest of caspases (Caspase-2, -3, -6, -7, -8, -9 and -10) are involved in the processes of cell 
death (Fig. 5). Those caspases can be further subdivided into two groups: initiator caspases 
(Caspase-2, -8, -9 and -10) and effector caspases (Caspase-3, -6 and -7). The initiator 
caspases first receive death signals and get activated in a caspase-activating signalling 
complex. Activation of effector caspases is dependent on activated initiator caspases and it is 
the effector caspases that execute apoptosis. 
     Structurally all caspases contain a highly homologous protease domain (Fig. 5), which 
consists of a ~18kDa large subunit (p18) and a ~10kDa small subunit (p10). In addition to the 
protease domain, some caspases also possess large prodomains (Fig. 5). For effector caspases, 
this prodomain is a short stretch of amino acids (~30 amino acids). On the contrary, initiator 
caspases and some cytokine-activating caspases feature long prodomains (>100 amino acids) 
containing either two “Death Effector Domain (DED)“ (Caspase-8 and -10) or one “Caspase 
Recruiting Domain (CARD)” (Caspse-2 and -9 (Boldin et al 1996, Fernandes-Alnemri et al 
1996, Muzio et al 1996)), which mediate homotypic interactions between upstream adaptor 
molecules that also contain either DED or CARD domains (Ashkenazi and Dixit 1998, 
Hofmann et al 1997).  
     Since the proteolytic cleavage mediated by caspases generally occur at the C-terminal of 
an aspartate residue, the presence of this amino acid is crucial and its mutation greatly 
reduces or abrogates the caspase recognition (Howard et al 1991, Sleath et al 1990). However, 
it was also found that at least three amino acids positioned N-terminal to this aspartate 
residue are important for substrate cleavage (Cohen 1997, Humke et al 1998, Mittl et al 1997, 
Rotonda et al 1996, Thornberry et al 1997, Van de Craen et al 1997, Walker et al 1994, 
Wilson et al 1994). The various caspases, regardless of their structure or function, have a high 
preference for those three amino acids (Fig. 5). One of the preferred sequences is DEVD 
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(aspartic acid-glutamic acid-valine-aspartic acid), which is preferentially used by Caspase-3 
and -7; VEHD (valine-glutamic acid-histidine-aspartic acid) targeted by Caspase-6, -8 and -
10; DEHD (aspartic acid-glutamic acid-histidine-aspartic acid) is used by Caspase-2; and 
W/LEHD (tryptophan/leucine-glutamic acid-histidine-aspartic acid) recognized by Caspase-1, 
-4, -5 and -9 (Thornberry et al 1997).  
 
 
 
 
2.2 Activation of Caspases 
Fig. 5 
Classification of Caspases 
Caspases can be classified by their i) sequence homology, ii) function, iii) structure, or iv) 
substrate preference. The phylogenetic tree of 14 representative mammalian caspases is 
shown on the left (mcaspase-11 and -12 are murine caspases). The caspases are divided into 
caspases involved in cytokine activation and apoptosis. Caspases involved in apoptosis can 
be further subdivided into effector and initiator caspases. All caspases contain a protease 
domain, which consists of large and small subunit. Initiator caspases and some cytokine-
activating caspases possess long prodomains of either DED or CARD. Caspases also have 
different preferences for the tri-amino acids N-terminal to the aspartic acid residue. 
Figure is adapted from Thornberry et al (Thornberry et al 1997). 
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2.2 Activation of Caspases 
     Caspases are not produced as an active enzyme from mRNA but are rather synthesised as 
an inactive pro-enzyme (zymogen). Therefore they require to be activated. The methods of 
activation for initiator and the effector caspases are different but the basic processes of 
activation follows similar steps and are outlined below (Fig. 6). A procaspase contains a 
prodomain and two subunits of the protease domain (the large p18 and small p10 subunits) as 
described above. Within a large subunit, there is a conserved pentapeptide activation motif 
(QACXG where X is R, Q or G) that contains the active cysteine residue, which is required 
for caspase binding. During the first stage of activation, the aspartate residue that flanks a 
large and small subunit is cleaved to produce two fragments: prodomain with the large 
subunit and the small subunit (Thornberry et al 1997). Following the first cleavage, the bond 
after the aspartate residue that separates the prodomain and the large subunit is cleaved. Then, 
the separated large and small subunits interact to form a pro-active heterodimerized enzyme 
bearing one active site. This heterodimer subsequently homodimerizes to form a fully mature 
active caspase. Thus, an active caspase is a heterotetramer containing two active sites (Wolf 
and Green 1999). The active initiator caspases (caspase-2, -8, -9 and -10) then trans activate 
effector caspases-3, -6 and -7 (Fernandes-Alnemri et al 1996, Muzio et al 1997, Orth et al 
1996, Stennicke et al 1998, Yang et al 1998c). 
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     The activation of initiator caspases were previously thought to occur by autoproteolytic 
activation by caspases. Two caspases that come into close proximity activate each other by 
self cleavage (known as “induced proximity model” (Ashkenazi and Dixit 1998, Martin et al 
1998, Muzio et al 1998, Yang et al 1998b)). However, recently this model was refined to the 
Fig. 6  
Mechanism of Caspase Activation 
Caspases are produced as an inactive zymogen. The first cleavage separates the small sub-unit 
of protease domain from the pro-domain and the large sub-unit. Then the second cleavage 
occurs to separate the pro-domain and the large sub-unit resulting in the production of three 
fragments. Small and large sub-units from the protease domain associate to form a pro-active 
heterodimer. This heterodimer then dimerizes to form a mature active caspase, which is a 
heterotetramer containing two active sites. 
Figure is adapted from thesis of Dr. Anne-Laure Mahul-Mellier 
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“proximity-induced dimerization model” as explained in figure 6. In this model, initiator 
caspases are recruited to a protein complex which serves as a platform for the caspase 
activation that harbours either a “death effector domain (DED)” or another homotypic protein 
interaction module called “caspase recruiting domain (CARD)” (refer to section 3 of the 
introduction for more detail) (Thornberry and Lazebnik 1998). The initiator procaspase-8 or -
10 are mainly activated at the plasma membrane within a complex known as death inducing 
signalling complex (DISC) (Varfolomeev et al 1998). The FADD adaptor protein in this 
complex contains the DED domain. The initiator procaspase-9, on the other hand, cannot be 
activated at this complex as procaspase-9 does not possess any DED. Instead, procaspase-9 is 
activated within a platform known as apoptosome, which is a protein complex of cytochrome 
c, CARD containing Apaf-1 and procaspase-9 (Hakem et al 1998, Kuida et al 1998). Effector 
caspases (procaspase-3, -6 and -7) are primarily activated by initiator caspases thereby 
establishing a cascade of caspase-dependent caspase activation.  
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2.3 Substrates of Caspases 
     Caspases mediate and orchestrate apoptotic signalling pathways by cleaving cellular 
proteins. There are over two hundreds caspase substrates identified to date and those include 
cell cycle-related proteins (such as the retinoblastoma protein), DNA repair proteins (such as 
poly ADP-ribose polymerase (Nicholson et al 1995, Tewari et al 1995)), structural proteins 
(such as nuclear lamins) and apoptotic proteins (Degterev et al 2003). One of the most 
prominent substrates of caspase are caspase themselves. Effector caspases are activated by 
the cleavage mediated by the initiator caspases (see section 2.2 of the introduction). The most 
important effector caspase is caspase-3 and the characteristics of apoptotic cells including 
DNA degradation, mitochondrial dysfunctioning, membrane blebbing and cell detachment 
are manifested mainly by caspase-3 cleavage of cellular protein substrates. However, 
caspase-6 and -7 share some substrates with caspase-3 and therefore the loss of caspase-3 can 
in part be compensated (Zheng et al 2000). 
     One of the most well characterized substrates is poly-ADP-ribose polymerase (PARP). It 
functions as one of the key DNA repair enzymes. The cleavage of PARP produces a 89kDa 
catalytic domain and a 24kDa DNA-binding domain (Kaufmann et al 1993). The 
conservation of the 89kDa catalytic domain allows cells to utilise ATP during the execution 
phase of apoptosis (Takahashi and Earnshaw 1996). However, the cleavage has been shown 
to interfere with the functionality of PARP as a DNA repair enzyme. Thus, the cleavage of 
PARP maintains its function to produce energy but loses its function as a DNA repair enzyme. 
The procession of PARP is a direct indicator of apoptosis and the activation of caspase-3. 
     Almost all apoptotic cells undergo DNA degradation and this feature is manifested by 
caspase-3. Caspase-activated DNase (CAD) and 40kDa DNA fragmentation factor (DFF) is 
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complexed with inhibitor of CAD (iCAD) and 45kDa DFF (DFF45) in healthy, non-apoptotic 
cells. However, iCAD/DFF45 inhibition of CAD/DFF40 is abrogated by the cleavage of 
iCAD induced by caspase-3, which allows the exposure of the catalytic domain of this DNase, 
which then cleaves A/T-rich regions of DNA to produce 50-200kbp DNA fragments (Enari et 
al 1998, Liu et al 1997, Sakahira et al 1998).  
     A 75kDa mitochondrial respiratory complex I protein, NADH dehydrogenase ubiquinone 
Fe-S protein 1 (NDUS1), is another important substrate of caspases. Caspase cleavage of 
NDUS1 is related to the dysfunctioning of mitochondria including outer mitochondrial 
membrane permeabilisation, disruption of the electron transport chain for ATP production 
and the production of reactive oxygen species (Ricci et al 2004).  
     A number of pro-apoptotic kinases are substrates of caspases. A Rho-associated coiled-
coil containing protein kinase 1 (ROCK1) was reported to be a substrate of caspases and its 
cleavage was observed in response to tumour necrosis factor (TNF) treatment. The cleaved 
ROCK1 was shown to be both necessary and sufficient to induce membrane blebbing of a 
cell (Coleman et al 2001). Another kinase, p21-activated kinase 2 (PAK2) is also cleaved by 
caspase-3 and reported to contribute to the formation of apoptotic bodies (Lee et al 1997, 
Rudel and Bokoch 1997).  
     As well as apoptotic proteins, cleavage of structural proteins contributes to the 
morphological characteristics of apoptotic cells. Cleavage of fodrin and gelsolin, for example, 
lead to a disruption of actin filament networks, which results in the loss of cell shape and 
detachment from the matrix (Kothakota et al 1997, Martin et al 1995a). Some adherent 
junction proteins, β-catenin and plakoglobin γ-catenin, that connect neighbouring cells are 
cleaved by caspases, too. Their cleavage disrupts the cell-cell communication thereby leading 
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to cell detachment in the tissues (Schmeiser et al 1998). The cleavage of nuclear lamin A and 
C is reported to be involved in nuclear condensation observed during apoptosis (Lazebnik et 
al 1995, Rao et al 1996, Takahashi et al 1996). 
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2.4 Inhibitors of Caspases 
2.4.1 Inhibitor of Apoptosis Proteins 
     The activation of caspases is regulated under tightly controlled conditions but cells also 
harbour natural negative regulators of caspases. Several such inhibitors have been identified 
from viruses to humans (Deveraux et al 1998, Irusta et al 2003, LeBlanc 2003, Tamm et al 
1998, Uren et al 1996), such as, crmA (Ray et al 1992), p35 (Zhou et al 1998), v-FLIP 
(Thome et al 1997) and inhibitor of apoptosis proteins (IAPs). The first IAP was described in 
Baculovirus where one of the viral proteins protected infected cells from undergoing 
apoptosis and enhanced viral replication (Uren et al 1998). In human, eight IAPs have been 
identified to date among them XIAP (Deveraux et al 1997), c-IAP1 (Roy et al 1997), c-IAP2 
(Roy et al 1997), Survivin (Ambrosini et al 1997), NAIP (neuronal apoptosis inhibitory 
protein (Liston et al 1996)) and BRUCE (BIR repeat containing ubiquitin-conjugating 
enzyme). All human IAPs contain at least one ~70 amino acid-long conserved motif of the 
BIR (Baculovirus IAP repeat) domain at the N-terminus (Table 3 and Fig. 7) (Salvesen and 
Duckett 2002).  
     Although IAPs are identified as apoptosis inhibitors, XIAP is the only IAP that can 
directly bind to caspases (caspase-3, -7 and -9) to inhibit apoptosis (Eckelman et al 2006) and 
other IAPs, such as cIAP1 and cIAP2 are inefficient in binding caspases directly in vitro. The 
linker region between BIR1 and BIR2 domain of XIAP enables the direct binding to the 
protease catalytic core of active caspase-3 and -7 allowing to hinder the substrate entry (Chai 
et al 2001, Huang et al 2001, Riedl et al 2001, Silke et al 2001, Suzuki et al 2001). The 
mechanism through which XIAP inhibits caspase-9 occurs differently. Unlike for caspase-3 
or -7, XIAP does not inhibit activated caspase-9 but rather it reduces the level of caspase-9 
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activation by keeping caspase-9 in a monemeric, inactive state via BIR3 domain (Shiozaki et 
al 2003, Srinivasula et al 2001). On the contrary, cIAP1 and cIAP2 function to suppress 
apoptosis via its function as a E3 ubiquitin ligase to modulate NF-κB signaling for example 
(see introduction section 3 for more detail).  
Table 3    Structures of human IAPs 
Protein Number of BIR domain Presence of RING domain 
XIAP 3 Yes 
c-IAP1 3 Yes 
c-IAP2 3 Yes 
Survivin 1 No 
NAIP 3 No 
BRUCE 1 No 
 
 
 
 
 
 
Fig. 7  
Inhibitor of Apoptosis Proteins (IAPs) 
Some of the human IAP family members are shown. IAPs are characterized by the 
presence of at least one BIR domain. Some also contain a RING finger domain for the E3 
ligases activity. cIAP1 and cIAP2 possess CARD domain for the caspase binding to inhibit 
their activity. NACHT (nucleotide binding domain) and LRR (leucine-rich domain) are 
other protein-protein interaction domains. 
Note that the number on top right corner of each IAP indicates the length of the proteins. 
Figure adapted from Reed  et al. (Reed et al 2004). 
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2.4.2 Inhibitors of IAPs 
     IAPs work to inhibit the activity of caspases, however, there are also proteins that bind to 
and inhibit the activities of IAPs. Procaspase-9 is activated in a protein complex, the 
apoptosome, which consists of procaspase-9, an adaptor protein Apaf-1 and mitochondria-
released protein cytochrome c (Fig. 8 I). In some cases, this activation or the activated 
caspase is inhibited by IAPs as discussed above (Fig. 8 II). However, together with 
cytochrome c, two proteins are also released from mitochondria, Smac/Diablo (second 
mitochondria derived activator of caspase/direct IAP binding protein with low PI (Du et al 
2000, Verhagen et al 2000)) and Htra2 (high temperature requirement protein 2)/Omi (van 
Loo et al 2002), and help activate caspases by suppressing the activity of IAPs (Fig. 8 III and 
IV). Both Smac/Diablo and Omi/Htra2 have a tetrapeptide IAP binding motif (IBM), alanine-
valine-proline-isoleucine (AVPI). The monomer of Smac/Diablo displaces caspase-9 from 
the IAPs by utilising an IBM similar to that of caspase-9 (Fig. 8 III). A dimerized 
Smac/Diablo binds to the BIR2 domain of XIAP leading to the activation of procaspase-3 by 
caspase-9 (Fig. 8 IV). It was found that Smac/Diablo can suppress the E3-ligase activity of 
XIAP as well (Creagh et al 2004). Therefore Smac/Diablo functions to promote the activation 
of procaspases by freeing the IAP bound caspases and by inhibiting IAPs (Fig. 8 (Chai et al 
2000, Ekert et al 2001, Suzuki et al 2001, Wu et al 2000)).  
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Fig. 8 
Mechanism of IAP Inhibition 
Mitochondria-released cytochrome c associates with Apaf-1 to form an apoptosome for 
procaspase-9 activation, which in turn results in the activation of downstream effector 
caspases (I). However, IAPs can bind to caspase-9 and inhibit its activity, thus suppressing 
the effector caspases activation (II). Another mitochondria-released protein, Smac/Diablo, 
can bind and antagonise the activity of IAPs. Monomers of Smac/Diablo bind to IAPs and 
this releases caspase-9 for the downstream effector caspases activation (III). Dimerized 
Smac/Diablo can bind to the BIR2 domain of XIAP and inhibits XIAP activity (IV). 
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3. Two Main Pathways of Apoptosis: Extrinsic and Intrinsic Pathway 
     Apoptotic pathways involve many proteins that are required to orchestrate complex 
signalling pathways. Two major pathways that lead to the activation of caspases and the 
induction of cell death are known: the extrinsic and intrinsic pathway. These two pathways 
share a basic signalling cascade: the initiation phase, the integration/decision phase and the 
execution phase. The initial reception of the apoptotic signal is highly heterogeneous and 
depends on the nature of the death-inducing signals. In the extrinsic pathway, it is the ligand 
ligation to a death receptor and in the case of the intrinsic pathway, it is damage inflicted on a 
cellular organelle (nucleus, endoplasmic reticulum, lysosomes, Golgi apparatus or 
mitochondria). The integration/decision phase involves the formation of a caspase-activation 
complex and caspase activation. Cells then pass the point of no return and are destined to die. 
In the last phase, morphological and biochemical changes occur due to the cleavage of 
cellular proteins by caspases. The major difference between the two pathways is the initial 
reception of the death signals. The extrinsic pathway often receives its first apoptotic signal at 
plasma membrane receptors, whereas BH3-only proteins of the Bcl-2 family usually sense 
the signals in the intrinsic pathway. 
3.1 Extrinsic Pathway 
    As mentioned the extrinsic pathway or the death receptor-dependent pathway of apoptosis 
first receives its signal from plasma membrane receptors (Ashkenazi and Dixit 1998). These 
receptors belong to the tumour necrosis factor (TNF) receptor superfamily and are 
characterized by the presence of two to five copies of cysteine-rich extracellular repeats. This 
superfamily includes Fas (also known as Apo-1 or CD95), TNF-receptor-1 (TNF-R1), death 
receptor-3, TNF-related apoptosis inducing ligand receptor-1 (TRAIL-R1), TRAIL-R2 and 
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death receptor 6. The TNF-R1 mediated and the Fas receptor mediated pathways are most 
intensively studied. 
3.1.1 Fas Receptor Mediated Extrinsic Pathway 
     Fas is a heavily glycosylated 40-45kDa protein involved in cytotoxic T-cell mediated 
killing. The Fas receptor homotrimerizes at the plasma membrane similar to the TNF-R1 
(Ashkenazi and Dixit 1998, Pitti et al 1996, Smith et al 1994). Ligation of Fas ligand to the 
Fas receptor forms a platform for the caspase activation known as “death inducing signalling 
complex (DISC)” via the DD of the Fas receptor (Fig. 10, Fas receptor mediated pathway 
(Boldin et al 1995, Chinnaiyan et al 1995, Kischkel et al 1995, Nagata 1997)). The adaptor 
protein FADD is first recruited to the Fas-receptor, and the DED of the FADD allows the 
association of procaspase-8 or -10 (Chinnaiyan et al 1995, Medema et al 1997). The 
formation of DISC quickly increases the local concentration of procaspases, which in turn 
become mature, active caspases (Boatright et al 2003, Donepudi et al 2003, Walczak and 
Krammer 2000). Activated caspase-8 or -10 then activate downstream effector procaspases 
such as procaspases-3 or -7 (Stennicke et al 1998), and the activated caspase-3 or -7 execute 
apoptosis by substrate cleavage (Fig. 10).  
     Another protein cFLIP (cellular FADD-like ICE inhibitory protein) negatively regulates 
death-receptor mediated apoptosis (Fig. 10, (Hu et al 1997, Irmler et al 1997, Srinivasula et al 
1997)). Two isoforms of cFLIP, cFLIPS and cFLIPL, have been identified (Inohara et al 1997, 
Irmler et al 1997). Both isoforms contain tandem repeats of death effector domains that are 
highly homologous to that of procaspase-8. In addition to the tandem repeats of DED, cFLIPL 
possesses inactive (due to mutations in the catalytic domain) protease-like domain similar to 
that of procaspase-8. The presence of this domain allows cFLIPs to be also recruited to the 
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DISC (Krueger et al 2001). However, since both isoforms of FLIPs do not have any protease 
activity, they act as a competitive antagonist of procaspase-8 at the DISC to inhibit the 
maturation of procaspase-8 for apoptosis induction. 
3.1.2 TNF Receptor Mediated Extrinsic Pathway 
     The tumour necrosis factor (TNF) is a multifunctional pro-inflammatory cytokine mainly 
produced by macrophages. TNF is involved in the progression of many diseases such as 
rheumatoid arthritis and Crohn’s disease and the inhibitor of TNF is used for therapeutic 
purposes.  
     On the plasma membrane, TNF-R1 forms, upon binding to its ligand, a homotrimer and 
each protein contains a death domain (DD) facing the cytosol. This DD is used to recruit 
several adaptor proteins to form a death-inducing signalling complex (DISC) leading to the 
activation of initiator caspases upon binding of TNF to the TNF-R1. However, in the absence 
of TNF, the receptor is bound to “silencer of DD” (SODD), which inhibits the recruitment of 
the adaptor proteins for caspase activation thus acting as a negative regulator of apoptosis 
(Fig. 10, TNF receptor mediated pathway (Jiang et al 1999)). In the presence and upon 
binding of TNF to its receptor, SODD dissociates from the TNF-R1 complex allowing the 
exposure of the DD and the recruitment of another DD-containing protein, “TNF-R1-
associated death domain protein” (TRADD) (Fig. 10 (Hsu et al 1995)). There are several 
downstream signaling cascades following the binding of TRADD to TNF-R1 complex. 
3.1.2.1 Complex I Formation 
     One scenario is that the DD of TRADD recruits “receptor interaction protein 1 (RIP1)” 
and “TNF receptor-associated factor-2” (TRAF2 (Chen and Goeddel 2002, Hsu et al 1996)). 
Subsequently TRAF2 recruits cIAP1 and cIAP2. This mult-protein complex is referred to as 
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complex I (Micheau and Tschopp 2003)(Fig. 10, TNF receptor mediated pathway, left). RIP1 
can recruit and associate with “RIP-associated ICH-1/CED-3 homologous protein with death 
domain” (RAIDD) or synonymously known as “caspase and RIP adapter with death domain” 
(CRADD) (Ahmad et al 1997, Duan and Dixit 1997). A domain similar to the caspase 
recruitment domain (CARD) of RAIDD is able to activate initiator procaspase-2 to a mature 
caspase-2 for the induction of cell death (Duan and Dixit 1997). 
     However, the canonical pathway elicit upon the formation of complex I is the activation of 
“nuclear factor-κB (NF-κB)” to promote cell survival (Lin et al 1999). This process is largely 
governed by the activity of cIAPs as an E3 ubiquitin ligase (Bertrand et al 2008, Haas et al 
2009, Mace et al 2010, Varfolomeev et al 2008, Vince et al 2009, Zheng et al 2010). cIAPs 
mediate ubiquitylation of RIP1 to produce linear K63 ubiquitin chain, which stimulate 
ubiquitin-dependent recruitment of the dimeric linear ubiquitin chain assembly. Such 
complex is composed of HOIL1/HOIP, kinase complexes TAK1/TAB2/TAB3 and 
IKKα/IKKβ/NEMO (Bianchi and Meier 2009). In cells, NF-κB is retained in the cytosol by 
the interaction with IκB. However, upon recruitment of IKK complex to the TNF-R1 
signalling complex I, IκB is targeted and phosphorylated by TAK1 kinase for proteolytic 
degradation by the proteasomes. The degradation of IκB releases the heterodimer of NF-κB 
(p55 and p65) and they translocate to the nucleus where they promote the transcription of 
survival genes such as Bcl-2, cFLIPs and cIAPs. Thus ubiquitination mediated by cIAPs 
centrally control the TNF-mediated NF-κB activation and plays a crucial role in protecting 
cells from potentially lethal effects of TNF. In support of this, the loss of both cIAP1 and 
cIAP2 strongly impairs this process and sensitizes cells for apoptosis by predominantly 
favouring the formation of caspase8-activating complex (Bertrand et al 2008, Haas et al 2009, 
Mahoney et al 2008, Varfolomeev et al 2008).  
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3.1.2.2 Complex IIA Formation 
     Complex I indeed serves to protect cells, however, caspase8-activating cytosolic complex 
IIA is also formed after TNF stimulation. Complex IIA is generated upon the detachment of 
complex I from the receptor in a RIP1-dependent manner and associates with “Fas-associated 
death domain” (FADD) via death domain of RIP1. In addition to a death domain, FADD also 
contains death effector domain (DED) for the recruitment of DED-containing initiator 
caspases such as procaspase-8. This procaspase-8 or -10 activating complex is known as 
complex IIA (Fig. 10, TNF receptor mediated pathway, right). This recruitment of 
procaspases results in a temporal elevation of caspase concentration around the TNF-R1, 
which leads to caspase activation (Kim et al 2000a) by the proximity-induced dimerization 
model. This mode of caspase-8 activation is in general inhibited by the upregulation of 
prosurvival genes mediated by NF-κB activation, such as cFLIPL which can antagonize 
caspase-8 to block its maturation. However, in the absence or upon the chemical inhibition of 
cIAPs by Smac mimetics, which induces the auto-ubiquitylation and proteasomal degradation 
of cIAP1 and cIAP2, complex IIA is rapidly formed to induce cell demise. Similarly, co-
administration of TNF and cycloheximide (CHX), which suppresses the transcription of 
cFLIP, leads to the activation of caspase-8. Although the activation of caspase-8 is the 
outcome in both cases, the mechanism of caspase-8 activation is different. Wang et al 
reported that application of Smac mimetics in conjugation with TNF induced autodegradation 
of cIAPs. In the absence of ubiquitin ligase, a protein of opposing function, deubiquitinating 
enzyme (CYLD for RIP1), removes K63 ubiquitin chains from RIP1 resulting in the release 
of RIP1 complex from the complex I to form complex IIA (Wang et al 2008, Bertrand et al 
2008, O'Donnell et al 2007). Furthermore, they have reported TNF and Smac mimetics did 
not alter the protein level of cFLIP although co-treatment of cells with TNF and CHX did 
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reduce basal level of cFLIP (Wang et al 2008). Also the expression of cFLIP potently 
inhibited apoptosis induced by TNF+CHX treatment whereas no inhibitory effect was 
observed when cells were stimulated for Smac mimetics. Lastly, Smac mimetic-induced 
apoptosis is dependent on RIP1 while TNF+CHX-mediated apoptosis was independent of 
RIP1 (Wang et al 2008). Overall, cells seems to harbour different mechanisms of caspase-8 
activation which are dependent on different set of proteins.  
3.1.2.3 Genotoxin-Induced complex I and Complex IIA Formation 
     Cells are capable of maintaining genomic integrity despite the frequent exposure to 
exogenous or endogenous insults throughout life. Such stability is achieved by DNA-damage 
response, which prevents adverse cellular homeostatic dysregulation such as malignancy. 
One of the topoisomeraze II inhibitors, etoposide, which induces a double-stranded breaks 
has recently been shown to provoke a prosurvival NK-κB activation through complex I 
whereas at high concentration, TNF autocrine positive feedback allowing the formation of 
complex IIA leading to apoptosis (Biton and Ashkenazi 2011). Low DNA damage caused by 
etoposide elicit DNA-damage response, which transmits signals to NEMO in a ATM-
dependent (ataxia telangiectasia mutated) fashion. NEMO subsequently interacts with IKKα, 
IKKβ and RIP1 to induce the NF-κB activity independent of RIP1 kinase activity or the 
TNFR for the cell survival (Biton and Ashkenazi 2011, Karin and Lin 2002, Karin 2006, Luo 
et al 2005, Rashi-Elkeles et al 2006). On the contrary, with the extensive DNA double-
stranded breaks, the activity of ATM is sustained resulting in the continuous NF-κB 
activation and positive feedback loop for TNF production. Exessive TNF production causes 
TNFR-mediated formation of complex IIB resulting in the activation of caspase-8 and 
apoptosis (Biton and Ashkenazi 2011). Thus the data presented indicate NEMO/RIP1 act as a 
molecular switch to decide the fate of cells. 
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3.1.2.4 TNF-Induced Caspase-Independent Programmed Necrosis (Necroptosis): 
Formation of Complex IIB 
     Necrosis, marked by the cellular/organeller swelling accompanied with the formation of 
intracellular vacuoles and the rapid rupture of plasma membrane, has been considered to 
occur only upon trauma. It is although ironically also true that TNF was first recognized to 
induce necrosis in 1970s (Carswell et al 1975). However, as dipicted above, the mechanism 
of TNF-induced NF-κB activation and the caspase-8 activation have been the central focus 
until recently. In 2000 Holler et al reported that Jurkat T cells deficient in FADD or caspase-8 
treated with death cytokines (TNF, FasL and TRAIL) induced necrotic cell death in RIP1-
dependent manner (Holler et al 2000) indicating that the death cytokines are capable of 
inducing cell death independent of caspase-8 (complex IIA). Furthermore, they have shown 
even wild type cells are capable of undergoing necrosis in a presence of pan-caspase inhibitor 
zVAD-fmk upon death cytokine treatment (Holler et al 2000). RIP1 is required for the 
prosurvival signaling initiated by TNF to activate NF-κB yet necrotic cell demise originated 
by TNF also depends on RIP1. The only difference seems that NF-κB activation does not 
involve the kinase activity of RIP1 whereas kinase function of RIP1 is crucial in mediating 
programmed neccrosis or also termed as necroptosis. Chan et al. showed that the kinase 
inactive form of RIP1 or reconstituting RIP1
-/-
 cells with inactive RIP1 failed to restore TNF-
induced programmed neccrosis (Chan et al 2003, Holler et al 2000). Moreover, the addition 
of necrostatin-1, inhibitor of RIP1, abrogated the TNF-induced programmed necrosis (He et 
al 2009). Recent genome-wide siRNA screen to identify factors controlling programmed 
necrosis indicated that another recepter interaction protein, RIP3, critically determines this 
process (Cho et al 2011, Cho et al 2009, He et al 2009, Zhang et al 2009, Zhang et al 2011). 
RIP3 unlike RIP1 does not possess death effector domain but it contains one kinase domain 
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and one RHIM (RIP homotypic interaction motif) for the heterodimerization between RIP1. 
During programmed necrosis, RIP1 and RIP3 dimerize to form a pro-necrotic complex 
termed as Complex IIB and both RIP1 and RIP3 are phosphorylated which stabilizes the 
complex (Cho et al 2009, He et al 2009). Although TNFR-expressing Jurkat T cells 
underwent both apoptosis and programmed necrosis dependent on complex IIA and IIB, 
caspase inhibition dramatically enhanced the programmed necrosis (Chan et al 2003, Cho et 
al 2009, Zheng et al 2006). Such sensitizing effect was partly due because both RIP1 and 
RIP3 are substrates of caspase-8 (Feng et al 2007, Zheng et al 2006). Overall, these indicate 
that TNF can cause apoptosis in caspase-dependent way while the inhibition of caspases tilt 
cells to induce programmed necrosis.  
3.1.2.5 Caspase-8 Regulation of Programmed Necrosis 
     Caspase-8 is best known for its proapoptotic function, however, knockout of caspase-8 
leads to the embryonic lethality in mice at E10.5 (Varfolomeev et al 1998) indicating its 
prosurvival activity. Moreover, caspase-8 is required for T-lymphocyte activation and 
resistance (Salmena et al 2003) to programmed necrosis induced by death ligands (Holler et 
al 2000, Vercammen et al 1998). Similarly, genetic ablation of FADD (Yeh et al 1998) or 
FLIP (Yeh et al 2000) result in a similar embryonic lethality at E10.5. This observation 
agrees with the report showing downregulation of caspase-8 by siRNA can sensitize cells for 
RIP1- and RIP3-dependent programmed necrosis in response to TNF (Vercammen et al 
1998). This led to a hypothesis that caspase-8 acting as a prosurvival factor to suppress 
RIP1/RIP3-mediated programmed necrosis during embryonic development. Indeed Oberst et 
al showed that the genetic ablation of caspase-8 caused embryonic lethality while double 
knockout of caspase-8 and RIP3 rescued the phenotype (Oberst et al 2011). However one 
conundrum is how caspase-8 can inhibit programmed necrosis without engaging itself into 
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apoptotic cell death. Since complex IIA is formed upon TNF treatment and caspase-8 is 
generally inhibited by its association with cFLIPL, it should allow the formation of 
RIP1/RIP3 pro-necrotic complex IIB to induce necrotic cell death. An important clue came 
when mutant of caspase-8 lacking cleavage site between the large and small subunits of the 
mature enzyme, which rendered unable to induce apoptosis (Hughes et al 2009, Oberst et al 
2010), rescued the phenotype of caspase-8-deficient animal (Kang et al 2008) indicating the 
dual activity of caspase-8. More definitive answer came by the publication by Oberst et al. 
They showed the heterodimerization of this non-cleavable form of caspase-8 was 
catalytically active when dimerized with FLIPL (Oberst et al 2011). Cells lacking RIP3 
underwent cell death by apoptosis upon TNF treatment only if they expressed wile-type 
caspase-8 in the absence of FLIPL, resulting in the engagement of complex IIA activation 
(Oberst et al 2011). However, cells expressing RIP3 underwent programmed necrosis when 
caspase-8 was absent or catalytically inactive caspase-8 was expressed upon TNF 
administration whereas cleavage-resistant form of caspase-8 made RIP3
+/+
 cells resistant to 
TNF-induced programmed necrosis and was only reverted in the absence of FLIPL (Oberst et 
al 2011). Overall, the expression of FLIPL inhibits caspase-8-dependent apoptosis by 
competitively binding to this protease while allowing the conformational change to expose 
catalytic core so that the proteins proximal to complex IIA, such as RIP3 and/or RIP1 can be 
cleaved to hinder the programmed necrosis (Oberst et al 2011, Pop et al 2011).  
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3.2 Intrinsic Pathway 
3.2.1 Bcl-2 Family Members 
     Bcl-2 was first identified as a proto-oncogene by a common translocation in human 
follicular B-cell lymphoma (Bakhshi et al 1985, Cleary et al 1986, Tsujimoto et al 1985) and 
the overexpression of Bcl-2 in transgenic animal models mimicked the human disease 
(McDonnell et al 1989, McDonnell and Korsmeyer 1991). Unlike other proto-oncogenes that 
promote cell proliferation to produce cancer, Bcl-2 was found to promote cell growth by 
inhibiting cell death induced by multiple physiological and pathological stimuli (Hockenbery 
et al 1990, Kinloch et al 1999, Vaux et al 1988). There are over twenty Bcl-2 family members 
identified and examples are shown in Table 4. Ced-9 is the homolog of Bcl-2 in C. elegans 
(Fig. 4 (Hengartner et al 1992, Hengartner and Horvitz 1994)) and viral homologues of Bcl-2 
have been also identified in Epstein-Barr virus (BHRF1 (Cleary et al 1986)), adenovirus 
(E1B 19K (Boyd et al 1994, Chiou et al 1994, Rao et al 1992, White et al 1992)) and African 
swine fever virus (LMW5-HL (Neilan et al 1993)). The sequence alignment of Bcl-2 family 
members revealed that they share at least one of the four conserved Bcl-2 homology domains 
(BH domain) and often contain transmembrane domain (TM) at the C-terminus for 
membrane anchorage (Fig. 9). The Bcl-2 family members can be divided into three groups: 
anti-apoptotic, pro-apoptotic and BH3-only pro-apoptotic (Table 4 and Fig. 9). The anti-
apoptotic members, such as Bcl-2 and Bcl-XL (Boise et al 1993), contain all four BH domains 
(BH1, BH2, BH3 and BH4 domains, Fig. 9). The pro-apoptotic members, Bax (Oltvai et al 
1993) and Bak (Chittenden et al 1995, Farrow et al 1995, Kiefer et al 1995) for example, 
contain only three BH domains (BH1, BH2 and BH3 domains, Fig. 9). Lastly, BH3-only 
members, such as Bim and Bid, possess only one BH domain (BH3 domain, Fig. 9) and act 
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as pro-apoptotic factors either by suppressing the activity of anti-apoptotic Bcl-2 family 
members or by activating/promoting the activity of pro-apoptotic members of Bcl-2 family 
members.  
Table 4   Bcl-2 family members 
Anti-apoptotic members   
 Bcl-2 Bcl-XL Bcl-W Bfl-1 
 Boo/Diva Mcl-1 Bcl-B  
     
Pro-apoptotic members   
 Bax Bak Bok  
 Bfk Bcl-XS   
     
BH-3 only pro-apoptotic   
 Bim Bik Bad Bim 
 Puma Noxa Bmf Nip3 
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     Bcl-2 is a 26kDa protein localized to mitochondria (Hockenbery et al 1990), the 
endoplasmic reticulum (ER) and other perinuclear membranes (Korsmeyer 1995). It is 
involved in the maintenance of mitochondrial membranes, balances the interaction between 
other members of Bcl-2 family members such as Bax, and calcium homeostasis in the ER. 
Together with other anti-apoptotic Bcl-2 family members, Bcl-2 works to prevent the release 
of cytochrome c from mitochondria, and thereby promotes cell survival. Detailed three 
dimensional studies of monomeric Bcl-XL have proven that the BH1, BH2 and BH3 domains 
are in close proximity to form a hydrophobic groove (Fesik 2000, Hengartner 2000, 
Muchmore et al 1996, Sattler et al 1997) that can accommodate the BH3 domain of the pro-
apoptotic Bcl-2 family members thus inhibiting their activation (Kluck et al 1997, Yang et al 
1997).  
     On the contrary, pro-apoptotic members promote the release of cytochrome c from 
mitochondria, and this decision is regulated by the ratio between anti-apoptotic and pro-
apoptotic Bcl-2 members present in the cell (Danial and Korsmeyer 2004). Bax was the first 
pro-apoptotic member of Bcl-2 family to have identified through its interaction with Bcl-2 
(Oltvai et al 1993). In accordance with its pro-apoptotic function, knock-out mouse model 
showed a selective expansion of cell population leading to a lymphoid hyperplasia (Knudson 
et al 1995). In the inactive state, Bax is localized largely in the cytosol as a monomer 
although some are loosely attached to the outer mitochondrial membrane. Upon reception of 
Fig. 9 
Bcl-2 Family Members 
Bcl-2 family members can be divided into three functional groups: anti-apoptotic, pro-
apoptotic, and proapoptotic BH3-only. Their functions vary but at least one of the Bcl-2 
homology domains (BH domain) is present in all members. Anti-apoptotic members contain 
all four BH domains (BH1, 2, 3 and 4) whereas pro-apoptotic members possess only three BH 
domains (BH1, 2 and 3). Many family members also contain a transmembrane domain for 
membrane anchorage. 
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apoptosis signals, however, Bax undergoes an allosteric conformational change and gets 
inserted to the outer mitochondrial membrane (OMM (Desagher et al 1999)). The activated 
Bax then undergoes homooligomerization (Gross et al 1998) or heterooligomerization with 
Bak, another pro-apoptotic Bcl-2 member. This oligomerization has been postulated to form a 
pore to allow the release of inner mitochondrial space proteins (discussed later in detail). The 
double knockout of Bax and Bak makes cells resistant to almost all the death-stimuli for the 
intrinsic pathway of apoptosis (Lindsten et al 2000, Wei et al 2001), and in fact, these 
proteins together constitute a required gateway for the intrinsic pathway operative in 
mitochondria (Wei et al 2001) and in the ER (Scorrano et al 2003). BH-3 only members 
trigger apoptosis in response to various stimuli by acting as upstream sentinels, which 
selectively respond to specific signals by first receiving the death signals and transmitting 
them to other members of Bcl-2 family proteins (Cheng et al 2001). BH3-only members 
alone, however, are insufficient to induce apoptosis (Cheng et al 2001, Zong et al 2001). 
3.2.2 Intrinsic Pathway 
     The intrinsic pathway or the mitochondria-dependent pathway of apoptosis is initiated by 
various stimuli such as growth factor deprivation, calcium flux, UV irradiation or treatment 
with chemotherapeutic drugs but all of these signals converge on mitochondria (Fig. 10 
(Green et al 2004)) for the induction of mitochondrial outer membrane permeabilisation 
(MOMP (Green and Kroemer 2004)). Details of the induction of MOMP will be discussed in 
later sections, but the activation of Bax seems to be fundamentally required for the MOMP 
and the signalling cues for the activation of the intrinsic pathway promote such activation by 
either directly enhancing Bax activation or by modulating/inhibiting the activity of anti-
apoptotic Bcl-2 family members, such as Bcl-2 or Bcl-XL (Fig. 10).  
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     The withdrawal of growth factors or the deprivation of cytokine activities, for example, 
inactivates PKB/AKT (protein kinase B/Rac-alpha serine/threonine-protein kinase (Datta et 
al 1997)). The inactivation of these kinases de-phosphorylates inactive Bad and activates it 
(Zha et al 1996). It is then able to inhibit the anti-apoptotic Bcl-2 and Bcl-XL, as well as 
promote Bax activation. Similarly, chemotherapeutic drugs signal and act on the transcription 
factor p53 to promote the expression of Bax and two BH3-only proteins, Noxa and Puma 
(Nakano and Vousden 2001, Oda et al 2000, Yu et al 2001). Noxa and Puma, too, are capable 
of inhibiting anti-apoptotic Bcl-2 members and promoting the Bax activation. Other apoptosis 
mediators such as calcium flux and UV irradiation activate the BH3-only protein Bim 
(Puthalakath et al 1999) and Bmf, respectively, and they inhibit anti-apoptotic Bcl-2 members 
to enhance Bax activation. 
     Following the activation of Bax and the induction of MOMP, several pro-apoptotic 
proteins are released from mitochondria into the cytosol (Fig. 10), such as endonuclease G 
(End. G), apoptosis inducing factor (AIF), Smac/Diablo, Omi/Htra2, and, most importantly, 
cytochrome c (Cyt.c (Liu et al 1996)). Cytosolic Cyt.c associates with the caspase recruiting 
domain- (CARD) containing adaptor protein “apoptotic peptidase activating factor 1 (Apaf-
1).” The CARD domain of Apaf-1 then recruits procaspases-9 to form a heptamer of Cyt. c, 
Apaf-1 and procaspases-9 known as apoptosome (Acehan et al 2002, Li et al 1997, Rodriguez 
et al 1999, Srinivasula et al 1998, Stennicke et al 1999, Yang et al 1998a, Zou et al 1999) in a 
ATP-dependent manner (Zou et al 1997, Zou et al 1999). This protein aggregate activates 
procaspase-9 which then activates procaspases-3, -7 and -6 for apoptosis execution (Fig. 10 
(Li et al 1997, Shi 2002a, Shi 2002b, Zou et al 1997)). 
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Fig. 10 
Overview of Extrinsic and Intrinsic Apoptosis Pathways 
(Receptor Mediated Extrinsic Pathway) 
Upon TNF binding to the TNF-R1, SODD dissociates and the receptor either forms complex I 
or complex II. Complex I consists of TNF-R1, TRADD, TRAF2 and RIP. It can either activate 
NF-κB, recruit RAIDD to activate procaspases-2, or activate the JNK pathway.  
Complex II is constituted of TNF-R1, TRADD, FADD and either procaspase-8 or -10. These 
caspases are activated at this complex. 
The ligation of Fas to the Fas-R results in a homotrimerization of Fas-R and recruits FADD and 
procaspase-8 or -10 to form a death-inducing signalling complex. Procaspase-8 or -10 are 
activated at the DISC complex and activate down-stream caspases. 
 
(Mitochondria Mediated Intrinsic Pathway) 
Cellular stresses such as growth factor deprivation, calcium influx, UV irradiation or 
chemotherapeutic drugs signal to BH3-only members of Bcl-2 family. They either suppress anti-
apoptotic members of Bcl-2 family proteins or promote the activation of Bax to induce the 
permeabilisation of the outer mitochondrial membrane. Such permeabilisation results in a 
release of proapoptotic proteins from mitochondria including cytochrome c, AIF, endonuclease 
G or Smac/Diablo. Released cytochrome c forms a complex with Apaf-1 and procaspases-9 to 
form the apoptosome where procaspase-9 is activated. 
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3.3 Bid: A Connector of Extrinsic and Intrinsic Pathways 
     Both extrinsic and intrinsic pathways converge on an effector caspases activation for 
apoptosis execution. However, their apoptotic pathways are initiated in a fundamentally 
distinct manner thus the two pathways were thought to be completely separable. The 
knockout of either caspase-8 (Varfolomeev et al 1998) or FADD (Yeh et al 1998) abrogates 
the responses mediated by death ligand-induced apoptosis whereas the mitochondrial 
pathway remains intact. Conversely, the knockout of either caspase-9 (Hakem et al 1998, 
Kuida et al 1998) or Apaf-1 (Cecconi et al 1998, Yoshida et al 1998b) abolishes apoptosis 
induced by stimuli such as cellular stress but the cells readily die through death ligands. A 
controversy arose when expression of Bcl-2 was found to alleviate the Fas-induced apoptosis 
(Scaffidi et al 1998). This led to a consideration that Bcl-2 family members may be involved 
in the extrinsic pathway (Scaffidi et al 1998). It was found to be a BH3-only protein, Bid, 
bridges the two pathways. Recruitment and the activation of procaspase-8 in the DISC 
complex provides sufficient concentration of activated caspase-8 for the execution of 
apoptosis in certain cell types (Type I cells). However, in type II cells activation of caspase-8 
in the DISC complex is insufficient to induce apoptosis and requires the presence of Bid. Bid 
is a substrate of caspase-8 (Gross et al 1999, Li et al 1998, Luo et al 1998) and the truncated 
Bid (tBid) translocates to mitochondria where it triggers the release of Cyt.c by interacting 
with Bax (Fig. 10 (Desagher et al 1999, Eskes et al 2000, Zamzami et al 2000)) thereby 
promoting the formation of the apoptosome and the activation of procaspases-9 (Li et al 1998, 
Luo et al 1998, Scaffidi et al 1998). The ectopic expression of Bid was also found to enhance 
the activation of procaspases-3 induced by TNF indicating the importance of Bid in linking 
the extrinsic and the intrinsic pathways of apoptosis (Luo et al 1998). 
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3.4 Other Apoptosis Domain-Containing Proteins and their roles for apoptosis 
signaling 
     The death domain superfamily of proteins comprises one of the largest protein domain 
superfamilies. The subfamilies include proteins containing the death domain (DD); the 
caspase recruitment domain (CARD); the death effector domain (DED); and the pyrin 
domain. Other proteins harbouring evolutionally conserved protein domains involved in 
apoptosis include the BIR domain of IAPs and the Bcl-2 homology domain (BH). These 
proteins regulate the tightly controlled apoptosis networks. Several representative proteins 
that govern the extrinsic and the intrinsic pathways of apoptosis as well as the protein 
complexes for the procaspases activation (DISC complex and apoptosome) were discussed 
above. However, the proteins that possess one of those domains are remarkably diverse. 
There are twenty-two proteins with CARD (excluding CARD-containing caspases), seven 
proteins with DED (including DED-containing caspases), thirty-two proteins with DD, eight 
with BIR domain and twenty-five with BH domains in human (Reed et al 2004).  
3.4.1 PIDDosome 
     During the intrinsic pathway of apoptosis, p53 regulates the transcription of Puma and 
Noxa (Fig. 10). In addition, p53 can stimulate the p53-induced protein with a death domain 
(PIDD). The death domain of PIDD is able to recruit RAIDD and it can activate procaspase-2. 
This aggregate of proteins was termed the PIDDosome (Park and Wu 2007, Tinel and 
Tschopp 2004, Vakifahmetoglu et al 2006). 
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3.4.2 CARD-containing proteins 
     CARD-containing proteins consitute one of the most diverse protein families among the 
apoptosis proteins. Although there are exceptions in which they possess only one CARD 
(excluding caspases, COP: CARD-only protein, Iceberg and TUCAN for example), many 
proteins contain multiple domains (Fig. 11). Apaf-1, for example, has a CARD for the 
recruitment of procaspase-9; a NB-ARC domain (nucleotide-binding Apaf-1, R-gene, and 
Ced-4)  for the formation of the heptamer structure of apoptosome; and the WD repeat 
domain (tryptophan-aspartic acid dipeptide repeats) for the binding of Cyt.c (Fig. 11) 
(Salvesen and Renatus 2002). The CARD-containing protein also functions to regulate NF-
κB. Nod1 uses a mechanism analogous to Apaf-1 to induce NF-κB activation. A ligand 
displayed by intracellular bacteria binds to leucine-rich repeat (LRR) and undergoes 
oligomerization using the central nucleotide-binding NACHT (neuronal apoptosis inhibitory 
protein, MHC class II transcription activator, incompatibility locus protein from Podospora 
anserina, and telomerase-associated protein) domain. CARD of Nod1 then binds to RIP2 
(receptor-interacting protein 2, also known as Cardiak) to induce NF-κB activation (Fig. 10 
and Fig. 11,  (Inohara et al 1999, Inohara et al 2000)). 
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3.4.3 DED-containing proteins 
     The death effector domain (DED) is composed of six α-helical bundles (Eberstadt et al 
1998) and, unlike CARD proteins, is involved only in the regulation of apoptosis through 
interaction with DED-containing caspases. There are thirteen DED family proteins including 
procaspase-8 and -10 (Fig. 12). Among them, seven are considered to be true DED proteins 
(FADD, procaspase-8 and -10, cFLIP, DEDD, DEDD2 and PEA-15) whereas other six 
(FLASH, Bap31, BAR, Dap3, HIP and HIPPI) possess a DED-like domain (DED-L) or a 
variant of DED (vDED, Fig. 12)). Similar to CARD proteins, DED proteins also contain 
multiple domains (Fig. 12): FADD contains a DD; caspases and cFLIP contain caspase-
ctalytic or pseudo caspase-catalytic domain; others possess a transmembrane domain (TM), a 
Fig. 11  
CARD-Containing Proteins 
CARD-containing proteins are highly diverse and over twenty proteins have been 
identified. Many of them contain multiple domains such as NB, WD repeats, LRR, 
DD, kinase domain, BIR or RING domain although some possess only the CARD 
domain. Most of them are involved in apoptosis regulation but Nod1, for example, is 
involved in NF-κB activation. 
Numbers represent the position of amino acid. 
Modified from Reed et al. (Reed et al 2004). 
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coiled-coil domain (CC), a RING domain for E3 ligase activity, a SAM domain, a GTP/GDP 
nucleotide-binding domain (NB), a Talin-like domain and a myosin-like domain (MLD). 
Although the presence of DED is required for the recruitment of procaspase-8 and -10, a 
recent discovery of DED-like proteins may offer different platforms for caspase activation 
other than complex II and the DISC complex at the plasma membrane (Reed et al 2004). 
Huntingtin-interacting protein (Hip) was described to interact with Huntingtin, a causative 
protein of Huntingdon’s disease (Banerjee et al 2006, Bhattacharyya et al 2008, Gervais et al 
2002). Hip was reported to contain a domain analogous to DED (vDED) of Hip-interacting 
protein (Hippi). Hip and Hippi appear to form a complex that can trigger procaspase-8 
activation thus serving as a new platform for caspase-8 activation (Gervais et al 2002). The 
ER transmembrane protein BAR (bifunctional apoptosis regulator) and Bap31 (B-cell 
activating protein 31) also contain vDED although their function and involvement in 
procaspases activation has not been reported (Ng et al 1997, Roth et al 2003, Zhang et al 
2000).  
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Fig. 12  
DED-Containing Proteins 
DED-containing proteins are primarily involved in apoptosis regulation. There are 
thirteen family members and seven are considered to be true DED proteins (FADD, 
procaspase-8 and -10, cFLIP, DEDD, DEDD2 and PEA-15), whereas the other six 
are considered to possess DED-like or a variant of DED (vDED). Similar to CARD 
proteins, DED proteins often possess multiple domains, such as DD, caspase or 
pseudo caspase domain, NLS, TM, CC domain, RING domain, SAM domain, NB, 
Talin-like domain or MLD. 
Numbers represent the position of amino acids. 
Figure taken from Reed et al (Reed et al 2004). 
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3.5 Alternative Forms of Cell Death 
     Classical apoptosis is defined by biochemical and morphological changes among them 
caspase activation, mitochondrial dysfunction and DNA fragmentation. There are, however, 
some forms of cell deaths that cannot easily be categorised. An irreversible inhibitor of 
caspases (zVAD-fmk), that binds to an catalytic site of a caspase substrate through an 
aspartate residue by mimicking the cleavage site and a fluoromethyl ketone (fmk) group 
forming a covalent inhibitor-enzyme complex (Thornberry et al 1994), should be able to 
inhibit all caspase-dependent apoptotic pathways. Controversially, however, not all the 
pathways are inhibited by this competitive inhibitor. Expression of Bax triggers apoptosis 
leading to the breakdown of mitochondrial function (loss of membrane potential, release of 
Cyt.c, AIF and other pro-apoptotic proteins), which was reported not to be inhibited by 
zVAD-fmk. Furthermore, other proteases, granzymeA/B, cathepsins and calpains for 
example, seem to play a role in apoptosis (Johnson 2000, Leist and Jaattela 2001). In fact, 
these proteases can also trigger caspase-independent apoptosis and also in part substitute for 
caspases activity. 
     Apoptosis inducing factor (AIF) is released from mitochondria upon permeabilisation of 
the outer mitochondrial membrane. AIF translocates to the nucleus when released and 
induces chromatin condensation and DNA fragmentation (Susin et al 2000). This process of 
DNA fragmentation induced by AIF is also promoted by another inner mitochondrial protein, 
endonuclease G, which also translocates to the nucleus upon its release (Li et al 2001). This 
form of cell death is required during embryoid body cavitation (Joza et al 2001). Importantly, 
this death-inducing pathway cannot be inhibited by zVAD-fmk (Green and Reed 1998, 
Vermeulen et al 2002, Xiang et al 1996). 
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     T cells and natural killer cells utilize a granule exocytosis pathway for the elimination of 
virally infected cells. The cytotoxic granules deliver a pore-forming protein, perforin, and a 
family of serine proteases. These granzymes have two isoforms and one of them, granzyme B, 
is able to activate caspase-3 and -9, which leads to the cleavage of Bid and iCAD resulting in 
apoptosis (Alimonti et al 2001, Heusel et al 1994). The other isoforms, granzyme A, can 
activate NM23-H1 DNase resulting in the formation of single stranded DNA nicks 
(Lieberman 2003). Calpain is known to share some substrates of caspases (Ghavami et al 
2010). 
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4. Molecular Mechanisms of MOMP 
     Mitochondria play a crucial role especially in the intrinsic pathway of apoptosis. One of 
the hallmarks and the key regulatory events in the mitochondria-dependent apoptosis 
pathway is the mitochondrial outer membrane permeabilization (MOMP), which results in 
the release of proteins from the inter-mitochondrial membrane space (IMS) including 
cytochrome c (Kroemer et al 2007). The MOMP is regarded as the “point of no return” in the 
cascade of events leading to apoptosis (Kroemer and Reed 2000) and precedes apoptotic cell 
death both in vitro (Zamzami et al 1995a) and in vivo (Zamzami et al 1995b). Although 
MOMP has been observed universally during cell death, the detailed mechanism of how the 
outer mitochondrial membrane (OMM) gets permeabilized remains unclear. As mitochondria 
release all of their Cyt.c within minutes following the apoptotic stimulus in a temperature-
independent manner, it was thought that an enzymatic transport is not involved in this process 
(Goldstein et al 2000). It was, however, disproved. There are now two dominant theories to 
explain the mechanism of MOMP. One involves the pro-apoptotic Bcl-2 family member 
proteins, Bax and Bak, and their oligomerization and insertion into the OMM to form a pore. 
The other theory involves a mega-protein complex known as permeability transition pore that 
alters the inner and outer mitochondrial membranes. 
4.1 MOMP and Bcl-2 Family Members 
4.1.1 Bax oligomerization and pore formation 
     The first indications that the Bcl-2 family members are involved in mitochondrial outer 
membrane permeabilisation (MOMP) surfaced due to their structural similarities with 
bacterial toxins that get inserted into the membrane (Suzuki et al 2000). Later they were 
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shown to regulate MOMP (Kroemer 1997, Susin et al 1996, Vaux and Korsmeyer 1999, Wei 
et al 2001). Anti-apoptotic members of Bcl-2 family were shown to prevent the release of 
Cyt.c from mitochondria indicating that Bcl-2, at least in some part, regulate the integrity of 
the mitochondrial membrane (Gross et al 1999, Kluck et al 1997, Yang et al 1997, Zamzami 
and Kroemer 2001). On the contrary, pro-apoptotic members of the Bcl-2 family, such as Bax 
or Bak, were reported to induce Cyt.c release (Rosse et al 1998). In healthy cells, Bax is 
localized mainly in the cytosol as a non-active monomer due to its interaction with DNA 
repair protein Ku autoantigen 70kDa (Ku70 (Sawada et al 2003a, Sawada et al 2003b)), 
although some are loosely attached to mitochondrial membrane (Hsu et al 1997, Saikumar et 
al 1998, Wolter et al 1997). Upon application of apoptotic stimuli, Ku70 is acetylated and 
dissociates from Bax (Cohen et al 2004), and Bax undergoes allosteric conformational 
change at both termini and translocates to the OMM (Goping et al 1998), which is required 
for a Bax-induced MOMP (Antonsson et al 2000, Desagher et al 1999). This activated form 
of Bax is then believed to homooligomerize to create selective protein-permeable pores (Fig. 
13 left (Antonsson et al 2001, Capano and Crompton 2002, De Giorgi et al 2002, Eskes et al 
2000, Kuwana et al 2002, Nechushtan et al 2001, Tan et al 1999)) that allow Cyt.c to be 
released into the cytosol. Similarly, Bak, which is localized to OMM (Griffiths et al 1999), 
also undergoes an allosteric conformational change and gets activated to homooligomerize 
contributing to the pore formation (Green 2005, Mikhailov et al 2003, Wei et al 2000). This 
pore allows proteins in the IMS to egress into the cytosol without affecting the function of the 
inner mitochondrial membrane (IMM) and/or the matrix. However, how these factors, 
especially Bax, “find their way” to the OMM or how they interact with the OMM to form a 
macromolecular protein-permeable pore remains an ongoing conundrum. It is possible that 
the lipid-protein interaction is important (Gonzalvez et al 2005, Lucken-Ardjomande and 
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Martinou 2005, Zamzami and Kroemer 2003) and it is also possible that Bax or Bak do not 
form a pore but simply destabilize the lipid bilayers instead (Basanez et al 2002).  
     In support of this model, Bax
-/-
-Bak
-/-
 cells are resistant to Cyt.c release and apoptosis 
induced by staurosporine, UV irradiation, growth factor deprivation, etoposide, and the ER 
stresses by thapsigargin and tunicamycin (Wei et al 2001). Overexpression of anti-apoptotic 
Bcl-2 proteins can likewise inhibit the apoptosis induced by ectopic expression of BH3-only 
proteins (Gross et al 1999), which induce apoptosis via Bax or Bak. Vesicles composed of 
purified mitochondrial outer membrane can be permeabilized in response to the activated 
form of recombinant Bax and vesicles made of mitochondrial lipids without the presence of 
any mitochondrial proteins were permeabilized by the introduction of recombinant 
monomeric Bax in the presence of Bid or Bid-derived BH3 peptide (Antonsson et al 1997, 
Antonsson et al 2000, Eskes et al 1998, Finucane et al 1999, Jurgensmeier et al 1998, Narita 
et al 1998). Bax oligomerizaion can also form a pore allowing the passage of 2MDa 
molecules in reconstituted liposomes (Kuwana et al 2002). 
4.1.2 Upstream signals of MOMP 
     Multiple distinct signalling pathways converge to MOMP. Some BH3-only proteins 
within Bcl-2 family act upstream of Bax or Bak activation (Cheng et al 2001, Letai et al 
2002)  by direct association (Bim, Bid and Puma (Kuwana et al 2002, Willis et al 2007)) or, 
conversely, by inhibiting the activity of anti-apoptotic Bcl-2 members (Bad and Bik) to 
favour the process of MOMP. There are other non-Bcl-2 family proteins that possess similar 
properties. The tumour suppressor p53 regulates the expression of BH3-only members such 
as Puma and Noxa by certain stimuli (Vousden and Lu 2002), and Puma-deficient cells 
display resistance to p53-induced apoptosis (Jeffers et al 2003, Villunger et al 2003). 
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However, p53 can also trigger MOMP and apoptosis in the absence of its transcription factor 
activity through direct activation of Bax (Chipuk et al 2004) or Bak (Leu et al 2004). 
Additionally, many other nuclear proteins function in the cytosol leading to MOMP. Nur77 
(neural orphan nuclear receptor)/TR3 (thyroid hormone receptor 3) protein is capable of 
binding to Bcl-2 thereby promoting the Bax activation (Lin et al 2004). Histone 1.2, which is 
released upon X-ray-induced DNA damage, can trigger MOMP (Konishi et al 2003). 
Hexokinase can interact with VDAC (see below), and this interaction can inhibit the MOMP 
induced by Bax (Majewski et al 2004).  
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4.2 The Mitochondrial Permeability Transition Pore 
     Another mechanism by which MOMP can occur is through mitochondrial permeability 
transition, which is defined as a sudden increase of inner mitochondrial membrane (IMM) 
permeability to solutes with low molecular weight (typically ~1.5kDa (Green and Kroemer 
2004)) caused by the opening of a voltage-dependent, high-conductance channel located in 
the IMM known as permeability transition pore (PTP) complex (Halestrap et al 2002). The 
PTP complex is composed of several, although not clearly defined, proteins. It is currently 
believed that the major PTP complex consists of “voltage-dependent anion channel” (VDAC 
(Mattson and Kroemer 2003)), an OMM protein; “adenine nucleotide translocator” (ANT 
(Kokoszka et al 2004)), which spans the IMM; and “cyclophilin D” (CypD (Waldmeier et al 
2003)), which associates with ANT and resides in the matrix (Fig. 13). In addition, 
hexokinase-II (HK), peripheral benzodiazepine receptor (PBR) associate with the OMM and 
creatine kinase1 is localized to the IMS, both of which have been reported to interact with the 
PTP complex (Verrier et al 2004). The PTP connects the outer and the inner mitochondrial 
membrane. The outer mitochondrial membrane has a semi-permeable nature due to VDAC 
which allows the passage of small solutes of up to 5kDa allowing the exchange of 
respiratory-chain substrates such as NADH, FADH, and ATP/ADP between the IMS and the 
cytosol. In contrast, IMM is almost impermeable and this creates an electrochemical proton 
gradient (ΔΨm) for the oxidative phosphorylation by complex I to IV of the respiratory chain 
(Colombini 1983, Mitchell and Moyle 1965a, Mitchell and Moyle 1965b). In a physiological 
condition, ΔΨm ranges between 120 to 180mV, with the intramitochondrial side being 
negative. This polarization attracts lipophilic cations and they accumulate at 100 to 1000 fold 
higher concentration in the matrix than in cytosol. As a result, several different cationic 
fluorochromes are employed to measure the ΔΨm (Castedo et al 2002, Metivier et al 1998). 
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These markers include 3,3’-dihexyloxacarbocyanine iodide (DiOC6, emits ~552nm), 
chloromethyl-X-rosamine (CMXRos or MitoTracker Red, emits ~599nm), 
tetramethylrhodamine ethyl ester (TMRE, emits ~580nm) and 5,5’,6,6’-tetrachloro-1,1’3,3’-
tetraethylbenzimidazolcarbocyanine iodide (JC-1, emission depends on the oligomerization 
status). However, cellular stresses such as excessive production of reactive oxygen species or 
the dysregulation of calcium homeostasis lead to the opening of PTP (Bernardi 1999, Duchen 
2000, Zoratti and Szabo 1995). Persistent PTP opening precipitates a bioenergetic crisis 
accompanied by a depletion of ATP, calcium dysregulation, and influx of solutes and H2O, 
which result in a distorted balance of osmotic pressure leading to a loss of mitochondrial 
membrane potential (ΔΨm) and swelling of the mitochondrial matrix (Fig. 13 (Kroemer and 
Reed 2000, Susin et al 1998)). The matrix swelling induces the swelling of IMM and finally 
the rupture of OMM leading to the release of IMS proteins (Fig. 13), resulting in the loss of 
mitochondrial structure and the functional integrity (Green and Kroemer 2004, Zamzami and 
Kroemer 2001). Apoptosis through calcium-mediated mitochondrial PT (see section 6.2.3 
Endoplasmic Reticulum-Mitochondria Interface, Calcium and Apoptosis for details) has been 
observed in variety of treatments such as calcium ionophores, thapsigargin, neurotoxins, 
chemotherapeutic agents and pro-oxidants. Such calcium-mediated apoptosis can often be 
suppressed by the repression of calcium uptake into mitochondria (treatment with ruthenium 
red or its derivative Ru360) or by the inhibition of PTP by cyclosporin A or bongkrekic acid 
(Bradham et al 1998, Cesura et al 2003, Halestrap et al 1997, Halestrap and Brennerb 2003, 
Lee et al 2005, Pritchard et al 2000, Waldmeier et al 2003, Walter et al 1998). However, the 
opening of PTP does not necessarily result in the permeabilisation of membranes. Transient 
opening of PTP provides mitochondria with a fast calcium release, which helps to regulate 
calcium homeostasis and signalling thereby preventing the induction of apoptosis (Kroemer 
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et al 1998, Zoratti and Szabo 1995). In addition, although the loss of the mitochondrial 
membrane potential has been regarded as one of the characteristics of apoptosis, this - 
especially if it happens only for a short duration - does not necessarily originate in PTP 
opening as many different signals can induce a transient loss of ΔΨm. 
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4.3 Other Models of MOMP 
     There is strong evidenc to support the two models discussed above. There are, however, 
numerous studies that presented contradictory data. Some reports indicated that  Bax-induced 
Cyt.c release occurs without any structural or functional damage to mitochondria, indicating 
the presence of a selective protein pore at the OMM rather than non-selective distortion of 
OMM by sustained opening of PTP (von Ahsen et al 2000). A blocker of PTP, cyclosporin A 
(CsA), inhibits PTP opening. However, Cyt.c release was not prevented in the isolated 
mitochondria from Xenopus eggs (Eskes et al 1998, Eskes et al 2000). Also, although ANT1 
has been described as a classical PT-pore component and the purified ANT can be induced to 
form pores in an artificial membrane (Brenner et al 2000, Brustovetsky and Klingenberg 
1996, Brustovetsky et al 2002) or ANT isoforms (ANT1 and 3) are able to induce apoptosis 
(Bauer et al 1999, Faustin et al 2004), recent knock-out studies demonstrated that cells 
deficient in ANT-1 and ANT-2 (a homolog of ANT-1) are still able to induce PT in response 
to increased Ca
2+
 concentrations and show only minor alterations in cell death induction 
(Halestrap 2004, Kokoszka et al 2004). Using knock-out mice, Baines et al. also claimed that 
VDAC is dispensable for mitochondria-dependent cell death (Baines et al 2007). 
Mitochondria from VDAC-null mice exhibited a Ca
2+
- and oxidative stress-induced 
mitochondrial PT that is indistinguishable from wild-type mitochondria (Baines et al 2005, 
Nakagawa et al 2005). In contrast, cyclophilin D has been firmly established as a regulator of 
the PT-pore, although its effect has been described as both, pro- and anti-apoptotic depending 
on the experimental settings and stimulus used to induce mitochondrial PT: overexpression of 
Cyclophilin D can repress mitochondria-mediated apoptosis (Li et al 2004, Lin and Lechleiter 
2002, Machida et al 2006, Schubert and Grimm 2004) but isolated mitochondria from liver, 
heart and brain of cyclophilin D knock-out mice are also resistant to mitochondrial swelling 
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caused by permeability transition although PTP opening can still be observed when a stronger 
stimulus was applied (Baines et al 2005, Nakagawa et al 2005). To this end, it is now 
generally considered that there is not one particular model that regulates the MOMP. There is 
also accumulating evidence that both Bax and PTP cooperate to induce the MOMP (Marzo et 
al 1998a).  
4.3.1 Bax and PTP 
     There is a plethora of data that indicate Bax and the components of the PTP may function 
together to induce MOMP and the release of Cyt.c (Jacotot et al 1999). Narita et al. showed 
that the expression of Bax and Bak induce PT (Narita et al 1998). Furthermore, they found 
that the addition of human recombinant Bax to the isolated rat liver mitochondria induced the 
dissipation of the mitochondrial membrane potential ΔΨm and the swelling of the matrix. 
Loss of ΔΨm induced by Bax was later shown to be inhibited by the PTP inhibitors CsA and 
bongkrekic acid (Yamaguchi et al 2008, Zhang et al 2008). This finding proposes a new 
function of Bax: involvement of Bax in cristae remodeling, which would not happen if the 
pore of oligomerized Bax at the OMM is sufficient to induce Cyt.c release.  
     The evidence of Bax involvement in PTP was first described by the presence of Bax in the 
purified PTP complex from rat brain by Marzo et al (Marzo et al 1998a). They also showed 
that Bax forms a complex with a component of PTP complex, ANT (Marzo et al 1998a, 
Marzo et al 1998b). Bax forms a pore on a reconstituted liposomes or planar lipid bilayers 
and its formation was enhanced in a presence of ANT (Belzacq et al 2002). Another report 
suggests that VDAC, too, is able to interact with Bax and induce OMM permeabilisation in 
the presence of Bax. The recombinant Bax and VDAC together induced a membrane 
permeabilisation of liposomes whereas heat-denatured VDAC was unable to undergo such 
permeabilisation (Shimizu et al 1999). This process was blocked by CsA or by oligomycin, 
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inhibitors of PT (Narita et al 1998). In support of this, purified mitochondria from yeast strain 
lacking VDAC failed to exhibit Bax/Bak-induced OMM permeabilisation, cyt.c release and 
ΔΨm (Pastorino et al 2002, Shimizu et al 1999). Similarly, blocking the activity of VDAC 
with an antibody also ceased such features as membrane rupture (Shimizu et al 2001). An 
isoform of VDAC, VDAC2 interacts with Bak in healthy cells to protect Bak from 
oligomerization (Cheng et al 2003). Moreover, Bak demonstrated enhanced allosteric 
conformational change and results in cyt.c release in the absence of VDAC2 (Cheng et al 
2003).  
4.3.2 Non-Bax- and Non-PTP-Induced MOMP 
     Accumulating data implicate that the release of cyt.c does not occur in an all-or-none 
fashion but rather seems to follow a biphasic kinetics (Scorrano et al 2002). A first step of 
cyt.c release allows only 15-20% of Cyt.c in the intermembrane space of mitochondria that 
are soluble and loosely bound to the membrane (Bernardi and Azzone 1981). The rest of 
Cyt.c, present in mitochondria, are bound to cristae and localized to inter-cristae space 
(Bernardi and Azzone 1981), and are released in a second step after the remodelling of cristae 
structure, possibly by Bax-induced cristae remodelling or sustained opening of PTP (Fig. 13). 
Alternatively or in parallel, the majority of Cyt.c may be sequestered by the interaction with 
cardiolipin (Orrenius and Zhivotovsky 2005, Ott et al 2002). Released Cyt.c after the first 
step is thought to mediate the activation of several amplification loops that lead to the second 
step of the Cyt.c release. Some apoptotic signals provoke the disruption of the electron 
transport system of the mitochondrial respiratory chain, which leads to the production of 
reaction oxygen species (ROS). The resulting ROS induce oxidation of cardiolipin in the 
inner membrane. The oxidised form of cardiolipin has less affinity to Cyt.c, thus dissociates 
from the inner membrane and is released from mitochondria (Kagan et al 2004, Nakagawa 
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2004, Orrenius and Zhivotovsky 2005). In support of this, loss of cardiolipin leads to 
alterations in the stability and permeability of mitochondrial membranes (Pfeiffer et al 2003). 
Another amplification loop leads to caspase activation. The knockdown of caspase-2 by 
siRNAs blocks the cyt.c release upon genotoxic stress (Almeida et al 2006, Bergeron et al 
1998, Lassus et al 2002, Robertson et al 2004). Lastly, released cytosolic Cyt.c is able to bind 
to an endoplasmic reticulum (ER) calcium receptor, inositol 1,4,5-trisphosphate receptor 
(IP3R). This binding elicits calcium mobilization (Berridge 2005) and lead to sustained 
calcium release from the ER, which in turn feeds back to mitochondria to activate PTP 
(Boehning et al 2005).  
     In addition, mitochondrial dynamics have also been suggested to link the MOMP 
(Perfettini et al 2005). Mitochondria, in healthy cells, undergo controlled continuous fission 
and fusion (see later section for details). However, many apoptotic stimuli induce 
mitochondrial fission and the timing of Cyt.c release occurs often simultaneously. Bax has 
been shown to associate with endophilin B1, one of the main regulators of mitochondrial 
division (Karbowski et al 2004b). Thus Bax may stimulate mitochondrial fission which in 
turn favours MOMP (Perfettini et al 2005).  Furthermore, dynamin-related protein 1 (Drp1), a 
necessary component of mitochondrial fission, participates in a cristae remodelling and Drp1 
is required for the efficient release of Cyt.c (Germain et al 2005). Another study also suggests 
that one of the mitochondrial fusion components, Opa1 (optic atrophy 1), maintains the 
junction between intracristae space and the IMS (Chen and Chan 2005, Frezza et al 2006, 
Perfettini et al 2005). This mitochondrial fission process and cell death seems to be connected 
in yeast such that the mitochondrial fission in yeast spontaneously induces cell death 
although it remains elusive in mammalian systems (Fannjiang et al 2004, Perfettini et al 
2005).  
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 5.     Mitochondrial Dynamics and Apoptosis 
5.1 Mitochondrial Dynamics in Apoptosis 
     Mitochondria function as a source of ATP; are involved in the urea cycle, lipid 
metabolism, steroid, hormone and porphyrin synthesis, interconversion of amino acids, 
glucose and insulin regulation, cellular calcium homeostasis; and production of reactive 
oxygen species (Brini 2003, Cannino et al 2007, Gunter et al 2000, Gunter et al 2004, 
Maechler 2002). Impairments in their functions are related to diseases such as 
neurodegenerative diseases, cancer and aging (Wallace 1999, Wallace 2005). Many cancer 
cells show reduced oxidative phosphorylation but have increased glycolysis. Furthermore, 
mitochondria are dynamic, semiautonomous organelles that undergo a balanced, continuous 
fusion and fission to adopt either a long interconnected tubular or a small spherical 
morphology (Fig. 16) (Bereiter-Hahn 1990, Bereiter-Hahn and Voth 1994, Bereiter-Hahn et 
al 2008, Chan 2006a, Okamoto and Shaw 2005). The frequencies of fission and fusion events 
are controlled and each event occurs every two minutes on average in yeast (Nunnari et al 
1997). However, the perturbation of such regulation leads to, for example, neonatal lethality, 
developmental delay, metabolic abnormality, and neurodegenerative diseases in humans 
(Nunnari et al 1997, Verstreken et al 2005, Waterham et al 2007). In fact, genetic mutations 
identified in patients led to the discovery of many proteins that govern the fusion and fission 
event. Charcot-Marie-Tooth disease subtype 2A (CMT2A), for example, is a peripheral 
neuropathy characterized by distal motor and sensory impairments (Kijima et al 2005, 
Zuchner et al 2004, Zuchner and Vance 2006). One of the mutant genes identified was Mfn2 
harbouring over forty mutations, which was later found to have a role in mitochondrial fusion. 
The similar disease CHM4A is associated with mitochondrial fission protein GDAP1 
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(Kabzinska et al 2006, Niemann et al 2005, Pedrola et al 2005, Pedrola et al 2008). A 
dominant optic atrophy, a common inherited autosomal dominant blindness, is often caused 
by a mutation is Opa1 gene which is involved in mitochondrial fusion (Alexander et al 2000, 
Delettre et al 2000, Delettre et al 2001, Delettre et al 2002). Over one hundred of mutation 
sites in this gene have been reported (Ferre et al 2005). The number of mitochondria and the 
integrity of the mitochondrial DNA are also important factors in developing 
neurodegenerative diseases (Petrozzi et al 2007) such as Alzheimer’s disease, Parkinson’s 
disease and amyotrophic lateral sclerosis (ALS). Mitochondrial morphology is also tightly 
connected to cell cycle. During G1 phase, when biosynthetic activities of the cell increase to 
prepare for the S phase, mitochondria are filamentous and interconnected (Van den Bogert et 
al 1988) whereas they show smaller spherical shape in late S and M phase which is required 
for the correct segregation of the organelles between two daughter cells (Barni et al 1996, 
Margineantu et al 2002, Martinez-Diez et al 2006). Moreover, recent publications implicated 
that the mitochondrial fusion/fission machineries regulate apoptosis from yeast to mammals 
(Abdelwahid et al 2007, Fannjiang et al 2004, Frank et al 2001, Goyal et al 2007, Jagasia et al 
2005). 
5.1.1 Mitochondrial Fusion Machinery - Mfn1 and Mfn2 
     Identification of mitochondrial fusion machineries first came by an identification of 
mitofusin gene in Drosophila melanogaster, Fzo, during spermatogenesis in 1997 (Hales and 
Fuller 1997). Yeast homolog of Fzo is Fzo1 (fuzzy onion (Hermann et al 1998)) and two 
mammalian homologues, mitofusin 1 and 2 (Mfn1 and Mfn2, Fig. 14 A) have been identified. 
Their gene products belong to a family of a large GTPase and are localized in the outer 
mitochondrial membrane (OMM) and are essential for OMM fusion (Hermann et al 1998, 
Meeusen et al 2004). Structural studies showed that mitofusin dimerizes (either 
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homodimerizes or heterodimerizes to form Mfn1/Mfn1, Mfn2/Mfn2, or Mfn1/Mfn2) via their 
coiled heptad repeat (HR) domain allowing the mitochondrial tethering and fusion (Chen et al 
2003, Chen et al 2005, Detmer and Chan 2007, Koshiba et al 2004). Additionally, the 
presence of two transmembrane domains allow mitofusin to form a U-shaped structure with 
both N- and C-terminus facing the cytosol (Fig. 14 B). Genetic studies revealed that cells 
show a reduced mitochondrial fusion with the loss of either Mfn1 or Mfn2, and mitochondria 
become fragmented due to the distorted fusion/fission balance (Chen et al 2003, Karbowski et 
al 2004a). Both Mfn1 and Mfn2 are necessary for the maintenance of normal mitochondrial 
morphology, however, loss of one can be partially compensated by the overexpression of the 
other. Despite Mfn1 and Mfn2 having redundant functions, Mfn1
-/-
 cells show more severe 
fragmentation, which can be fully rescued by the expression of Mfn2. Similarly, Mfn1
-/-
-
Mfn2
-/-
 cells can be recovered by overexpression of either gene (Chan 2006b).  
     The fusion of OMM occurs in a similar way to viral endocytosis and SNARE-mediated 
vesicle fusion. Viral glycoprotein binds to the cell surface receptor on the host cell to form a 
complex. Similarly, R- and Q-SNAREs form a protein complex between donor and acceptor 
in trans. Mitochondrial fusion seems to happen by the formation of a trans protein complex 
between two mitochondria (Koshiba et al 2004, Meeusen et al 2004). Supporting evidence 
suggest that either Mfn1 or Mfn2 is required at the OMM of both adjacent mitochondria: 
mutant mitochondria lacking Mfn cannot fuse with wild type mitochondria. Crystalographic 
study showed that Mfn can dimerize, however, the distance between two mitochondria (95Å) 
was too far apart to complete OMM fusion (Fig. 14 B). To date, the exact OMM fusion 
mechanism remains unclear. 
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5.1.2 Mitochondrial Fusion Machinery - Opa1 
     Proteins involved in the inner mitochondrial membrane (IMM) fusion are also known. 
Mgm1p in yeast (Meeusen et al 2006) and its homolog in mammals, Opa1 (Chen et al 2005, 
Cipolat et al 2004), localize to the IMS, associate with IMM and are dynamin-like GTPas 
(Fig. 14 A). Downregulation of Opa1 by siRNA results in the increased mitochondrial 
fragmentation and aberration in the cristae structure. However, overexpression of Opa1 can 
lead to mitochondrial fragmentation or elongation depending on the experimental system. 
Opa1 is also involved in the mitochondrial DNA maintenance. Another protein in yeast, 
Ugo1, localized to OMM physically associates with Fzo1 (OMM fusion protein) and Mgm1p, 
thereby helping to coordinate the outer and inner mitochondrial membrane fusion. Curiously, 
no mammalian ortholog or homolog of Ugo1 has been identified so far. 
      
      
A 
B Fig. 14 
Mammalian Mitochondrial Fusion Factors 
(A) The central mammalian fusion factors are 
mitofusin 1, 2 (Mfn1 and Mfn2) and Opa1. 
Mitofusins contain one GTPase domain, one 
transmembrane domain (TM) and two hepted 
repeat domains (HR1 and HR2). Opa1 is also a 
GTPase containing two HR domains. MTS: 
mitochondria targeting signal 
(B) Mitofusins are localized to the outer 
mitochondrial membrane and can dimerize 
homotypically or heterotypically through their HR 
domains by forming a U-shaped structure. Such 
protein interaction can tether two adjacent 
mitochondria with a distance of 95 Å. 
Figure taken from Chan et al. (Chan 2006a) 
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     It is commonly assumed that OMM and IMM fusion occur concordantly. In yeast fusion 
assay, OMM fusion requires close association of two adjacent mitochondria, low GTP 
concentration while IMM fusion needs additional GTP and intact ΔΨm. Perturbation of ΔΨm 
by H
+
 or K
+
 ionophores disrupt IMM fusion but not the OMM fusion and results in 
mitochondrial fragmentation (Legros et al 2002, Malka et al 2005). The necessity of Opa1 for 
mitochondrial fusion is well established, but the exact mechanism of IMM fusion is largely 
unknown. Moreover, Opa1 or Mgm1p are essential for OMM fusion though they are not 
exposed to the cytosol. Opa1 as well as IMM fusion play a role in the maintenance of cristae 
structure as knockout of Opa1 leads to severe defects in cristae morphology (Amutha et al 
2004, Frezza et al 2006, Meeusen et al 2006, Olichon et al 2003, Sesaki et al 2003). Recent 
studies also identified several other important factors involved in IMM fusion. Mitochondrial 
morphology screens in yeast revealed several proteins involved in the ergosterol synthesis 
pathway as being required for normal mitochondrial morphology (Altmann and Westermann 
2005, Dimmer et al 2002). Mitochondrial phospholipase D, too, was reported to be important 
for fusion of mitochondria (Choi et al 2006). 
     Several other proteins for the regulation of mitochondrial fusion have been identified: 
Mitofilin is involved in the maintenance of cristae morphology (John et al 2005); MitoPLD is 
a mitochondrial phospholipase (Choi et al 2006); MISC1 (mitochondrial morphology and 
cristae structure) is an IMM protein necessary for the maintenance of mitochondrial 
morphology (Oka et al 2008); and β-subunit of the protein phosphatase 2A is also involved in 
mitochondrial fusion (Dagda et al 2008). 
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5.1.3 Mitochondrial Fission Machineries - Drp1 and Fis1 
      Genetic screens to identify suppressors of mitochondrial fusion mutants and the study of 
dynamin-related proteins in C. elegans led to the identification of number of mitochondrial 
fission proteins. The best characterized of these are the yeast homologs of mitochondrial 
fission protein (Fis1p), hFis1 (mammalian Fis1), and dynamin-related protein, Drp1. Fis1 is 
an integral OMM protein essential for a mitochondrial fission in yeast and is distributed 
equally throughout the membrane (Fekkes et al 2000, Mozdy et al 2000, Tieu and Nunnari 
2000). hFis1 is an evolutionary conserved (homologues are found in plants, yeast, worms, 
flies to mammals, Fig. 15 A) 17kDa, 152 amino acids long protein harbouring a single 
transmembrane domain at its C-terminus (Fig. 15 B, C). The bulk part of hFis1 faces the 
cytosol and forms six antiparallel α-helices (Fig. 15 C). The structural studies by NMR and 
by protein crystallography revealed that the central four α-helices consists of two tandem 
tetratricopeptide repeat (TPR) domain, which is a helix-turn-helix motif involved in a 
protein-protein interaction (D'Andrea and Regan 2003, Dohm et al 2004, Suzuki et al 2003). 
The structural study revealed that yeast Fis1, too, contains six α-helical structures with two 
TPR domains. However, unlike hFis1, yeast Fis1 has an extended N-terminus, which 
facilitates the recruitment of adaptor proteins (Fig. 15 A,C, see later for details).  
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H.sapiens       ----------MEAVLNELVSVEDLLKFEKKFQSE-KAAGSVSKSTQFEYAWCLVRSKYND 49 
M.musculus      ----------MEAVLNELVSVEDLKNFERKFQSE-QAAGSVSKSTQFEYAWCLVRSKYNE 49 
D.melanogaster  ----------MEDLLNEVVPQEDLERFEKKYHHELELDGEVTTDTKFEYAFCLVRSRYTN 50 
C.elegans       ---------------MEPESILDFHTEQEEILAARAR--SVSRENQISLAIVLVGSEDRR 43 
S.pombe         MTEKHTLRLADPSAIDSIISVDEFLQIKEQYDAEQPL---ITLQTKFNLAWALVRSDSTQ 57 
S.cerevisiae    --MTKVDFWPTLKDAYEPLYPQQLEILRQQVVSEGGP--TATIQSRFNYAWGLIKSTDVN 56 
                                .     ::   ..:           : ..::. *  *: *     
 
H.sapiens       DIRKGIVLLEELLPKGSK-EEQRDYVFYLAVGNYRLKEYEKALKYVRGLLQTEPQNNQAK 108 
M.musculus      DIRRGIVLLEELLPKGSK-EEQRDYVFYLAVGNYRLKEYEKALKYVRGLLQTEPQNNQAK 108 
D.melanogaster  DVRKGIMILEELARTHPD--GRRDYIYYLAFGNARIKEYTSGLKYCRAFLDIES-NDQVR 107 
C.elegans       EIKEGIEILEDVVSDTAHSEDSRVCVHYLALAHARLKNYDKSINLLNALLRTEPSNMQAT 103 
S.pombe         HVQQGLSLFCSIYKDSPE--RRLECLYYIALSHYKLKQYEESRRYLNMLLSKDPNSPEAL 115 
S.cerevisiae    DERLGVKILTDIYKEAES--RRRECLYYLTIGCYKLGEYSMAKRYVDTLFEHERNNKQVG 114 
                . : *: :: .:             :.*::..  :: :*  . .    ::  :  . :.  
 
H.sapiens       ELERLIDKAMKKDGLVGMAIVGGMALGVAGLAGLIGLAVSKSKS- 152 
M.musculus      ELERLIDKAMKKDGLVGMAIVGGMALGVAGLAGLIGLAVSKSKS- 152 
D.melanogaster  SLEEYIKKEIDKEVAKGMVVAGGAALVLG---GILGLGIAMARK- 148 
C.elegans       ELRRAVEKKMKREGLLGLGLLGGAVAVVGGLV-IAGLAFRK---- 143 
S.pombe         KLKNRLYDAVTKEGYIGMVVVAGAVVSVAALVGWASKRLFSKRRP 160 
S.cerevisiae    ALKSMVEDKIQKETLKGVVVAGG---VLAGAVAVASFFLRNKRR- 155 
                 *.  : . : ::   *: : .*    :.      .  .       
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Fig. 15 
Structure of Mammalian Fis1 (hFis1) 
(A) Multiple sequence alignment of human (H. sapiens, gene ID 51024), mouse (M. 
musculus, gene ID 66437), fly (D. melanogaster, gene ID 2213330005), worms (C. 
elegans, gene ID 185630) and yeasts (S. pombe, gene ID 2539939 and S. cerevisiae, gene 
ID 854745) are shown. The alignment was performed using Clustal 2.0.12 programme. 
(B) The protein sequence of hFis1 is shown. α1-α6 indicate the α-helices domain. 
(C) The structure of hFis1 is depicted (left). The bulk part of hFis1 faces the cytosol 
including six α-helices. The central four α-helices (α2-α5) form two tetratricopeptide 
repeat (TPR) domains. The structure of yeast Fis1 is shown on the right. Yeast Fis1, too, 
contains six α-helices and forms two TPR domains. However, yeast Fis1 has an extended 
N-terminus in comparison to hFis1 (N-terminal extension). This extension is required for 
the interaction with other adaptor molecules.   
C 
B 
Yeast Fis1 hFis1 
N-terminal 
extension 
C-terminus 
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     The overexpression of hFis1 induces mitochondrial fragmentation in a Drp1-dependent 
manner and likewise the downregulation leads to mitochondrial elongation (Fig. 16) (Arai et 
al 2004, Lee et al 2004, Stojanovski et al 2004, Yoon et al 2003). Although it is primarily 
localized to mitochondria, some portion of hFis1 seems to be localized to and regulate 
peroxisome morphogenesis (Kobayashi et al 2007).  
     Drp1 or Dnm1 in yeast is a dynamin family GTPase. Drp1 is localized mostly in the 
cytosol whereas upon mitochondrial fission induction Drp1 translocates to punctate spots on 
the mitochondrial tubules where mitochondrial fission occur (Bleazard et al 1999, Frank et al 
2001, Sesaki and Jensen 1999, Smirnova et al 2001, Yoon et al 2003). The recruitment of 
Drp1 to the OMM was initially thought to be dependent on hFis1, where hFis1 acting as a 
receptor, however, Drp1 was found to translocate to the OMM even when hFis1 was 
knocked-down (Lee et al 2004). Downregulation of Drp1 leads to increased mitochondrial 
length and the interconnectivity of mitochondrial tubules. In C. elegans, downregulation of 
Drp1 by siRNA results in an embryonic lethality (Labrousse et al 1999). Similarly, 
overexpression of Drp1 or dominant-negative mutant (K38A/E) promotes mitochondrial 
fission (Breckenridge et al 2003, Estaquier and Arnoult 2007, Frank et al 2001, Lee et al 
2004, Parone et al 2006, Smirnova et al 2001, Szabadkai et al 2004) whereas, controversially, 
no effect on mitochondrial length was observed in COS-7 cells (Smirnova et al 1998).  
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     The mechanism how mitochondrial fission proceeds in mammals remains obscure. The 
current model is outlined in figure 17. At the beginning of the fission, Drp1 translocates from 
cytosol to the punctate spots of mitochondria where it forms a ring structure. The formation 
of the ring seems to constrict the mitochondria and finally cleaves off one mitochondrion into 
two mitochondria. Alterations in the protein expression levels (overexpression or 
downregulation) and the observation that human recombinant Drp1 is able to tubulate 
artificial liposomes clearly indicate the involvement in the control of mitochondrial fission 
(Danino et al 2004, Ingerman et al 2005, Naylor et al 2006, Roux et al 2006), however, there 
are several questions remain to be answered. One conundrum is how Drp1, which is largely 
localized to the cytosol translocates to the sites of fission. hFis1 was thought to be important 
for such an event, however, Drp1 was able to translocate even in the absence of hFis1 (Lee et 
al 2004).  
Fig. 16 
Morphology of Mitochondria 
Mitochondrial morphology was determined by manipulating the expression level of Fis1. The 
middle panel represents the control-transfected cells (using β-galactosidase expression plasmid). 
The left panel shows a cell in which Fis1 was stably down-regulated with Lentiviral shRNA, 
showing tubular structure. The right panel represents mitochondrial morphology upon Fis1 
overexpression, which reveals spherical fragmented form of mitochondria.  
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     Similarly to the fusion machinery, yeast seems to have more adaptor proteins than 
metazoans. Two additional proteins, Caf4p and Mdv1p (product of FIS2 gene), are found in 
yeast that cooperate with Fis1 to recruit Dnm1 (Cerveny et al 2001, Cerveny and Jensen 2003, 
Griffin et al 2005, Mozdy et al 2000, Tieu and Nunnari 2000). These two adaptor proteins 
contain coiled-coil domain at their N-termini to facilitate the interaction with Fis1 and WD40 
Fig. 17 
Mechanism of Mitochondrial Fission 
Fis1 is equally distributed to the outer 
mitochondrial membrane (A). Upon the initiation 
of mitochondrial fission (B), Drp1 is recruited to 
the site of fission (C), which constricts a 
mitochondrion (D). Finally one mitochondrion is 
split into two mitochondria (E). 
Note that requirement of Fis1 in the recruitment of 
Drp1 to the site of fission is controversial. 
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domain at C-terminus for the binding of Dnm1 (Cerveny and Jensen 2003, Griffin et al 2005, 
Tieu et al 2002). Fis1 interacts with them through TPR domain and the N-terminal extension 
seems to facilitate such association (Dohm et al 2004, Suzuki et al 2003, Suzuki et al 2005, 
Zhang and Chan 2007). Through these domains, Fis1 and Dnm1 indirectly interact to form a 
scaffold for mitochondrial fission. The absence of Mdv1, for example, allows correct Dnm1 
localization for fission, however, mitochondria fail to undergo successful fission. To date, no 
homologs of Mdv1 or Caf4 are reported in mammals.  
     Several other proteins that orchestrate mitochondrial fission have been identified: 
overexpression of the mitochondrial membrane protein, MTP18, induces mitochondrial 
fragmentation and the downregulation results in elongation (Tondera et al 2004, Tondera et al 
2005); mitochondria Rho GTPase, Miro1 and Miro2, regulate mitochondrial morphology 
(Gem1 is its ortholog (Fransson et al 2006, Frederick et al 2004)); and ganglioside-induced 
differentiation associated protein1 (GDAP1) is also known to play a role in mitochondrial 
fission (Niemann et al 2005). Furthermore, pro-apoptotic members of the Bcl-2 family, such 
as Bax and Bak, are also involved in mitochondrial fusion and fission. Bax and Bak interact 
with Mfn2 in healthy cells and may activate the fusion complex as the Bax
-/-
-Bak
-/-
 cells show 
fragmented mitochondria and Mfn2 gets mislocalized (Karbowski et al 2002). Ectopic 
expression of CED-9, homolog of Bax or Bak in C. elegans, is also capable of interacting 
with Mfn2 in HeLa cells and induces mitochondrial fusion (Delivani et al 2006). Additionally 
Endophilin B1 (synonymously known as Bif-1 or SH3GLB1) has been reported to interact 
with Bax and its suppression leads to the defect in fission and the production of tubular and 
spherical mitochondria mixture (Cuddeback et al 2001, Pierrat et al 2001). Bax is able to 
interact with Endophilin B1 (Farsad et al 2001, Karbowski et al 2004b, Peter et al 2004).   
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5.2 Mitochondrial Dynamics and Apoptosis 
     Despite tha fact that mitochondrial fission and fusion occur continuously in healthy cells, 
the mitochondrial network disintegrates during mammalian apoptotic cell death resulting in 
mitochondrial fragmentation and condensation (Breckenridge et al 2003, De Vos et al 1998, 
Desagher et al 1999, Desagher and Martinou 2000, Frank et al 2001, Karbowski et al 2002, 
Mancini et al 1997, Pinton et al 2001a, Zhuang et al 1998). This happens prior to any caspase 
activation or membrane blebbing but at approximately the same time when activated Bax 
translocates to the OMM and Cyt.c gets released, and has been proposed to be an alternative 
or additional mechanism for apoptosis induction (Bossy-Wetzel et al 2003, Frank et al 2001, 
Karbowski and Youle 2003, Youle and Karbowski 2005). The process of mitochondrial 
fragmentation observed during apoptosis requires Drp1 and hFis1 and it cannot be inhibited 
by the pancaspase inhibitor zVAD-fmk (Breckenridge et al 2003, Frank et al 2001, Lee et al 
2004). Mitochondria undergo rapid fragmentation when treated with acetic acid, ethanol, 
H2O2 or amiiodarone (fungicide) in yeast (Fannjiang et al 2004, Kitagaki et al 2007, 
Ludovico et al 2001, Mazzoni et al 2005, Sokolov et al 2006). Furthermore, D. melanogaster 
and C. elegans exhibit mitochondrial fragmentation during apoptosis (Abdelwahid et al 2007, 
Goyal et al 2007, Jagasia et al 2005, Kornbluth and White 2005) and likewise proteins 
involved in mitochondrial dynamics are implicated in the control of apoptosis. However, it 
remains highly controversial and several questions remain to be answered, for example; 
whether fragmentation of mitochondria is required for the induction of apoptosis, whether 
mitochondrial fission occurs before, or required for, MOMP and Cyc.c release (Breckenridge 
et al 2003, Frank et al 2001, Germain et al 2005, Lee et al 2004, Neuspiel et al 2005, Sugioka 
et al 2004), or whether fission observed is an secondary effect of the MOMP (Arnoult et al 
2005a, Arnoult et al 2005b, Delivani et al 2006, Dinsdale et al 1999, Esseiva et al 2004, 
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Frezza et al 2006, Gao et al 2001, Parone et al 2006, Zhuang et al 1998). Inhibition of Drp1 
or hFis1 indeed delays the release of Cyt.c but it does not prevent it. Additionally, release of 
Smac/Diablo or Htr2/Omi are unaffected by the inhibition of Drp1 or hFis1 expression level 
(Estaquier and Arnoult 2007, Parone et al 2006). Several reports described the occurrence of 
MOMP and Cyt.c release happening before the fission event. On the other hand, several 
independent studies showed the release of Cyt.c before mitochondrial fragmentation. 
Although extensive mitochondrial fission is known to occur during apoptosis, fission alone 
does not cause apoptosis. One of the mitochondrial electron potential uncoupler, p-
trifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP), can elicit mitochondrial fission 
without apoptosis and the removal of the drug will retain normal mitochondrial morphology. 
One of the cytomegaloviral proteins, vMIA (viral mitochondria-localized inhibitor of 
apoptosis), interacts with Bcl-2 family members and induces mitochondrial fission while 
functioning to block cell death (Arnoult et al 2004, Karbowski et al 2006, McCormick et al 
2003, Poncet et al 2004).  
5.2.1 Mitochondrial Fusion and Apoptosis 
     Where mitochondrial fission in some experimental systems promotes apoptosis, its 
opposing event, mitochondrial fusion, seems to prevent cells from undergoing apoptosis 
(Karbowski et al 2004a). In support of this, mitochondrial fusion is often reduced during 
apoptosis and depletion of Opa1, Mfn1 or Mfn2 result in poor cell growth and enhances 
susceptibility to apoptotic stimuli (Chen and Chan 2005, Chen et al 2005, Lee et al 2004, 
Olichon et al 2003, Sugioka et al 2004). Downregulation of Mfn1 or Mfn2 increases 
mitochondrial fragmentation as well as the sensitivity of cells to undergo apoptosis (Sugioka 
et al 2004). Increased expression of Mfn1 or Mfn2, on the other hand, delays Bax activation, 
Cyt.c release and apoptotic cell death (Jahani-Asl et al 2007, Neuspiel et al 2005). Ectopic 
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expression of Opa1 is also known to prevent apoptosis induced by the intrinsic pathway but 
not by the extrinsic pathway (Frezza et al 2006). The function of Opa1 as a mitochondrial 
fusion mediator is necessary to exert its protective effect as a genetic mutant of Opa1 that 
fails to initiate fusion can no longer reduce apoptotic cell death (Cipolat et al 2004, Frezza et 
al 2006). 
5.2.2 Drp1 and Apoptosis 
     Although Drp1 expression is sufficient to induce apoptosis in C. elegans (Jagasia et al 
2005), overexpression alone does not induce cell death in mammalian cells, however, the 
level of Drp1 expression controls apoptosis mediated by certain stimuli. Upon apoptotic cue, 
Drp1 is recruited to the OMM where it colocalizes with Bax and Mfn2 (Arnoult et al 2005b, 
Breckenridge et al 2003, Frank et al 2001, Karbowski et al 2002, Wasiak et al 2007). The 
expression of dominant negative Drp1 (K38A) or knock-down of endogenous Drp1 by 
siRNA not only inhibits mitochondrial fragmentation (Barsoum et al 2006, Breckenridge et al 
2003, Frank et al 2001, Germain et al 2005, Lee et al 2004, Smirnova et al 2001) but also 
delays the release of Cyt.c and prevents the events such as loss of ΔΨm or DNA 
fragmentation (Frank et al 2001). On the contrary, overexpression of Drp1 in HeLa cells 
increased the release of Cyt.c and activation of caspases upon staurosporine treatment 
(Szabadkai et al 2004), although another study showed conflicting data (Karbowski et al 
2002). Post-translational modification of Drp1 also regulates its role in apoptosis. Expression 
of phosphomimetic mutant (S656D) leads to elongation and increased resistance to 
staurosporine- and etoposide-induced apoptosis (Cribbs and Strack 2007). Conversely, 
expression of a phosphorylation incompetent mutant (S656A) failed to suppress apoptosis 
mediated by exogenous signals and showed increased mitochondrial fission (Cribbs and 
Strack 2007).  
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     Involvement of Drp1 in apoptosis is not limited to mammalian systems. A knockout yeast 
strain for DNM1 is resistant to death stimuli and mitochondrial fragmentation is significantly 
slower than wild type strains (Fannjiang et al 2004, Ivanovska and Hardwick 2005). In the C. 
elegans system, reducing the activity of Drp1 by a dominant negative mutant (K40A, 
equivalent mutation of human Drp1 K38A) forms more elongated mitochondria and 
moreover causes inappropriate survival of approximately 15% of the cells that are destined to 
die (Jagasia et al 2005). Similarly, overexpression of wild type Drp1 during embryogenesis 
induces mitochondrial fragmentation and results in aberrant cell proliferation culminating in 
about 20% of cells surviving, which are normally cleared by apoptosis (Jagasia et al 2005). 
Flies, too, display fragmented mitochondria (Abdelwahid et al 2007, Goyal et al 2007) upon 
certain treatments (etoposide, actinomycin D, cyclohexamide or ceramide). Downregulation 
of Drp1 by siRNA or genetic mutants inhibits this fragmentation and suppresses cell death 
(Goyal et al 2007). A small molecule that inhibits Drp1 or Dnm1, (Mdivi-1) was reported to 
inhibit mitochondrial fragmentation in both yeast and mammals, and to inhibit Bax-induced 
Cyt.c release and cell death in mammalian system (Cassidy-Stone et al 2008). 
5.2.3 hFis1 and Apoptosis 
      The endogenous role of Fis1 is to promote mitochondrial fission. However, the 
expression of this protein has also been known to induce extensive mitochondrial fission (Fig. 
16) as well as apoptosis in mammalian system (James et al 2003). In support of this, 
Fannjiang and colleagues found that a yeast strain lacking Fis1 increases viability induced by 
H2O2 and acetic acid and the externalisation of phosphatidylserine and the activation of 
caspases were alleviated in Fis1 knock-out yeast strain (Fannjiang et al 2004). Furthermore, 
they showed the fragmentation of mitochondria was still observed during yeast apoptosis in 
the absence of Fis1 but the lack of Fis1 increases cell viability by improper recruitment of 
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Dnm1 to the sites of fission (Fannjiang et al 2004). It was, however, shown by a same group 
that this Fis1 knock-out yeast strain harboured a second mutation on WHI2 gene, which 
compensates for the cell death and growth control defects (Cheng et al 2008).   
     In mammalian system, the expression of Fis1 is accepted as a proapoptotic factor (Alirol 
et al 2006, James et al 2003, Lee et al 2004, Parone et al 2006) though there are some 
discrepancies in how Fis1 can induce apoptosis. The overexpression of Fis1 is known to 
induce the release of cytochrome c from mitochondria (Alirol et al 2006, James et al 2003) 
and this can be inhibited by the co-expression of Bcl-XL or the dominant negative form of 
Drp1 (Drp1 K38A (James et al 2003)). Furthermore, mitochondrial fission induced by Fis1 
overexpression can also be inhibited by the co-expression of these two factors. However, the 
apoptosis induced by Fis1, as measured by nuclear fragmentation, can only be inhibited by 
the expression of Bcl-XL but not by Drp1 K38A (James et al 2003), suggesting that the 
fission induced by Fis1 expression is genetically separable from its ability to induce apoptosis.  
Another report described that the apoptosis induced by Fis1 is dependent on Bax and Bak, 
and more specifically the presence of mitochondria-localized Bax, although strangely Fis1 
does not activate Bax (Alirol et al 2006).  Moreover mitochondrial fission caused by Fis1 is 
Bax/Bak-independent (Alirol et al 2006). While these publications were based on the gain-of-
function experiment of Fis1, some reverse genetic studies were also reported. For example, 
Lee et al revealed that the down-regulation of Fis1 makes cells resistant to various pro-
apoptotic stimuli including staurosporine, actinomycin D, etoposide and the activation of Fas 
receptor as determined by the Bax activation/translocation, cytochrome c release, caspase-3 
activation and nuclear fragmentation (Lee et al 2004). On the contrary, Parone et al reported 
that the knock-down of Fis1 does not make cells refractile to apoptotic stimuli such as 
actinomycin D or UV irradiation (Parone et al 2006). 
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6.     Involvement of the Endoplasmic Reticulum in Apoptosis 
6.1 Mechanism of ER Stress Responses 
     The endoplasmic reticulum is primarily recognized as an organelle for calcium storage 
and the site of protein synthesis and folding. Correct folding of nascent proteins, achieved by 
ER chaperones, is important for the maintenance of cellular functions. To maintain this, the 
ER utilises a mechanism that senses the accumulation of misfolded proteins in the ER lumen. 
Unfolded proteins are normally disposed by a process known as “ER-associated protein 
degradation” (ERAD), whereby improperly folded proteins are recognized, retrotranslocated 
to the cytosol, ubiquitinated and then disposed by proteasome degradation (Baffy et al 1993, 
Kaiser and Edelman 1977, Kaiser and Edelman 1978, Schroder and Kaufman 2005a). It is, 
however, possible that an excess of misfolded proteins are produced when the capacity of the 
ERAD system is surpassed. In such a situation, the ER-stress response or the unfolded protein 
response (UPR) is activated (Schroder and Kaufman 2005b, Schroder and Kaufman 2005c). 
Several chemicals are known to induce ER-stress: tunicamycin inhibits N-glycosylation, 
thapsigargin modulates the ER Ca
2+
 homeostasis, dithiothreitol (DTT) disrupts disulfide bond 
formation and brefeldin A inhibits retrograde transport from the ER to Golgi apparatus 
(reviewed in (Yoshida 2007). There are four main mechanisms in the UPR system. Firstly, 
cells transiently reduce protein synthesis to decrease the burden on the ER. Secondly, the 
UPR induces the transcription of ER chaperones and ERAD component genes to increase the 
folding capacity or the ERAD ability. Lastly, if the proper homeostasis of the protein folding 
cannot be restored, cells are disposed through apoptotic cell death. These responses are 
regulated by three main pathways as described below (Fig. 18).  
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6.1.1 ATF-6 Pathway 
     ATF-6 is an ER-localized transmembrane protein that senses the accumulation of unfolded 
proteins in the ER (Haze et al 1999, Yoshida et al 1998a, Yoshida et al 2000, Yoshida et al 
2001). In the absence of stress, Grp78 (glucose-regulated protein 78) or synonymously 
known as BiP (Binding protein) is bound to and hindering the Golgi-localization signal (GLS, 
(Chen et al 2002, Shen et al 2002, Shen and Prywes 2004, Ye et al 2000)). In response to ER 
stress, Grp78 dissociates from ATF-6 allowing the exposure of the GLS, which induces the 
translocation of ATF-6 to the Golgi apparatus. ATF-6 is then proteolytically cleaved at two 
sites in the Golgi apparatus and one of the fragments generated translocates to the nucleus 
where it induces gene expression of ER chaperons (such as Grp78), C/EBP homologous 
protein (CHOP) and X-box binding protein 1 (XBP-1 (Yoshida et al 1998a)).  
6.1.2 PERK Pathway 
     PERK is another ER protein involved in mediating the ER stress pathway (Harding et al 
1999, Harding et al 2000, Harding et al 2001). In the absence of ER stress, the interaction 
between Grp78 and PERK suppresses PERK activation. Conversely, upon ER stress, Grp78 
dissociates from PERK and PERK is activated through oligomerization and by trans 
phosphorylation (Bertolotti et al 2000). Active PERK then phosphorylates eukaryotic 
initiation factor 2 (eIF2), which broadly inhibits gene transcription. However, this attenuation 
of transcription can be bypassed in certain genes, for example genes with an internal 
ribosomal entry site in their 5’ untranslated regions such as ATF-4. The upregulation of ATF-
4 induces the expression of several genes such as stress response and redox reaction genes 
and CHOP (Harding et al 2003).   
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6.1.3 IRE1 Pathway 
     The third sensory protein in the ER is inositol requirement 1 (IRE1 (Iwawaki et al 2001, 
Tirasophon et al 1998, Wang et al 1998)). Upon ER stress, Grp78 dissociates from IRE1 
allowing the activation of IRE1 through oligomerization and phosphorylation similar to 
PERK activation (Bertolotti et al 2000). Activated IRE1 removes a 26-nucleotide intron from 
the XBP-1 mRNA, previously upregulated by ATF-6 (Calfon et al 2002, Yoshida et al 2001). 
This new mRNA encodes a stable and active transcription factor sXBP-1 (for splice variant 
of XBP-1). Translated sXBP-1 translocates to the nucleus and induces the gene expression of 
ERAD components, ER chaperones, lipid synthesis and ER biogenesis (Lee et al 2003, 
Sriburi et al 2004). 
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Fig. 18 
The ER Stress Response Pathways 
ATF-6 pathway: Dissociation of Grp78 from ATF-6 results in the translocation of ATF-6 to the 
Golgi apparatus where ATF-6 is cleaved. One of the fragments translocates to the nucleus where 
it induces the gene expression of chaperones, such as CHOP and XBP-1. 
PERK pathway: Monomeric PERK oligomerize and transphosphorylates. The activated PERK 
then phosphorylates eIF2, which in one scenario inhibits transcription. However, certain genes 
are upregulated, such as ATF-4. ATF-4 translocates to the nucleus and induces the expression of 
stress response and redox response genes as well as CHOP. 
IRE1 pathway: Similar to PERK, IRE1 is activated through oligomerization and 
phosphorylation. Activated IRE1 removes 26-nucleotides from the XBP-1 mRNA, which is 
produced by ATF-6 to create new mRNA for XBP-1. The newly synthesized more stable and 
active sXBP-1 protein translocates to the nucleus and expresses genes for the ERAD 
components, ER chaperones, lipid synthesis and ER biogenesis. 
Figure modified from (Szegezdi et al 2006) 
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6.2 The Interplay of the Endoplasmic Reticulum, Mitochondria and Calcium 
for Apoptosis Regulation 
6.2.1 Calcium Channels in the Cell 
     Cytoplasmic calcium concentration is maintained at a relatively low level of around 
100nM whereas the extracellular environment has calcium concentrations of around 1.2mM 
(1.8mM in normal tissue culture medium). This gradient is regulated by Ca
2+
 channels 
(voltage-sensitive, store-operated or receptor-operated channels) and Na
+
/Ca
2+
 exchangers 
localized on the plasma membrane of a cell (Fig. 19). Intracellularly, both the nucleus and the 
mitochondria contain similar calcium concentrations of ~100nM. However, the endoplasmic 
reticulum or the sarcoplasmic reticulum in muscle cells are the storage compartments of 
calcium ions in the cell with a [Ca
2+
]ER of up to 1mM (ranges between 100-1000µM). 
Calcium flux into nucleus is largely mediated by passive diffusion through the nuclear pores. 
Although the affinity to this ion is low, a calcium uniporter located in the inner mitochondrial 
membrane allows the calcium influx to this organelle (Fig. 19). Conversely, Na
+
/ Ca
2+ 
and 
H
+
/Ca
2+ 
exchanger and the PT-pore mediate the egression of calcium ions from this organelle 
(Fig. 19). On the endoplasmic reticulum, there are three proteins that regulate calcium 
movement. The sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) is involved 
in the uptake of calcium into the ER whereas the inositol-1,4,5-trisphosphate receptor (IP3R) 
and the ryanodine receptor (RyR) mediate the release of calcium ions from the ER (Fig. 19 
(Berridge et al 2000)).  
     Calcium ions represent one of the most important intracellular secondary messengers that 
regulate numerous signalling pathways and play crucial roles in maintaining cellular 
homeostasis. It is, however, possible that, when calcium ions are overloaded in the cytosol by 
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the opening of calcium channels located on the plasma membrane or the ER, cells undergo 
apoptosis. Such dysregulation of intracellular calcium homeostasis is observed in various 
pathological and experimental settings (Krieger and Duchen 2002). Furthermore, recent 
studies indicate that the interface between mitochondria and the ER plays a crucial role 
mediating the calcium-induced apoptotic pathway. 
 
 
 
 
 
 
Fig. 19 
Cellular Calcium Channels 
Major calcium channels found in the cell are shown. On the plasma membrane, three calcium 
channels, receptor-operated, store-operated and voltage-sensitive channels are expressed to 
import calcium ions into the cells. Nifedipine can inhibit voltage-sensitive calcium channel. 
Conversely, calcium-sodium exchanger exports calcium ions out of the cells. On the membranes 
of the ER, sarcoplasmic and endoplasmic reticulum calcium ATPase regulates the influx of 
Ca
2+
. Two additional receptors, inositol 1,4,5-trisphosphate receptor (IP3) and ryanodine 
receptor govern the efflux of calcium ions from the ER. Competitive inhibitors for each channel 
are also indicated. On the mitochondrial membrane, a calcium uniporter takes up Ca
2+
 from the 
cytosol, which can be inhibited by the drug Ru360.  Egression of calcium is mediated either by 
the opening of PTP or calcium-sodium/hydrogen exchanger. 
Note that arrow heads represent the direction of ion movement. 
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6.2.2 Mitochondrial Calcium and Apoptosis 
     The import of calcium ions into mitochondria requires VDAC, a component of the PTP, 
and the uniporter (Bathori et al 2006, Gincel et al 2001, Kirichok et al 2004, Rapizzi et al 
2002). Such movement of Ca
2+
 is largely mediated by the electrochemical gradient of the 
mitochondrial membrane potential (ΔΨm) being 180mV. Both VDAC and the uniporter show 
calcium-dependent activation, which is necessary for the homeostatic control of the 
cytoplasmic calcium concentration (Bathori et al 2006, Gincel et al 2001, Rapizzi et al 2002). 
The involvement of calcium in regulation of the mitochondrial metabolism stems from the 
finding that four metabolic enzymes, phosphate, pyruvate, α-ketoglutarate and isocitrate 
dehydrogenases, require calcium for their activation (Denton et al 1972, Denton et al 1978, 
Hansford and Chappell 1967, McCormack and Denton 1979, Mccormack et al 1990, Nichols 
and Denton 1995). These enzymes are important for the production of ATP and thus 
enhancing such signalling pathway by mitochondrial calcium results in the increased 
synthesis of ATP production. Likewise, when the rise of [Ca
2+
]m is inhibited by BAPTA, a 
cytosolic calcium chelator, no increase in ATP provision was observed (Jouaville et al 1999). 
By contrast, sequestration of excess calcium ions in mitochondria occurs under various 
pathophysiological conditions and leads to the demise of the cells. It is known that high 
[Ca
2+
]m result in transient PTP opening through cyclophilin D interaction (Basso et al 2005). 
Furthermore, C2-ceramide pre-treated cells undergo partial loss of mitochondrial membrane 
potential and facilitate the release of cyt.c (Pinton et al 2001a, Szalai et al 1999). Both 
processes were inhibited by the application of cyclosporin A, implicating the involvement of 
PTP (Pinton et al 2001a, Szalai et al 1999). Mitochondria are capable of buffering calcium 
overload and the transient opening of PTP is not immediately lethal to the cells. However, if 
both mitochondrial and cytosolic calcium concentrations are persistently high, the efflux of 
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mitochondrial calcium will not reduce [Ca
2+
]m as exported calcium ions are taken up by 
mitochondria due to high level of cytosolic calcium. This leads to the continuous opening of 
PTP and solute flux into the mitochondrial matrix leading to the MOMP and cell death.  
6.2.3 Interface Between Endoplasmic Reticulum and Mitochondria 
     While mitochondria and the endoplasmic reticulum are two distinctive organelles in the 
cell, their physical interaction has been known for many decades as detected by electron 
microscopy and cell fractionation studies (Csordas et al 2006, Mannella 2006, Meier et al 
1981, Shore and Tata 1977a). However, only recently were several proteins identified that 
facilitate the functional and/or physical interaction between the two cellular organelles; for 
example, PACS-2 and BIK have been shown to transmit signals for apoptosis from the ER to 
mitochondria (Simmen et al 2005); Mitofusin 2 (de Brito and Scorrano 2008a) and 
Mmm1/Mdm10,12,34 were discovered to facilitate the physical association between 
mitochondria and the ER; and inositol 1,4,5-trissphosphate  (IP3) receptor and the voltage 
dependent anion channel (VDAC) connect these two organelles through glucose regulating 
protein 75 (GRP75, (Szabadkai et al 2006)). Some of these factors are simply structural 
components. However, some proteins, such as VDAC and IP3 are heavily involved in the 
calcium homeostasis and likewise it is now accepted that the calcium modulation in the ER 
regulates some of the apoptosis pathways.  
     The original connection between the ER and mitochondria in calcium signalling came to 
light in late 90s. During the study of IP3R- and RyR-mediated [Ca
2+
]c change, it was found 
that [Ca
2+
]m oscillation correlates with changes in [Ca
2+
]c and mitochondria eventually 
underwent MOMP and cell death (Rizzuto et al 1993, Rizzuto et al 1994, Rutter et al 1996). 
Later, it was discovered that the ER-released calcium ions are taken up by juxtaposed 
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mitochondria, which induces MOMP and the release of cyt.c (Csordas et al 1999, Rizzuto et 
al 1993). This released cytochrome c then binds to IP3R and blocks Ca
2+
-mediated inhibition 
of IP3-induced calcium efflux thereby enhancing and propagating the MOMP. Moreover, a 
tight connection between the ER and mitochondria has been reported and several factors such 
as PACS-2 and BIK were identified (Simmen et al 2005). This spatial proximity also 
promotes the efficient calcium transfer between these organelles and avoids cytosolic calcium 
buffering.  
     This calcium signalling propagation process can be affected by several factors. The 
expression of tBid enhances the MOMP and thus promotes the IP3R-mediated calcium 
signals to mitochondria (Csordas et al 2002). Moreover, overexpression of anti-apoptotic Bcl-
2 family protein, Mcl-1 or ER-targeted Bcl-2, or the enhancement of mitochondrial 
biogenesis by PGC-1α reduces the efficacy of mitochondrial Ca2+ uptake (Bianchi et al 2006, 
Minagawa et al 2005). The morphology of mitochondria seems to also play a role. The 
mitochondrial calcium signalling was reduced upon Drp1-mediated mitochondrial fission 
(Szabadkai and Rizzuto 2004, Szabadkai et al 2004). Strengthening the ER-mitochondria 
connection also promoted the inter-organelle calcium transfer (Csordas et al 2006). The 
expression of a synthetic crosslinker that bridges ER and mitochondria was found to enhance 
the Ca
2+
 signalling and MOMP (Csordas et al 2006). Similarly, enhancing the transfer of Ca
2+
 
from the ER to mitochondria by expressing VDAC augmented ceramide-induced apoptosis. 
     Although these studies show a strong connection between the ER-mitochondria calcium 
signalling and the apoptotic cell death, it is, however, not clear if such a process is necessary 
for the execution of cells or if it is simply an additional stress that enhances cell death. The 
group of Luca Scorrano demonstrated that the transfer of calcium ions from the ER to 
mitochondria is required for some, but not all, apoptosis signals (Scorrano et al 2003). It was 
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known previously that the amplitude of mitochondrial signal determines the fate of cells. It 
was, however, shown that the content of the ER calcium plays a pivotal role in deciding if 
cells undergo apoptotic cell death (Scorrano 2003). The ablation of the ER Ca
2+
 buffering 
protein calreticulin or overexpression of the plasma membrane Ca
2+
/Na
+
 exchanger, which 
decreases [Ca
2+
]ER, protected cells from apoptosis (Nakamura et al 2000, Pinton et al 2001a). 
Similarly, when two prominent pro-apoptotic factors, Bax and Bak, were removed from the 
cell, the ER calcium load was reduced and several pro-apoptotic stimuli including 
arachidonic acid, oxidative stress, C2-ceramide and tBid were unable to induce apoptosis. 
Furthermore, inhibiting mitochondrial calcium uptake reduced Bax/Bak-induced apoptosis 
(Nutt et al 2002a, Nutt et al 2002b). However, when the ER Ca
2+
 level was increased by the 
expression of SERCA in a Bax
-/-
Bak
-/-
 genetic background, those pro-apoptotic stimuli 
sensitised cells for apoptosis, indicating that the ER calcium content, and as a consequence 
the surge of calcium release or the influx into mitochondria is necessary for the execution of 
cells (Arnaudeau et al 2002, Pinton et al 2001a). It was later found that the balance between 
anti-apoptotic (Bcl-2 and Bcl-XL) and pro-apoptotic (Bax and Bak) Bcl-2 family members 
control the ER calcium content (Chen et al 2004, Mathai et al 2005, Oakes et al 2005, White 
et al 2005). Overexpression of ER-targeted Bcl-2 decreases [Ca
2+
]ER whereas the expression 
of Bax or Bak increases it (Pinton et al 2000, Pinton et al 2001b, Vanden Abeele et al 2002).  
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6.3 Involvement of Bap31 in Apoptosis 
     Another ER-localized protein that regulates calcium-mediated apoptosis is B-cell 
activating protein 31 (Bap31). Bap31 is an evolutionally conserved (Fig. 20), ubiquitously 
expressed 28kDa protein highly enriched in the outer membrane of the ER that 
homodimerises and heterodimerises with the closely related Bap29 protein (Adachi et al 1996, 
Annaert et al 1997, Kim et al 2000b, Lambert et al 2001, Ng et al 1997). Bap31 and Bap29 
share a 50% protein sequence identity and possess an conserved di-lysine motif for the ER 
localization at the C-terminus (Fig. 21) but they are encoded by different genes. 
M.musculus     MSLQWTTVATFLYAEVFAVLLLCIPFISPKRWQKVFKSRLVELVVTYGNTFFVVLIVILV 60 
R.norvegicus   MSLQWTAVATFLYAEVFAVLLLCIPFISPKRWQKIFKSRLVELVVTYGNTFFVVLIVILV 60 
M.auratus      MSVQWTAVATFLYAEVFAVLLLCIPFISPKRWQKIFKSRLVELVVTYGNTFFVVLIIILV 60 
H.sapiens      MTLQWTAVATFLYAEVFVVLLLCIPFISPKRWQKIFKSRLVELLVSYGNTFFVVLIVILV 60 
D.rerio        MSLQWTAVATFLYAEVLAVLLLCVPFISPKRWSKFFKSRLVTAITSYGNTAFIVIICILV 60 
               *::***:*********:.*****:********.*.******  :.:**** *:*:* *** 
 
M.musculus     LLVIDAVREILKYDDVTEKVNLQNNPGAMEHFHMKLFRAQRNLYIAGFSLLLSFLLRRLV 120 
R.norvegicus   LLVIDAVREIRKYDDVTEKVNLQNNPGAMEHFHMKLFRAQRNLYIAGFSLLLSFLLRRLV 120 
M.auratus      LLVIDAAREIRKYDDVTEKVNLQNNPGAMEHFHMKLFRAQRNLYIAGFSLLLSFLLRRLV 120 
H.sapiens      LLVIDAVREIRKYDDVTEKVNLQNNPGAMEHFHMKLFRAQRNLYIAGFSLLLSFLLRRLV 120 
D.rerio        FLLIDAFREVRKYS-VAEKVDLSNNPVAIEHIHMKLFRAQRNEYIAGFALLLCLLLRRLA 119 
               :*:*** **: **. *:***:*.*** *:**:********** *****:***.:*****. 
 
M.musculus     TLISQQATLLASNEAFKKQAESASEAAKKYMEENDQLKKGAAEDGDKL-DIG-NTEMKLE 178 
R.norvegicus   TLISQQATLLASNEAFKKQAESASEAAKKYMEENDQLKKGTAEDGGKL-DVG-SPEMKLE 178 
M.auratus      TLISQQATLLASNEAFKKQAESASEAAKKYMEENDQLKKEAAEDGAKL-DVG-NTEVKLE 178 
H.sapiens      TLISQQATLLASNEAFKKQAESASEAAKKYMEENDQLKKGAAVDGGKL-DVG-NAEVKLE 178 
D.rerio        TLLSQQATLMASHEAFQKQAEGANDAAKKYMEENEKLQEKLRQAGIEVPEVGGKAKGGME 179 
               **:******:**:***:****.*.:*********::*::     * :: ::* ..:  :* 
 
M.musculus     E-NKSLKNDLRKLKDELASTKKKLEKAENEALAMQKQSEGLTKEYDRLLEEHAKLQASVR 237 
R.norvegicus   E-NKILKTDLKKLKDELASTKKKLEKAENEALAMQKQSEGLTKEYDRLLEEHAKLQASVR 237 
M.auratus      E-NKTLKNDLKKLKDELANTKKKLEKAENEALAMQKQSEGLTKEYDRLLEEHAKLQASVH 237 
H.sapiens      EENRSLKADLQKLKDELASTKQKLEKAENEVLAMRKQSEGLTKEYDRLLEEHAKLQAAVD 238 
D.rerio        EDKKNLKEEVRQLKDELDATKKALQKSDSDVKAMKKQAENLTTEYDRLLEEHARLQAKCD 239 
               * :: ** ::::*****  **: *:*::.:. **:**:*.**.**********:***    
 
M.musculus     GPSVKKEE 245 
R.norvegicus   GPSDKKEE 245 
M.auratus      GPSAKKEE 245 
H.sapiens      GPMDKKEE 246 
D.rerio        AQQDKKSD 247 
               .   **.: 
 
 
 
 
 
 
 
Fig. 20 
Multiple Sequence Alignment of Bap31 from Different Species 
Human Bap31 and Bap31 from other primates share an identity of over 90% and 64% between 
zebra fish showing the high conservation of this protein between species. 
Accession number for each sequence is as follows: M. musculus (NP_036190.2), R. norvegicus 
(NP_001004224), M. auratus (ABF71880), H. sapiens (CAA57415.1) and D. rerio 
(NP_956386). 
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Bap31  MTLQWTAVATFLYAEVFVVLLLCIPFISPKRWQKIFKSRLVELLVSYGNTFFVVLIVILV 60 
Bap29  MTLQWAAVATFLYAEIGLILIFCLPFIPPQRWQKIFSFNVWGKIATFWNKAFLTIIILLI 60 
       *****:*********: ::*::*:***.*:******. .:   :.:: *. *:.:*::*: 
 
Bap31  LLVIDAVREIRKYDDVT--EKVNLQNNPGAMEHFHMKLFRAQRNLYIAGFSLLLSFLLRR 118 
Bap29  VLFLDAVREVRKYSSVHTIEKSS-TSRPDAYEHTQMKLFRSQRNLYISGFSLFFWLVLRR 119 
       :*.:*****:***..*   ** .  ..*.* ** :*****:******:****:: ::*** 
 
Bap31  LVTLISQQATLLASNEAFKKQAESASEAAKKYMEENDQLKKGAAVDGGKLDVGNAEVKLE 178 
Bap29  LVTLITQLAKELSNKGVLKTQAENTNKAAKKFMEENEKLKR-ILKSHGK----DEECVLE 174 
       *****:* *. *:.: .:*.***.:.:****:****::**:    . **    : *  ** 
 
Bap31  EENRSLKADLQKLKDELASTKQKLEKAENEVLAMRKQSEGLTKEYDRLLEEHAKLQAAVD 238 
Bap29  AENKKLVEDQEKLKTELRKTSDALSKAQNDVMEMKMQSERLSKEYDQLLKEHSELQDRLE 234 
        **:.*  * :*** ** .*.: *.**:*:*: *: *** *:****:**:**::**  :: 
 
Bap31  GPMDKKEE 246 
Bap29  -RGNKKRL 241 
          :**.  
 
 
 
 
 
     Bap31 is comprised of three transmembrane domains with a 13kDa C-terminus cytosolic 
domain. This cytosolic domain is known (I) to interact with a specific isoform of γ-actin 
(Ducret et al 2003, Nguyen et al 2000); (II) to associate with and promote the vesicular 
trafficking of cellubrevin (Annaert et al 1997), major histocompatibility complex class I 
molecules (Paquet et al 2004, Spiliotis et al 2000), tetraspanins (Stojanovski et al 2004), 
CD11b/CD18 (Zen et al 2004), and cystic fibrosis transmembrane conductance regulator 
(Lambert et al 2001, Wang et al 2008); and (III) to retain mIgD (Schamel et al 2003), 
tyrosine phosphatase-like protein (Wang et al 2004), and cytochrome P450 CYP2C2 in the 
ER (Szczesna-Skorupa and Kemper 2006). Additionally, Bap31 also interacts with proteins 
that are involved in apoptosis: Bcl-2, Bcl-XL, caspase-8 and Spike (Ng et al 1997) 
(Breckenridge et al 2002, Mund et al 2003). Bap31 possesses two identical caspase cleavage 
sites at D164 and D238 (Fig. 21, highlighted in blue). A non-cleavable form of Bap31 was 
Fig. 21 
 Multiple Sequence Alignment of Human Bap31 and Bap29 
Human Bap31 and Bap29 display a 50% protein sequence identity but they are encoded by 
different genes.  The ER localization signal is indicated with a box at the C-terminus. Multiple 
sequence alignment was performed using ClustalW2. Accession no: CAA57415.1 (Bap31) and 
AAH08478.1 (Bap29) 
Sequence highlighted in blue (AAVD) indicates the caspase recognition sites and C-terminal 
dilysine (highlighted in yellow) indicates the ER-localization signal. 
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implicated to be anti-apoptotic through the association with Bcl-2 and Bcl-XL proteins 
(Nguyen et al 2000). On the other hand, upon cleavage by caspase-8, Bap31 produces an 
integral membrane fragment, p20Bap31, and releases Bcl-2 and Bcl-XL, when Spike was 
overexpressed (Mund et al 2003). This cleaved fragment of Bap31 has been reported to 
induce mitochondrial fission and apoptosis in a calcium-dependent manner when expressed 
ectopically (Annaert et al 1997, Granville et al 1998, Ng et al 1997, Nguyen et al 2000, Shore 
and Tata 1977b). Several other papers reported the connection between Bap31 cleavage and 
apoptosis induction upon ER stress (Chandra et al 2004, Maatta et al 2000, Zuppini et al 
2002). Moreover, cells expressing a dominant-negative, caspase-cleavage resistant Bap31 are 
refractory to Fas-induced apoptosis indicating the importance of this protein both in the 
intrinsic and the extrinsic pathway of apoptosis (Nguyen et al 2000). Although the 
involvement of Bap31 in apoptosis has been widely accepted, the precise mechanism of how 
Bap31 regulates apoptosis is poorly understood. 
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Objectives and Hypothesis 
      
 This project is aimed to study how mitochondrial fission factor Fis1 induces apoptosis. 
Though several groups have reported the effects of Fis1-mediated apoptosis, the exact 
cellular mechanism and the signalling pathway emanated from Fis1 is yet to be uncovered. 
Scorrano and colleagues indicated that Fis1 signals to the endoplasmic reticulum for 
apoptosis induction (Alirol et al 2006). However, they did not identify the protein that Fis1 
signals to. We hypothesized that the expression of Fis1 leads to the activation of the Bap31 
protein that is localized to the ER. This protein was proposed to be a target because of the 
presence of two caspase cleavage sites and since the cleaved fragment (p20Bap31) is known 
to induce apoptosis (Breckenridge et al 2003). Therefore, we thought that the expression of 
Fis1 results in the activation of Bap31 leading to the cleavage of Bap31 to produce p20Bap31. 
We proposed that this pro-apoptotic factor then signals back to mitochondria for cell death 
execution. 
 
 
Hypothesis 
I propose that mitochondrial fission protein, Fis1, 
induces apoptosis first by signalling to the endoplasmic 
reticulum-localized protein Bap31. This activates Bap31 
by the proteolytic cleavage of this protein to produce the 
cleaved fragment p20Bap31. Subsequently, p20Bap31 
induces apoptosis by signalling back to mitochondrial 
for apoptosis execution. 
Scissor marks indicate the caspase recognition sites. 
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Materials and Methods 
1.    Reagents 
     The following products were purchased from Sigma-Aldrich: 2-mercaptoethanol 
(M7522), acrylamide (40% solution, A7168), actinomycin D (A1410), agarose (A9539), 
ammonium persulfate (A3678), ampicillin sodium salt (A9518), bongkrekic acid (BA, 
B6179), bovine serum albumin (BSA, A7906), calcium chloride (C7902), cycloheximide 
(C7698), dimethyl sulfoxide (D2650), DMEM AQmedia
TM
 (D0819), doxorubicin (D1515), 
EGTA (E4378), etoposide (E1383), foetal calf serum (F7524), glucose (G7021), HEPES 
(H3375), histamine (H7125), LB-broth (L3022), L-glutamine (G7513), magnesium sulphate 
heptahydrate (63138), Mdivi-1 (M0199), NP-40 (I3021), Polybrene® (H9268), propidium 
iodide solution (1mg/ml, P4864), puromycin dihydrochloride (P8833), sodium azide (S8032), 
sodium butyrate (30,341-0), sodium citrate (S1804), sodium deoxycholate (30970),  sodium 
pyruvate (S8636), staurosporine (S4400), TEMED (T9281), Triton X-100 (T8532), 
TWEEN
®
 (P5927) and yeast extract (Y1625). 
     10x PBS (14200-067), DAPI (D3571), DiOC6 (D273), DMEM (21969-035), Fluo-4/AM 
(F14217), Fura-2/AM (F1221), library efficiency
®
 DH5αTM chemocompetent bacteria 
(18263-012), Mito Tracker
®
 Red CMXRos (M7512), oligofectamine (12252-011), Opti-
MEN (22600134), penicillin/streptomycin (100U/ml and 100μg/ml, respectively, 15070-063), 
PicoGreen (P7589), pLenti7.3/V5-TOPO
®
 TA cloning kit (K5310-00), PureLink
TM
 HiPure 
plasmid filter purification kit (K2100-07), Rhod-2/AM (R1245MP), TMRE (T669) and 
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Trypsin-EDTA solution (0.5%, 15400-54), were from Invitrogen or Molecular Probes. Note 
that all the oligos (both primers and siRNAs) were also purchased from Invitrogen. 
     The following reagents were purchased from Fermentas: 5x protein loading buffer 
(R0891), 6x DNA loading dye (R0611), 50x TAE buffer (#B49), Bradford (500-0006), 
GeneRuler
TM
 1kb DNA ladder (SM0314), GeneRuler
TM
 1kb plus DNA ladder (SM1334), 
PageRuler
TM
 prestained protein ladder (SM1811 or SM0671), ProteoBlock
TM
 protease 
inhibitor cocktail (R1321). The following enzymes were also from Fermentas: AgeI 
(FD1464), BamHI (FD0055), DraI (FD0224), EcoRI (FD0274), HindIII (FD0505), NcoI 
(FD0575), NotI (FD596), SacI (FD1134), XhoI (FD0695) and T4 DNA ligase HC (EL0013). 
     2-APB (100065), BAPTA/AM (196419), dantrolene (251680), nifedipine (481981), 
thapsigargin (586005) and zIETD-fmk (218759) were purchased from EMD4Biosciences 
     0.5M Tris-HCl pH 6.8 solution (161-0799), 1.5M Tris-HCl pH 8.8 solution (161-0798), 
10x TGS buffer (161-0772) and SDS solution (10% w/v, 161-0416) were from Bio-Rad 
Laboratories; Hyperfilm
TM
 high performance chemoluminescent film (28906837), protein G 
sepharose
TM
 4 fast flow (17-0618-01), superpose-12 10/300 GL gel filtration/size-exclusion 
chromatography column (17-5173-01) from GE Healthcare; and CaspaTag
TM
 caspase-3/7 in 
situ assay kit sulforhodamine (APT503), CaspaTag
TM
 caspase-8 in situ assay kit fluorescein 
(APT408), PureProteome magnetic protein G beads (LSKMAGG10) and PVDF membrane 
(IPVH00010) were from Millipore. 
     QuickChange II site-directed mutagenesis kit (#200523) and StrataClone mammalian 
expression vector systems (#240230) were from Agilent Technologies; potassium chloride 
(101984) and sodium chloride (10241) from BDH Laboratory Supplies; polyvinyl alcohol 
mounting medium with DABCO (10981) and saponine (47036) from Fluka; and 
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pAdVantage
TM
 vector (E1711) and Wizard SV gel PCR clean-up system (A9282) from 
Promega; Effectene (301427) and SuperFect (301307) from QIAGEN.  
     GelRed
TM
 nucleic acid gel stain (41002) from Biotium; trypton (0123-17-3) was from 
DIFCO laboratories; TNF-α (522-008-C050) from Enzo Lifesciences; PhusionTM DNA 
polymerase (F-553) from Finnzymes; zVAD-fmk (O103) from MP Biomedicals; LB-agar 
(852323) from OXOID Ltd.; enhanced chemoluminescent reagent (#32106) from Pierce; and 
paraformaldehyde (28908) from Thermo Scientific.  
     Calcium free DMEM (E15-078) was purchased from PAA Laboratories GmbH. 
     Please refer to the appropriate sections for the details of antibodies used. 
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2.    Cell Culture 
     HeLa (human cervical carcinoma), HEK293T (human embryonic kidney), 293FT (for 
viral production) cells were cultivated in high glucose (4.5g/L) Dulbecco’s modified eagle 
medium (DMEM, Invitrogen) or DMEM AQmedia
TM
 (Sigma-Aldrich) supplemented with 
10% v/v heat inactivated foetal calf serum (FCS, Sigma-Aldrich), 2mM L-glutamine (Sigma-
Aldrich), 2mM sodium pyruvate (Sigma-Aldrich), penicillin (100U/ml, Invitrogen) and 
streptomycin (100μg/ml, Invitrogen). Cells were cultured in tissue culture flasks or dishes 
and maintained in 5% atmospheric CO2 at 37 ℃ in a humidified incubator.  
     HeLa cells stably downregulated for Fis1 or Bap31 by Lentiviral shRNA were cultured as 
above in a presence of 1µg/ml puromycin (Sigma-Aldrich). 
     Cells were routinely passaged to a new tissue culture dish or flask by detaching them with 
trypsin-EDTA solution (final concentration of 0.05% diluted in PBS, Invitrogen) upon 
confluency. 
 
 
 
 
 
 
 
 
118 | P a g e  
 
3.    Plasmid Vectors  
     Mammalian expression plasmids used were cloned into pcDNA3Δ, which is a modified 
plasmid of pcDNA3 (Invitrogen) that lacks the neomycin cassette, or pCMV-SC-CF (Agilent 
technologies, for Flag-tagged vectors) vectors unless otherwise stated and were sequence- 
verified. Fis1 was isolated in a genetic screen for apoptosis inducers (Albayrak and Grimm 
2003) and subsequently tagged C-terminally with hemagglutinin epitope (Fis1-HA). 
Mammalian expression vectors coding for Bap31-myc, caspase cleavage resistant Bap31 
(crBap31-myc), Bap31-EYFP and tBid, were previously described (Mund et al 2003) as was 
Bax (Schoenfeld et al 2004). Membrane-embedded cleaved fragment of Bap31 (p20Bap31-
myc), p20Bap31-EYFP, full length Bap31-Flag, Bap31 ΔvDED-myc, Bap31 ΔvDED-Flag 
Bap31 ΔCC/vDED-myc and Bap31 ΔCC/vDED-Flag were produced in the lab. Lentiviral 
shRNA vector (pLKO.1-TRC cloning vector) was purchased from AddGene and the target 
sequences were subcloned in the lab. Mammalian expression vectors coding for DsRed-ER 
and YFP-mito were a kind gift of Dr. Remy Sadoul (Inserm U836, Grenoble, France).  
     Short hairpin RNA (shRNA) against Fis1 was cloned into the pSuper vector (OligoEngine, 
by previous PhD student) with the target sequence of 5’-GAGCACGCAGTTTGAGTAC.  
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4.    Cloning 
4. 1 Cloning of p20Bap31-myc and p20Bap31-EYFP into pcDNA3Δ vector 
     Cleavage product of Bap31, p20Bap31, was cloned using Phusion
TM
 DNA polymerase 
(Finnzymes) with full length Bap31-myc plasmid as a template. Primers used for the cloning 
were 5’-AAAAGGAAAAGCGGCCGCCGTCAACAGCAGCTCCCTTC (forward) and 5’-
CCGGAATTCAGGATGAGTCTGCAGTGG (reverse). In the PCR reaction, buffer (5x), 
dNTP (final concentration of 200μM), sense and antisense primers (final concentration of 
0.5μM), template (5ng), PhusionTM enzyme (0.5μl) and DNase, RNase free water (to make up 
to 50µl) were prepared. PCR cycle was performed with 98°C (30 seconds), 98°C (10 
seconds), 54°C (30 seconds), 72°C (30 seconds), back to step 2 for 34 more cycles, 72°C (10 
minutes). PCR products were separated on a 1% agarose (Sigma-Aldrich) gel and the 
appropriate band of the expecting size (492 base pairs) was excised and purified using wizard 
SV gel and PCR clean-up system (Promega). Concordantly, pcDNA3Δ vector was linearlised 
with EcoRI and NotI endonuclease (Fermentas) digestion, likewise separated on 1% agarose 
(Sigma-Aldrich) gel and the backbone of the vector was purified. Purified PCR product and 
the linerlised pcDNA3Δ vector were then incubated with T4 DNA ligase (Fermentas) 
overnight at 4°C. The ligation product was then transformed into chemocompetent bacteria 
(Invitrogen) as described below (refer to section “Transformation of E. coli” below). 
     Expression vectors coding for p20Bap31-myc and Bap31-EYFP in the pcDNA3Δ vector 
(Mund et al 2003) were digested with EcoRI and NotI endonucleases (Fermentas), which 
excise either p20Bap31 or Bap31 fragment from respective plasmids. The p20Bap31 
fragment from p20Bap31-myc plasmid and the backbone containing EYFP from Bap31-
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EYFP plasmid were subsequently gel purified and ligated as above to create p20Bap31-EYFP 
in pcDNA3Δ vector. 
     For both vector preparations, DNA was isolated from the resulting bacterial colonies (see 
“Extraction of plasmid DNA” section) and digested with EcoRI and NotI restriction enzymes 
(Fermentas). The digests were separated on a 1% agarose (Sigma-Aldrich) gel to confirm the 
presence of the insert. 
4. 2 Production of Bap31 ΔvDED-myc and Bap31 ΔCC/vDED-myc      
     Bap31 ΔvDED-myc and Bap31 ΔCC/vDED-myc were cloned using QuickChange II site-
directed mutagenesis kit (Agilent Technologies) with wild type Bap31-myc plasmid in the 
pcDNA3Δ vector as a template. Primers were designed by QuickChange® primer design 
programme (http://www.stratagene.com/sdmdesigner/default.aspx). Primers used to create 
Bap31 ΔvDED-myc were as follows: 5’-GTCGGGAATGCTGAGCACGCAAAGCTGCAG 
(forward) and 5’-CTGCAGCTTTGCGTGCTCAGCATTCCCGAC (reverse). Primers used 
to create Bap31 ΔCC/vDED-myc were as follows: 5’-
TCTCATTTCGCAGCAGCACGCAAAGCTGCA (forward) and 5’-
CCTGCAGCTTTGCGTGCTGCTGCGAAATGA (reverse). PCR sample was prepared with 
10x reaction buffer, dsDNA template (25ng), forward and reverse primer (125ng each), 
dNTP mix (1µl), Pfu Ultra high fidelity DNA polymerase (1µl) and made up to 50µl with 
DNase, RNase free H2O. PCR cycle was performed as follows: 95°C (30 seconds), 95°C (30 
seconds), 55°C (1 minute), 68°C (7.5 minutes) and back to step 2 for 17 cycles. The PCR 
product was digested with DpnI for 1 hour at 37°C. The digested PCR product (1µl) was 
transformed (see below). DNA was isolated from the resulting bacterial colonies (see 
“Extraction of plasmid DNA” section) and digested with XhoI and BamHI restriction 
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enzymes (Fermentas). The digests were separated on a 1% agarose (Sigma-Aldrich) gel to 
confirm the presence of the insert. 
4.3 Production of Bap31-Flag, Bap31 ΔvDED-Flag and Bap31 ΔCC/vDED-Flag      
     Full length Bap31-myc, Bap31 ΔvDED-myc and Bap31 ΔCC/vDED-myc in pcDNA3Δ 
vector were PCR-amplified and C-terminally tagged with a Flag epitope using StrataClone 
mammalian expression vector system (Agilent Technologies). The DNA fragment for Bap31, 
Bap31 ΔvDED or Bap31 ΔCC/vDED were PCR amplified using PhusionTM enzyme 
(Finnzymes) with the following primers: 5’-GGGCCGCCATGAGTCTGCAGTGGA 
(forward) and 5’-CTCTTCCTTCTTGTCCAT (reverse). Note that the same pair of primers 
was used for all the reactions as these three fragments possess the same C- and N-termini. 
PCR reaction was prepared as described above and the PCR performed as follows: 98°C (30 
seconds), 98°C (10 seconds), 48°C (30 seconds), back to step 2 for 29 cycles, 72°C (10 
minutes). PCR products were run on a 1% agarose (Sigma-Aldrich) gel and the appropriate 
bands were purified using wizard SV gel and PCR clean-up system (Promega). StrataClone 
blunt cloning buffer (3µl), PCR product (100ng), StrataClone vector mix (1µl) were mixed 
and made up to 6µl with DNase, RNase free H2O and incubated at room temperature for 5 
minutes. Two micro litres of the reaction was transformed into StrataClone SoloPack 
competent cells provided by the manufacturer according to their instructions. DNA was 
isolated from the resulting bacterial colonies (see “Extraction of plasmid DNA” section) and 
digested with DraI and XhoI (for Bap31-Flag and Bap31 ΔvDED-Flag) or SacI or HindIII 
(for Bap31 ΔCC/vDED-Flag) restriction enzymes (Fermentas). The digests were separated on 
a 1% agarose (Sigma-Aldrich) gel to confirm the presence of the insert with a correct 
orientation (Appendix 2). 
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4.4 Cloning of Lentiviral shRNA pLKO.puro Fis1 and Bap31 
     Primers used to create pLKO.puro scramble (as a control), Fis1 and Bap31 are as follows: 
Table  5   Primers for pLKO.puro Lentiviral shRNA vectors 
Scramble 
Fr 
5’-
CCGGCCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGGCGACTTA
ACCTTAGGTTTTTG 
Re 
5’-
AATTCAAAAACCTAAGGTTAAGTCGCCCTCGCTCTAGCGAGGG
CGACTTAACCTTAGG 
Fis1 
Fr 
5’-
CCGGCAAGAGCACGCAGTTTGAGTACTCGAGTACTCAAACTGC
GTGCTCTTGTTTTTG 
Re 
5’-
AATTCAAAAACAAGAGCACGCAGTTTGAGTACTCGAGTACTCG
AGTACTCAAACTGCGTGCTCTTG 
Bap31 
Fr 
5’-
CCGGGACGCCTGGTGACTCTCATTTCTCGAGAAATGAGAGTCAC
CAGGCGTCTTTTTG 
Re 
5’-
AATTCAAAAAGACGCCTGGTGACTCTCATTTCTCGAGAAATGAG
AGTCACCAGGCGTC 
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     Each pair of primers (1µl of 3mg/ml stock) was annealed in the annealing buffer (48µl, 
100mM NaCl, 50mM HEPES pH7.4). Mixture was incubated at 90°C (4 minutes), 70°C 
(10minutes) then slowly cooled down to 37°C over a period of ~1h. pLKO.puro TRC cloning 
vector (purchased from AddGene) was digested with AgeI and EcoRI restriction enzymes 
(Fermentas), separated on a 1% agarose (Sigma-Aldrich) gel and the vector backbone was gel 
purified as described below (section “DNA electrophoresis and DNA recovery”). The vector 
backbone and the annealed primers were ligated using T4 DNA ligase (Fermentas), digested 
with AgeI endonuclease to remove self-ligated vector backbone prior to the transformation 
(Appendix 3). DNA was isolated from the resulting bacterial colonies (see “Extraction of 
plasmid DNA” section) and digested with NcoI and EcoRI restriction enzymes (Fermentas). 
The digests were separated on a 1% agarose (Sigma-Aldrich) gel to confirm the presence of 
the insert. Two DNA fragments of 2 and 5 kbp are expected if the shRNA was correctly 
inserted whereas 2 and 7 kbp fragments are expected if the shRNA was not cloned. 
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5.    DNA Electrophoresis and DNA Recovery 
     The DNA electrophoresis was performed using agarose (Sigma-Aldrich) gels. Briefly, 
agarose (usually 1% w/v) was dissolved in TAE buffer (Fermentas). The GelRed
TM
 nucleic 
acid gel stain (Biotium) was then added (1/20000 dilution), cooled and poured into custom-
made DNA gel electrophoresis cassette to solidify. The DNA was mixed with 6x DNA 
loading dye (Fermentas) and separated by gel electrophoresis in TAE buffer (Fermentas). The 
GeneRuler
TM
 1kb plus DNA ladder or GeneRuler
TM
 1kb DNA ladder (Fermentas) was used 
for the size estimation. 
     Upon completion of DNA gel electrophoresis, the piece of agarose containing DNA of 
interest was excised under the UV lamp and subsequently DNA was recovered using wizard 
SV gel and PCR clean-up system (Promega). Briefly, a gel piece was mixed with binding 
buffer to dissolve agarose. The dissolved gel and the buffer were transferred to a spinning 
column, centrifuged, washed twice, and eluted either with DNase, RNase free H2O or with 
TE buffer. 
 
 
 
 
 
 
 
125 | P a g e  
 
6.    Transformation of E. coli 
     Plasmid DNA was transformed into chemo-competent, library efficient DH5α E. coli 
bacteria (Invitrogen). Aliquots stored in -80°C were thawed on ice, the corresponding 
plasmid DNA was added to the cells. After 30 minutes of incubation on ice, the cells were 
treated by heat shock (45 seconds at 42°C) with a subsequent quick chill on ice (2 minutes). 
Then 1ml of SOC medium (2% tryptone, 0.5% yeast extract, 10mM NaCl, 10mM MgSO4, 
2.5mM KCl, 20mM glucose) was added to the transformed cells and incubated for 1 hour at 
37 °C in a shaker to allow bacteria to express resistance gene. Afterwards, bacteria were 
either given LB medium containing appropriate antibiotics (usually 100μg/ml of Ampicillin) 
or were plated onto LB agar containing the appropriate antibiotics (usually 100μg/ml of 
Ampicillin) and cultured over night at 37°C incubator. 
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7.    Extraction of plasmid DNA from E. coli 
     For the extraction of plasmid DNA from transformed bacteria, the bacteria were grown 
(3ml for miniprep and 200ml for maxiprep) in a Lauria-Bertani broth supplemented with 
yeast extract (10g/L, Sigma-Aldrich) in a presence of appropriate antibiotics over night in a 
shaking incubator at 37°C. The plasmid DNA was extracted from the bacteria using the 
Plasmid Maxi Prep kit (QIAGEN) or the PureLink
TM
 HiPure plasmid filter purification kit 
(Invitrogen). The resulting DNA pellet was resuspended in 500-1000µl of DNase, RNase free 
water or TE buffer and the concentration measured using NanoDrop (ThermoScientific) or 
with PicoGreeen (Molecular Probes). Briefly, DNA was sequentially diluted to make 
concentration of approximately 0.1µg/µl. 1µl of diluted DNA was added to a well of 96-well 
plate. 1µl of standard DNA (0.1µg/µl) was also included as a reference. Then 50µl of TE 
buffer was added to each well followed by 50µl of diluted PicoGreen (1:200 in TE buffer). 
Plate was incubated 5 minutes. The fluorescence was measured with FLUOstar OPTIMA 
(BMG Labtech) with excitation at 480nm and emission at 520nm.     
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8.    Transfections 
8.1 Plasmid Vector Transfections 
     HeLa cells were plated onto either 24-well (2-2.4*10
4
 cells/well) or 6-well (1-1.2*10
5
 
cells/well) plate approximately 15 hours prior to the transfections. HEK293T cells were 
plated onto either 24-well (10-12*10
4
 cells/well) or 6-well (5-6*10
5
 cells/well) approximately 
15 hours prior to the transfections. Effectene (QIAGEN) was used for HeLa cells and 
SuperFect (QIAGEN) was used for HEK293T cells for the DNA trasfection. Briefly, plasmid 
DNA (0.2μg per 24-well plate or 0.4μg per 6-well plate) was mixed in EC buffer with 
Enhancer, incubated for 5 minutes, Effectene reagent was added (2.5μl or 5μl for 24- or 6-
well plate, respectively), incubated for 10 minutes, and the DNA-lipid mix was added to the 
cells for Effectene transfection. For SuperFect transfections, DNA was diluted in DMEM 
(1μg or 2μg for 24- or 6-well plate, respectively), SuperFect was added (5µl or 10µl for 24- 
or 6-well plate, respectively), incubated for 10 minutes and the DNA-lipid mix was added to 
the cells. Transfection mixes were removed from the plate after 5-6 hours, fresh medium 
added and incubated. 
8.2 siRNA Transfections 
     Short interfering RNA (siRNA) transfections were performed using Oligofectamine 
(Invitrogen) with the target sequence of 5’-GAAGUACAUGGAGGAGAAUTT for Bap31 
siRNA (Szczesna-Skorupa and Kemper 2006) and 5’-GCCGTGGCTGGCGGTGTATTT for 
the control siRNA. Control siRNA was designed using “RNAi designer” from Invitrogen. 
The sequence was BLAST-searched to confirm that no human gene matched the exact 
sequence. The closest human sequence has 14 nucleotides identity out of 21. Cells were 
seeded the night before the transfection so that the plate was approximately 40% confluent on 
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the day of transfection. On the day of transfection, 4μl of Oligofectamine and 15μl of OPTI-
MEM (Invitrogen) were mixed in one tube, 10μl of 20μM siRNA (Invitrogen) was diluted in 
175μl of OPTI-MEM in another tube, and both tubes incubated for 10 minutes at room 
temperature for one well of a 6-well plate. After incubation, the contents of the two tubes 
were mixed thoroughly with vortexing for 10 seconds and further incubated for 20 minutes. 
Cells were washed once with DMEM containing 6mM glutamine without serum or 
antibiotics and 800μl of the same medium was added to each well. The lipid-siRNA complex 
was then added drop-wise and incubated for 5 hours. Afterwards, cells were washed once 
with FCS and antibiotics free medium and maintained in a normal growth medium with FCS 
and antibiotics. The consecutive plasmid transfections were performed as described above.  
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9.    Apoptosis Assays 
9.1 Propidium Iodide Staining 
     The supernatant and the adherent cells were harvested, centrifuged (1500rpm, 5 minutes) 
and resuspended in lysis buffer (0.1% sodium citrate and 0.1% Triton X-100 in PBS) 
containing propidium iodide (PI, 20μg/ml). Upon the lysis of cells, resulting nuclei were 
acquired with flow cytometor (FACSCalibur
TM
, BD Biosciences) using FL-2 channel to 
quantify the percentage of cell population with subG1 DNA content. The pan-caspase 
inhibitor, zVAD-fmk (MP Biomedicals), was used at a concentration of 50μM. 
9.2 3,3-dihexaoxacarbocyanine Iodide (DiOC6) Staining 
     To quantify the percentage of cells undergoing mitochondrial outer membrane 
depolarization, supernatant and the adherent cells were harvested, centrifuged (1500rpm, 5 
minutes) and resuspended in 100-200µl of PBS containing 40nM 3,3-dihexaoxacarbocyanine 
iodide (DiOC6) and PI (6μg/ml) for 40 minutes in the incubator and further incubated for 40 
minutes at room temperature in dark. Cells were then analysed using a flow cytometor (BD 
Biosciences) using FL-1 (for DiOC6 staining) and FL-2 (for PI staining) channels. 
Bongkrekic acid (Sigma-Aldrich), a blocker of permeability transition pore, was used at a 
concentration of 75μM. 
9.3 Caspase-3 and Bax Activity Assay 
     The supernatant and the adherent cells were harvested and centrifuged (1500rpm, 5 
minutes) and fixed in 4% paraformaldehyde in PBS (PFA, Thermo Scientific) for 20 minutes 
at 4ºC, then blocked in 3% bovine serum albumin (BSA) for 30 minutes in Tris-buffered 
saline (TBS, 50mM Tris-HCl, 155mM NaCl, pH 7.6) and permeabilized with saponine 
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(0.02% w/v) in TBS (TBSS) for 30 minutes in the incubator. Cells were then centrifuged 
(1500rpm, 5 minutes) and the primary antibody, diluted in TBSS, that recognizes either 
active caspase-3 (polyclonal rabbit anti-cleaved Caspase-3 Asp175, Cell Signaling, #9661) or 
Bax (monoclonal mouse anti-Bax, BD Pharmingen, 556467, clone 6A7) was added (50μl) at 
a dilution of 1/200 or 1/100, respectively, and incubated for 1 hour in the incubator. Cells 
were then washed with 2ml of TBSS, centrifuged and the isotype-matched secondary 
antibody conjugated with Alexa Fluor 488 (Molecular probes), diluted in TBSS at a dilution 
of 1/500, was added to the tube (50μl) and incubated for 1 hour in the incubator. TBSS (2ml) 
was then added to wash the secondary antibody; the cells were centrifuged, resuspended in 
TBSS (300μl), and analysed with flow cytometor (BD Biosciences) using the FL-1 channel.  
9.4 Caspase-8 Activity Assay 
     Caspase-8 activity assay was performed using CaspaTag
TM
 Caspase-8 In situ assay kit 
according to the manufacturer’s instructions (Millipore). Briefly, supernatant and adherent 
cells were harvested, centrifuged (1500rpm, 5 minutes) and resuspended in PBS (300μl). 
Then 10μl of 30xFLICA (fluorochrome inhibitors of caspase) reagent, which contains peptide 
inhibitor of caspase-8 (carboxyfluorescein-labeled fluoromethyl ketone or FAM-LETD-
FMK) was added to the tube and incubated for 1 hour in the incubator. After the incubation, 
cells were washed twice with 2ml of wash buffer provided and centrifuged for 5 minutes. 
Supernatant was resuspended in 400μl of wash buffer and analysed by FACS (BD 
Biosciences) immediately using FL-1 channel. 
9.5 Cleavage of procaspase-3 and poly ADP ribosome polymerase (PARP) 
     The supernatant and the adherent cells were harvested and the pellet was lysed in RIPA 
buffer (150mM NaCl, 1% NP-40, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS, 50mM 
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Tris-HCl pH 8) containing protease inhibitors (Fermentas). The total cell lysate was separated 
and immunoblotted with caspase-3 and PARP antibody to determine the procession of 
procaspase-3 or full length PARP (see section “SDS-PAGE and Immunoblotting”). 
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10.    Immunoprecipitation 
10.1 Immunoprecipitation of Endogenous Proteins 
     HeLa cells were washed once with PBS and lysed in 500μl of RIPA buffer containing 
protease inhibitors (Fermentas). Approximately 5mg of total cell lysate per condition was 
used. The cell lysates were centrifuged (13x10
3 
rpm) for 20 minutes at 4°C. The supernatant 
was pre-cleared twice with 50μl of protein G sepharoseTM 4 fast flow (GE Healthcare) or with 
PureProteome magnetic protein G beads (Millipore) for 30 minutes each with gentle rotation 
at 4°C. After the pre-clearing, 100μl of either rabbit polyclonal α-Fis1 (produced in our lab), 
rat monoclonal α-Bap31 (Santa Cruz Biotechnology, sc-56007, clone CC-1), or rabbit 
monoclonal α-procaspase-8 (Millipore, 04-574, clone E6, in 1/50 dilution) antibody was 
added to the supernatant and incubated overnight with rotation at 4°C. No antibody was 
added to the control immunoprecipitations. The antibody-protein complexes were then 
precipitated with 80μl of beads and incubated for at least 1 hour at 4°C. Beads were washed 
five times with the lysis buffer and resuspended in gel loading dye (Fermentas) supplemented 
with reducing agent (usually 2-mercaptoethanol). Each tube was immediately boiled for 10 
minutes and immunoprecipitates were subjected to protein separation by SDS-PAGE (see 
section “SDS-PAGE and Immunoblotting”). 
10.2 Immunoprecipitation of Overexpressed Proteins 
     HEK293T cells were transfected with the appropriate plasmids as indicated and cell 
lysates were prepared in RIPA buffer. Protein concentration was measured (see section 
“SDS-PAGE and Immunoblotting”) and equal amounts of protein in an equal volume 
(adjusted with RIPA buffer) were pre-cleared once with 50μl of PureProteome magnetic 
protein G beads (Millipore) for 30 minutes with gentle rotation at 4°C. The supernatant was 
133 | P a g e  
 
then immunoprecipitated with the indicated antibodies overnight. No antibody was added for 
the control tubes. The antibody-protein complexes were then precipitated with 80μl of beads 
and incubated for 1 hour at 4°C. Beads were washed five times with lysis buffer and 
resuspended in gel loading dye (Fermentas) supplemented with reducing agent. Each tube 
was immediately boiled for 10 minutes and immunoprecipitates were subjected to protein 
separation by SDS-PAGE.  
     Antibodies used were polyclonal rabbit α-Flag (Sigma-Aldrich, F7425, used at 1/50 
dilution), monoclonal mouse α-HA (Sigma-Aldrich, H3663, used at 1/50 dilution) and 
monoclonal mouse α-myc (Santa Cruz Biotechnologies, sc-40, clone 9E10, used at 1/20 
dilution) 
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11.   Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-
PAGE) and Immunoblotting 
11.1 Preparation of Whole Cell Lysate 
     Cells were trypsinized, centrifuged (1500rpm, 5 minutes) and lysed or were directly lysed 
on the plate by adding RIPA buffer. Total cell lysates were then centrifuged for at least 10 
minutes (13x10
3 
rpm) at 4°C. The resulting supernatant, which contained soluble proteins, 
was transferred to a new tube and used immediately or stored at -20°C until use. 
11.2 Protein Concentration Measurement 
     Protein concentration was determined using the Bradford assay (BioRad). To obtain a 
standard curve, BSA of known concentration was sequentially diluted (from 0-6μg/ul) and 
placed on a flat-bottom 96-well plate. To each well, 200μl of Bradford (diluted 5 times in 
water) was added and the absorbance measured at 595nm using FLUOstar OPTIMA (BMG 
Labtech). The resulting absorbance values were plotted against BSA concentration and used 
as a standard curve to measure the protein concentration.  
11.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
     Following the protein concentration measurement, 20-100μg of the total cell lysate was 
separated by SDS-PAGE (stacking gel: 4.8% polyacrylamide, 125mM Tris-HCl pH6.8, 0.1% 
SDS, 0.1% APS, 0.1% TEMED; resolving gel: 10-15% polyacrylamide, 375mM Tris-HCl 
pH8.8, 0.1% SDS, 0.1% APS, 0.05% TEMED) in TGS-running buffer (25mM Tris-HCl, 
192mM Glycin, 0.1% w/v SDS). PageRuler
TM
 prestained protein ladder (Fermentas) was 
used for the protein size estimation. Proteins were then transferred to nitrocellulose or PVDF 
membrane (Millipore) in transfer buffer (20% methanol in TGS buffer). Conditions used for 
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the transfer were as follows: constant 400 mA with varying voltage. Proteins were transferred 
for 90 minutes (if two gels are transferred together) or 50 minutes (if only one gel is 
transferred). 
11.4 Immunoblotting 
     The membranes were blocked with 3% BSA (Sigma-Aldrich) in PBS containing 0.1% 
Tween (PBS-T) for minimum of 30 minutes, incubated with the primary antibody, washed 
three times with PBS-T (10 minutes each), and incubated with horseradish peroxidise-
conjugated isotype-matched secondary antibody. The membrane was then washed as before, 
treated with enhanced chemoluminescent reagent (Pierce) and subjected to autoradiography 
using high performance chemoluminescence film (GE Healthcare).  
Antibodies used for immunoblottings are listed below (Table 6). 
 
 
        Table  6 Antibodies used for Immunoblotting 
Antigen Source Clonality Dilution Company Cat. no Clone 
ATF-4 Goat polyclonal 1:500 Abcam ab1371 ------------ 
ATF-6 Mouse monoclonal 1:500 IMAGENEX IMG-273 70N1413.1 
Bap31 Rabbit polyclonal 1:5000 ProteinTech 11200-1 ------------ 
β-actin Mouse monoclonal 1:2000 Sigma-Aldrich A2228 AC-74 
Bax Mouse monoclonal 1:2000 
BD 
Pharmingen 
556467 6A7 
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Bid Rabbit polyclonal 1:2000 
Cell Signaling 
Technology 
2002 ------------ 
BiP/GRP78 Goat polyclonal 1:500 
Santa Cruz 
Biotechnology 
SC-1050 N-20 
Caspase-3 Rabbit polyclonal 1:2000 
Cell Signaling 
Technology 
9665 8G10 
Caspase-8 Mouse monoclonal 1:2000 
Enzo 
Lifesciences 
ALX-
804-429 
C15 
CHOP 
/GADD153 
Mouse monoclonal 1:500 Abcam Ab11419 9C8 
Flag Rabbit polyclonal 1:2000 Sigma-Aldrich F7425 ------------ 
GAPDH Mouse monoclonal 1:2000 
Santa Cruz 
Biotechnology 
SC-
32233 
6C5 
HA Rabbit polyclonal 1:2000 Sigma-Aldrich H6908 ------------ 
myc Mouse monoclonal 1:1000 
Santa Cruz 
Biotechnology 
SC-40 9E10 
p38 Rabbit polyclonal 1:3000 
Santa Cruz 
Biotechnology 
SC-728 N-20 
PARP Rabbit polyclonal 1:2000 
Cell Signaling 
Technology 
9542 ------------ 
XBP-1 Goat polyclonal 1:500 
Santa Cruz 
Biotechnology 
SC-
32135 
L-13 
GFP-HRP Rabbit polyclonal 1:2000 
Santa Cruz 
Biotechnology 
SC-8334  
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Mouse HRP Sheep  1:2000 GE Healthcare   
Mouse HRP Goat  1:5000 
Molecular 
Probes 
G21040  
Rabbit HRP Goat  1:20000 Sigma-Aldrich   
Goat HRP Rabbit  1:2000 Sigma-Aldrich A5420  
 
     Polyclonal antibody against Fis1 was previously produced in rabbit (Max-Planck Institute, 
Germany). Briefly, rabbits were immunised with GST tagged full length protein as an 
immunogen and the antibody was affinity purified. The specificity of the antibody was 
determined by comparing sera from pre-immune and immunised rabbits and the product of 
overexpression of the gene in western blots, by immunofluorescence assay of both 
overexpressed and endogenous proteins, and by down-regulation of the mRNA by shRNA 
(refer to “Result” section).   
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12.    Immunofluorescence 
12.1 Immunofluorescent Assay 
     HeLa cells were seeded on coverslips, transfected with indicated genes and grown for 24 
hours, then fixed in 4% PFA (Thermo Scientific) in PBS for 20 minutes at 4°C. After 
blocking with 3% BSA (Sigma-Aldrich) in for 30 minutes at room temperature, cells were 
permeabilized in 3% BSA in TBS with 0.02% w/v saponine (TBSS, Sigma-Aldrich). Cells 
were then incubated with the primary antibody (Table 7) for 1 hour at RT. Cells were rinsed 
five times in TBSS and then incubated with the secondary antibody (Table 8) for 1 hour at 
RT. Cells were washed five times in TBSS and incubated with DAPI (2ug/ml, Invitrogen) for 
30 minutes at RT (where necessary). Cover slips were then washed once with water to 
remove any salt before being mounted on a glass plate with polyvinyl alcohol mounting 
medium with DABCO (Sigma-Aldrich). Cells were observed under the confocal laser-
scanning microscope (Leica), pictures acquired with LAS AF software and analysed with 
LAS AF lite software.  
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       Table 7 Primary antibodies used for Immunofluorescence 
Antigen Source Clonality Dilution Company Cat. no Clone 
HA Mouse monoclonal 1:100 Sigma-Aldrich   
myc Rabbit polyclonal 1:100 Santa Cruz   
cleaved 
Caspase-3 
Asp175 
Rabbit polyclonal 1:200 
Cell Signaling 
Technologies 
#9661  
Bax Mouse monoclonal 1:200 
BD 
Pharmingen 
556467 6A7 
Bap31 Rat monoclonal 1:100 
Santa Cruz 
Biotechnologie
s 
SC-
56007 
CC-1 
 
       Table  8  Secondary antibodies used for Immunofluorescence 
Antigen Dilution Company 
Anti-mouse Alexa Fluor 488 1:500 Molecular Probes 
Anti-mouse Alexa Fluor 594 1:500 Molecular Probes 
Anti-mouse Alexa Fluor 633 1:500 Molecular Probes 
Anti-rabbit Alexa Fluor 488 1:500 Molecular Probes 
Anti-rabbit Alexa Fluor 405 1:500 Molecular Probes 
Anti-rabbit Alexa Fluor 594 1:500 Molecular Probes 
Anti-rat Alexa Fluor 488 1:500 Molecular Probes 
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     Plasmid vectors conjugated with fluorescent protein used are: YFP conjugated with 
mitochondrial localization signal (YFP-mito), DsRed conjugated with an ER localization 
signal (DsRed-ER). Those plasmids were a kind gift of Remy Sadoul (Inserm U836, 
Grenoble, France). Bap31 conjugated with EYFP (Bap31-EYFP) was previously described 
(Mund et al 2003) and p20Bap31 conjugated with EYFP (p20Bap31-EYFP) was subcloned 
(see above). 
12.2 Mitochondrial Staining 
     Mito Tracker
®
 Red CM-H2XRos (MitoTracker) and tetramethylrhodamine ethyl ester 
(TMRE) were used at a concentration of 50nM (Molecular Probes) for the visualization of 
mitochondria. Both probes were diluted in a culture medium and added to the cells for 15-20 
minutes at 37ºC. When specific mitochondrial staining was visible, dyes were removed, 
washed three times with DMEM and fresh medium (minimum quantity, ~250µl per a well of 
24-well plate) was added.  
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13.    Calcium Measurement 
13.1 Cytosolic and Mitochondrial Calcium Measurement Using Fluo-4/AM or Rhod-
2/AM dyes 
     Cells were seeded so that the plate was 60-70% confluent on the day of the transfection. 
After appropriate times post-transfection, cells were harvested and resuspended in PBS 
containing either 2μM of Fluo-4/AM or 1.0μg/ml of Rhod-2/AM (Molecular Probes) for 
45minutes in the CO2 incubator with frequent agitation. Cells were then washed twice with 
PBS and resuspended in PBS for FACS acquisition (BD Biosciences) using the CellQuest 
programme (BD Biosciences). Note that PBS used in the experiment was without calcium or 
magnesium supplement. FL-1 channel for Fluo-4/AM and FL-2 channel for Rhod-2/AM was 
used for the acquisition. Under the “Acquisition & Storage” dialog box, “Event Counter or 
Time” parameter was selected to add a time parameter. The time resolution of 500ms was 
used throughout the experiment. The parameter setting used was as follows: FSC (7.00), SSC 
(238), FL-1 (530) for Fluo-4/AM and FL-2 (620) for Rhod-2/AM measurement. Note that 
both FL-1 and FL-2 channels were at a linear scale rather than at a logarithmic scale. 
     Kinetic analysis was performed with the FlowJo programme (Tree Star Inc.). The average 
of Fluo-4/AM or Rhod-2/AM fluorescence intensity of an entire population acquired was 
used to compare the relative cytosolic and mitochondrial calcium concentration. All the 
experiments were performed on 6-well plate.  
13.2 ER Calcium Measurement 
     To quantify the ER calcium content, 10μM of thapsigargin (EMD4Biosciences), a 
reversible inhibitor of the sarcoplasmic endoplasmic reticulum calcium ATPase, was added to 
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the cells stained with Fluo-4/AM after 30-60 seconds baseline calcium measurement. The 
difference between the peak Fluo-4/AM fluorescent intensity after the addition of 
thapsigargin and the baseline Fluo-4/AM fluorescence was considered as the ER calcium 
content as described previously (Breckenridge et al 2003).  
13.3 Cytosolic Calcium Measurement using Fura-2/AM 
     After harvesting cells, cells were incubated with 5μM of Fura-2 dye conjugated with 
acetoxy-methylester (Fura-2/AM, Molecular Probes) in DMEM for 45minutes in the 
incubator. Cells were briefly washed twice with PBS to remove unbound extracellular Fura2-
AM and 300μl of PBS was added. Cells were then excited at 340nm and 380nm alternatively 
and emission at 520nm was recorded using a FLUOstar OPTIMA (BMG Labtech). The 
release of Ca
2+
 from the ER was indirectly measured by releasing the Ca
2+
 from ER by 
addition of thapsigargin (10μM, EMD4Biosciences). Rmax (F340nm/F380nm when the dye is 
saturated) was measured upon addition of triton X-100 (Sigma-Aldrich) and CaCl2 at a final 
concentration of 0.2% (v/v) and 5mM respectively. Rmin (F340nm/F380nm when the dye is 
unbound) was measured by addition of EGTA (Sigma-Aldrich) at a final concentration of 
20mM. Following the measurement, intracellular [Ca
2+
] ([Ca
2+
]i) was estimated with the 
following equation: [Ca
2+
]i=Kd∙Q∙(R-Rmin)/(Rmax-R) where Kd is a dissociation constant for 
Fura2/AM (224nM), Q is Fmin/Fmax (Fmin and Fmax are fluorescent intensity at 380nm at Rmin 
and Rmax respectively), and R is F340nm/F380nm at a given time point. Note that all solutions 
were devoid of calcium or magnesium unless otherwise noted. Note also that the PBS used 
was devoid of calcium or magnesium ions. 
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14.    Production of Lentiviral particles 
14.1 Production of Viral Particles 
     For the production of lentiviral particles, the following viral plasmids were used: 
Lentiviral shRNA (pLKO.puro) containing scramble, Fis1 or Bap31 target sequences. 
Plasmids encoding vesicular stomatitis virus glycoprotein (pVSV-G), group antigen and 
reverse transcriptase (pGag.Pol) and reverse transcriptase (pRev) were isolated from 
ViraPower
TM
 lentiviral packaging mix (Invitrogen). Expression vector for the pAdVantage 
was from Promega. The cell line used was 293FT cells from Invitrogen.  
     The day before the transfection, 293FT cells were plated onto 10cm
2
 dishes so that the 
plate would be approximately 50-60% confluent on the day of transfection. Two hours prior 
to the transfection, the medium was replaced with fresh DMEM. 5.4µg of the pVSV-G, 3.8µg 
of the pRev, 7.8µg of the pGag.Pol, 9µg of the pAdVantage and 20µg of your lentiviral 
transgene plasmid were mixed in a 2ml eppendorf tube and made up to 437.5µl with H2O. 
Then 62.5µl of 2M CaCl2 was added, mixed thoroughly and incubated for 5 minutes. 
Meanwhile, 500µl of 2xHBS (50mM HEPES, 280mM NaCl, 1.5mM Na2HPO4 pH 7.06-7.08, 
filter sterilized) was prepared in a 15ml conical tube. After 5 minutes incubation, the 
DNA/CaCl2 mixture was added drop by drop into 15ml conical tube while vigorously 
shaking the tube on a vortex machine. The mix was incubated for 5 minutes and added to the 
dish drop by drop.  
     The culture medium was replaced with fresh warm medium containing sodium butyrate 
(1mM, Sigma-Aldrich), dissolved in PBS, on the following morning. Note that sodium 
butyrate was freshly prepared every time. After 2 to 3 days post transfection, the supernatant 
was harvested and centrifuged (500g, 10 minutes, RT) to remove cells and large debris, then 
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through 0.45μm sterile filter. Note that 0.2µm filter should not be used as it can damage viral 
outer glycoproteins.  
14.2 Calculation of Viral Titre 
     In order to measure the viral titre, the cells of interest (HEK293T or HeLa cells) were 
seeded on the 12-well plate to make a plate ~30% confluent on the day of transduction. On 
the day of the transduction the viral stock was diluted (three different dilution to achieve 
accurate measurements) in 400µl of DMEM containing polybrene
® 
(hexadimethrine bromide, 
6µg/ml, Sigma-Aldrich). The diluted viruses were added to the cells and incubated for 48 
hours to allow integration of genome and the expression. The number of cells present in a 
well was counted. The cells were then selected with puromycin (5µg/ml) for 24 hours and the 
number of surviving cells was recorded.  
The viral titre was calculated using the following equation:                  
Where TU is the transforming unit (=number of virion), F is the percentage of surviving cells, 
N is the number of cells at the time of transduction, D is the dilution factor, and V is the 
volume of diluted viral sample added into each well in ml. 
14.3 Production of Stable Cell Line 
     The cell line of interest was seeded on a well of 6-well plate 15 hours prior to the 
transduction. On the following day, cells were transduced with the viral supernatant 
supplemented with 1µg/ml of Polybrene
®
 (Sigma-Aldrich) for 6 hours or overnight. The viral 
supernatant was then removed, fresh medium added and incubated for a further two to three 
days. The medium was replaced with DMEM containing puromycin (varying concentration, 
5µg/ml for HeLa cells) after 72-96 post-infection and further cultivated for three days for the 
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selection. Upon completion of the selection, cells were maintained in DMEM containing 
1µg/ml of puromycin to retain the resistance.   
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15.    Gel Filtration 
     HeLa cells with or without treatment were lysed in RIPA buffer and centrifuged. 250µl of 
the supernatant were loaded onto a Superose-12 10/300 GL gel filtration/size-exclusion 
chromatography column (GE healthcare). The flow rate used was 0.3ml/min and samples 
were collected every minute for 60 minutes. After sample collection, gel loading dye 
(Fermentas) was added to each sample and subjected to separation on SDS-PAGE. Molecular 
weight estimation (performed by Dr. Robert J Edwards, Imperial College London) was 
performed with a sample containing ferritin (440kDa), aldolase (158kDa), transferrin 
(80kDa), ovalbumin (43kDa) and myoglobin (17kDa).  
16.    Densitometry analysis 
     A scanned image of a western blot was uploaded onto ImageJ programme and converted 
to 8-bit image (image → type → 8-bit). The image was then inverted (Edit → invert) and 
appropriate fields selected using “recutangular selection” tool. The plot profile (analyse → 
plot profile) was created and the background intensities were removed by drawing a straight 
line using “straight line selection.” Then distinctive peaks were separated with “straight line 
selection” and the intensities of bands were analysed upon selection of the appropriate area 
with “wand tool” followed by the measurement (analyse → measure). Note that pressing the 
“Shift” key during line drawing allows to draw a straight line and “Ctrl+D” allows approve 
your line draw.  
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17.    Statistical analysis 
     Statistical analysis was performed using unpaired student’s t-test using Microsoft Office 
Excel 2007. Two samples were regarded to have an equal variance when the f-test between 
two sample sets gave p>0.05. Data were regarded as statistically significant if p<0.05 based 
on the t-test. 
 18.    Common Buffers Used 
2x HBS 
50mM HEPES, 280mM NaCl, 1.5mM Na2HPO4 pH 7.06-7.08 
PBS 
137mM NaCl, 2.7mM KCl, 8mM Na2HPO4 and 2mM KH2PO4. Adjust pH to 7.4 
RIPA buffer 
150mM NaCl, 1% NP40, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS, 50mM Tris-HCl 
pH 8 
SOC medium 
2% tryptone, 0.5% yeast extract, 10mM NaCl, 10mM MgSO4, 2.5mM KCl and 20mM 
glucose 
Sodium-dodecyl sulfate gel 
[Stacking gel] 
4.8% polyacrylamide, 125mM Tris-HCl pH 6.8, 0.1% SDS, 0.1% APS and 0.1%TEMED 
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[Resolving gel] 
10-15% polyacrylamide, 375mM Tris-HCl pH 8.8, 0.1% SDS, 0.1% APS and 0.05% 
TEMED 
TAE buffer 
40 mM Tris-acetate and 1 mM EDTA at pH 8.3 
TBS 
50mM Tris-HCl (pH 7.4), 155mM NaCl 
TE buffer 
100 mM Tris-HCl (pH 7.5) and 10 mM EDTA (pH 8.0) 
TGS buffer 
25mM Tris, 192mM Glycin and 0.1% w/v SDS 
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Results 
1.  Functional Interaction between Fis1 and Bap31 
Summary 
     One of the mammalian mitochondrial fission proteins, Fis1, was first described as a pro-
apoptotic protein in 2003 (James et al 2003). While many publications investigated its 
functions, it is still controversial how Fis1 induces apoptosis. It was recently reported that 
Fis1-induced apoptosis requires the endoplasmic reticulum (ER) gateway for its apoptosis 
signaling (Alirol et al 2006) but the exact target remained undefined. B-cell activating protein 
(Bap31) is one of the integral ER membrane proteins implicated in apoptosis. Bap31 is also a 
substrate of several caspases and the membrane-embedded cleaved product, p20Bap31, is a 
potent apoptosis inducer (Breckenridge et al 2002, Breckenridge et al 2003, Chandra et al 
2004, Ducret et al 2003, Granville et al 1998, Gyan et al 2008, Mukasa et al 2007, Ng et al 
1997, Ng and Shore 1998, Nguyen et al 2000, Wang et al 2003). Therefore, the involvement 
of Bap31 in Fis1-induced apoptosis was studied. 
     Here I show that Bap31 is a target protein of Fis1 and the cleavage product of Bap31, 
p20Bap31, is produced upon overexpression of Fis1 in a caspase-dependent manner. 
Moreover, Fis1-induced apoptosis requires the presence of Bap31 to induce apoptosis but 
apoptosis mediated by p20Bap31 is independent of Fis1 revealing a novel unidirectional 
apoptosis signalling pathway initiated from mitochondria that first targets the ER. 
Furthermore, expression of Fis1 is able to activate caspase-8, Bax and caspase-3. 
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1.1  Overexpression of Fis1 induces cleavage of Bap31-EYFP and of 
endogenous Bap31 
     To first set up an appropriate experimental settings, a mammalian expression vector 
coding for Bax, a potent apoptosis inducer of the Bcl-2 family, was transfected into HeLa 
cells and the level of apoptosis compared with Fis1 by measuring the percentage of the cell 
population with subG1 DNA content. A condition was found under which transfecting 40ng 
of Bax plasmid (1/5
th
 of Fis1 plasmid transfected) induced apoptosis comparable to Fis1 (Fig. 
1-1, top). Additionally, only minor indications of apoptosis were observed after 30 hours of 
Fis1 expression, but there was robust DNA fragmentation 48 hours post-transfection (Fig. 1-1, 
top). Total cell lysates were prepared from Fis1- or Bax- transfected cells and the expression 
of the respective proteins analysed on western blot (Fig. 1-1, bottom) 
 
     In order to determine the functional interaction between Fis1 and Bap31, Bap31 was C-
terminally tagged with the enhanced yellow fluorescent protein (Bap31-EYFP, (Mund et al 
2003)). The localization of endogenous Bap31 and this fusion protein were found to be in the 
ER as expected (Fig. 1-2 A,B (Breckenridge et al 2003)). Furthermore, the pro-apoptotic 
Fig. 1-1 
Fis1 expression induces robust DNA degradation after 
48 hours but not 30 hours post-transfection 
(Top) HeLa cells, seeded on a 24-well plate, were 
transfected with Fis1 (200ng of DNA) or Bax+β-gal 
(40ng+160ng of DNA, respectively) and the percentage of 
cells with subG1 DNA content was measured at 30 and 48 
hours post-transfection. Data are represented as means±S.D. 
of three independent experiments.  
(Bottom) A western blot is shown to indicate the expression 
of Fis1 and Bax proteins. GAPDH was used as a loading 
control. 
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cleavage product of Bap31, p20Bap31, was also found to localize to the ER upon co-
transfection with Discosoma sp. red fluorescent protein (DsRed) tagged with an ER retention 
signal (Fig. 1-2 C).   
 
 
 
      
Fig. 1-2 
Endogenous Bap31, Bap31-EYFP and p20Bap31-EYFP localize to the ER 
HeLa cells were seeded on cover slips, transfected with (A) DsRed-ER alone, (B) DsRed-ER with 
Bap31-EYFP and (C) DsRed-ER with p20Bap31-EYFP for 24 hours. The endogenous Bap31 was 
immunostained (with α-rat Alexa Fluor 488 as a secondary antibody, green) and the other constructs 
were observed as a direct fluorescence using laser scanning confocal microscope. DAPI was used to 
stain nucleus.  
Scale bar represents 10μm. 
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     Next, I sought to determine if Fis1 is able to induce the cleavage of Bap31. The Bap31-
EYFP fusion construct was co-transfected with β-gal (as a control for the transfection 
procedure), Fis1 or Bax (to determine the specificity of the effect). The principle of using this 
fusion construct is that, upon cleavage of Bap31 at D164 and D238, (Fig. 1-3 A top panel, 
indicated as triangles), it produces three fragments and one of them is EYFP with an eight 
amino acids extension (Fig. 1-3 A, top). The production of this fragment directly implicates 
the procession of Bap31, which can be determined by Western blotting (Fig. 1-3 A, bottom). 
As Figure 1-3A shows Fis1 is able to induce the cleavage of Bap31-EYFP in HeLa cells in a 
time dependent manner, which starts 24 hours post-transfection and increases over time (Fig. 
1-3 A, Western blot top panel). On the contrary, neither β-gal- nor Bax- transfected cells were 
capable of inducing the Bap31-EYFP cleavage indicating that the cleavage mediated by Fis1 
is a specific functional interaction between Fis1 and Bap31 and not a general feature of dying 
cells. Expression of Fis1 and Bax are also shown on a western blot (Fig. 1-3 A). Similar result 
was obtained using HEK293T cells (Fig. 1-3 B). 
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     I then attempted to see if endogenous Bap31 can be cleaved upon the overexpression of 
Fis1. HeLa cells were transfected with β-gal or Fis1, cell lysates collected 27 hours post-
transfection and the production of p20Bap31 was analysed by immunoblotting. The blot 
showed that Fis1 but not β-gal was able to induce the cleavage of endogenous Bap31 and 
resulted in the production of the pro-apoptotic p20Bap31 fragment (Fig. 1-4), recapitulating 
the result of Bap31-EYFP fusion protein cleavage shown before (Fig. 1-3).   
 
Fig. 1-3 
Bap31-EYFP is cleaved upon Fis1 expression but not by Bax expression 
(A) Bap31 was C-terminally tagged with EYFP (top panel). Bap31 has two caspase cleavage sites 
(D164 and D238, shown as triangles) and three fragments are produced upon cleavage. One of 
them is EYFP and with an eight amino acid extension.  
Bap31-EYFP was co-transfected with β-gal, Fis1 or Bax (using the same amounts of DNA as Fig. 
1-1) into HeLa cells. Cell lysates were prepared at the indicated time points post-transfection, 
separated by SDS-PAGE and immunoblotted with anti-GFP antibody to examine the cleavage of 
Bap31 (bottom panel). Fis1 and Bax were also probed to indicate their overexpression. GAPDH 
was used as a loading control. 
(B) Same experiment as a) was performed using HEK293T cells. β-actin was used as a loading 
control. p.t.: post-transfection 
B 
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     Collectively, these data suggest that the cleavage induced by Fis1 is an early (please see 
later sections for more supporting data) and a specific event during Fis1-induced apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-4 
Endogenous Bap31 is cleaved upon Fis1 expression 
HeLa cells were transfected either with β-gal or Fis1 and 
cell lysates collected at 27 hours post transfection. 
Proteins were separated and immunoblotted with an anti-
Bap31 antibody. Note that the bands were from the same 
membrane with the same exposure time. p38 was used as 
a loading control. 
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1.2  Cleavage of Bap31-EYFP is caspase-dependent 
     The expression of Fis1 leads to the cleavage of Bap31, however, whether Fis1 is directly 
involved in such cleavage remained unclear. Fis1 has never been reported to possess any 
protease activity. Bap31 possesses two caspase recognition sequences and has been shown to 
be a substrate of several caspases (caspase-3, 8 and 10, (Breckenridge et al 2002, Granville et 
al 1998, Ng et al 1997, Ng and Shore 1998)). Furthermore, Bap31 is able to associate with the 
long isoform of procaspase-8 (Breckenridge et al 2002). Therefore, I attempted to determine 
whether the cleavage of Bap31 occurs in a caspase-dependent manner. Cells were co-
transfected with Bap31-EYFP with Fis1 in the presence or the absence of zVAD-fmk, a pan-
caspase inhibitor, and the Bap31 cleavage was analysed as before (Fig. 1-5). As shown in 
figure 1-5, the application of zVAD-fmk completely abrogated the Bap31-EYFP cleavage 
induced by Fis1 indicating the involvement of caspases in Bap31 cleavage. 
 
     To further dissect which caspase or caspases are responsible for the cleavage of Bap31, the 
activation of caspase-8 and caspase-3 were analysed upon Fis1 expression. The activity of 
caspase-8 was measured using a specific inhibitor of caspase-8 that is conjugated with 
carboxyfluorescein (FAM-LETD-fmk, Fig. 1-6). The data indicated that there was no 
significant caspase-8 activation after 24 hours of transfection with Fis1 when compared with 
β-gal (p=0.28, Fig. 1-6 A) even thought the cleavage of Bap31 was clearly detectable at this 
Fig. 1-5 
Bap31-EYFP cleavage mediated by Fis1 
is caspase-dependent 
HeLa cells were co-transfected with Bap31-
EYFP and Fis1 in a presence (+zVAD) or 
the absence (-zVAD) of the pancaspase 
inhibitor zVAD-fmk (50μM). Cell lysates 
were prepared at the indicated time points 
post-transfection and the Bap31 cleavage 
was determined as before. p38 was used as 
a loading control. p.t.: post-transfection 
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time point (Fig. 1-3 A). However, significantly increased caspase-8 activity was observed 48 
hours post Fis1 transfection (p=0.034, Fig. 1-6 A). The proapoptotic p20Bap31 was included 
as this factor is down-stream of Fis1-induced apoptosis. The activation of caspase-8 by this 
factor had a similar kinetics as Fis1 (Fig. 1-6 A). The treatment of HeLa cells with tumour 
necrosis factor and cycloheximide (TNF+CHX) was used as a positive control for caspase-8 
activation (Fig. 1-6 A). Representative dot plots from the FACS acquisition are shown (Fig. 
1-6 A, bottom). In accordance with caspase-8 activation upon Fis1 or p20Bap31 expression, 
one of its downstream substrates, Bid, was processed; indicated by the disappearance of full 
length Bid, which implicates the production of truncated Bid upon cleavage (Fig. 1-6 B).        
                  
      
Fig. 1-6 
Caspase-8 is activated and Bid is cleaved 
after 48 hours post Fis1 transfection  
(A) HeLa cells were transfected with the 
indicated genes and caspase-8 activity was 
measured 24 and 48 hours post-transfection 
using an irreversible caspase-8 inhibitor 
conjugated with carboxyfluorescein (FAM-
LETD-fmk) using flow cytometry. Cells 
treated with TNF (tumour necrosis factor, 
50ng/ml) and CHX (cycloheximide, 1μg/ml) 
for 24 hours were used as a positive control. 
Data are presented as means±S.D. 
n=4,3,3,4,4,5,4 (from left). Representative dot 
plots are shown on the bottom. 
(B) HeLa cells were transfected with the 
indicated genes and cell lysates were 
prepared 48 hours post-transfection. Cleavage 
of Bid was determined as the disappearance 
of full-length protein. GAPDH was used as a 
loading control. 
A 
B 
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    It has been reported that the activation of caspase-3 is linked to the cleavage of Bap31 
(Granville et al 1998). Thus the activity of caspase-3 was measured by immunostaining with 
an antibody that specifically recognizes the activated form of caspase-3 (Fig. 1-7 A,B). In 
conjugation with the activation of caspase-3, the activation of Bax was also analysed with an 
antibody that selectively recognizes the active form of Bax as the procession of Bid can 
activate Bax (Fig. 1-6 B and Fig. 1-7 B). The activation of caspase-3 was not detectable after 
24 hours with Fis1 transfection but increased significantly after 48 hours with a p-value of 
7.7x10
-3
 upon Fis1 expression (Fig. 1-7 A,B). A representative FACS analysis of active 
capase-3 and Bax is shown in figure 1-7C. Pro-apoptotic p20Bap31 was also included as a 
positive control as any down-stream effects of Fis1-induced apoptosis is thought to happen in 
p20Bap31-induced apoptosis as the data obtained placed Fis1 upstream of this cleaved 
protein fragment. In support of above data, western blot analysis of procaspases-3 after Fis1 
or p20Bap31 expression revealed the reduction of full length procaspases-3 when compared 
with β-gal transfection indicative of procaspases-3 being converted to active caspase-3 (Fig. 
1-7 D). Another characteristic feature of apoptotic cells and a substrate of active caspase-3, 
poly ADP ribosome polymerase (PARP), was likewise cleaved (Fig. 1-7 D). Similarly, the 
activation of Bax was observed only after 48 hours post-transfection but not at 24 hours 
corresponding to the activation of caspase-8 (Fig. 1-7 A,B and Fig. 1-6 A). A close analysis 
of activated Bax revealed that it localizes to the periphery of mitochondria, in accordance 
with a previous report (Fig. 1-8, (Tikhomirov and Carpenter 2005)). 
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Fig. 1-7 
Caspase-3 and Bax are activated upon Fis1 overexpression 
(A) HeLa cells were seeded on cover slips, transfected with the indicated genes and 
immunostained with antibodies that recognize active caspase-3 (using α-rabbit Alexa Fluor 488 
as a secondary antibody, green) or active Bax (using α-mouse Alexa Fluor 594 as a secondary 
antibody, red) after 24 or 48 hours post-transfection. Cells were then analysed by confocal 
microscopy. DAPI staining was used to indicate nucleus. Cells of representative fields are 
shown. Scale bar indicates 20μm unless otherwise noted. 
(B) HeLa cells were transfected with the indicated genes, immunostained with an antibody that 
recognizes either active caspase-3 or active Bax after 24 or 48 hours post-transfection and 
counter stained with a secondary antibody conjugated with Alexa Fluor 488. The percentage of 
cells showing either active Bax (red bars) or active caspase-3 (green bars) were analysed with 
flow cytometry. Data are presented as the means±S.D. n=5,5,4,4,4,4,5,4,3,3,4,4 (from left).  
(C) Representative histograms of FACS data are shown.  The population with red fill represents 
the β-gal transfected cells and the green-lined population represents Fis1 transfected cells. 
Although the β-gal transfected cells show only one peak, indicative of no activation of caspase-3 
or Bax, Fis1 transfected cells show two distinctive peaks indicating that the population on the 
right is a cell population with active caspase-3 or active Bax. 
(D) Cells were transfected with the indicated genes and total cell lysates collected 48 hours post-
transfection. Proteins were separated and probed for PARP and procaspase-3. GAPDH was used 
as a loading control. 
C 
D 
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Fig. 1-8  
Activated Bax localizes to the periphery of mitochondria  
HeLa cells were transfected with p20Bap31. 24 hours post-transfection, cells were treated with 
mitotracker red CMXRos (red) and stained for active Bax (using α-mouse Alexa Fluor 488 as a 
secondary antibody, green). DAPI staining was used to indicate the nucleus. Cells were analysed 
with confocal microscopy.  Scale bar indicates 10μm unless otherwise indicated. 
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1.3  Bap31 is required for Fis1-induced apoptosis but p20Bap31 does not 
require Fis1 
     Having shown the functional interaction between Fis1 and Bap31, I investigated if Bap31 
is required for Fis1-induced apoptosis. The endogenous Bap31 protein was down-regulated 
using short interfering RNA (siRNA). Immunoblot revealed that the endogenous protein level 
of Bap31 was reduced after 48-96 hours (D2-D4) post-transfection in cells transfected with 
siRNA against Bap31 but not with a control siRNA (Fig. 1-9 A). Densitometry analysis 
revealed that the Bap31 protein level was diminished by ~70% on day 2 and 3, and ~50% on 
day 4 compared with the endogenous level. An antibody against Bap31 recognised two bands 
at around 28kDa (Fig. 1-9 A). Because Bap31 is a 28kDa protein, it is likely that one of the 
bands represents Bap31 and the overexpression of Bap31 indeed gave a band of the same size. 
The most likely explanation for this duplex band is that the top band represents the full length 
Bap31 and the band below represents a single cleavage product of Bap31 (Fig. 1-3 A, 
cleavage at D238), which produces 27kDa protein. A production of the duplex band was also 
detected when caspase-8 was activated in the cell (Fig. 1-9 B) and similar results were 
observed by other groups when cells underwent apoptosis (Maatta et al 2000, Ng et al 1997, 
Wang et al 2003). Since both bands were reduced in Bap31 siRNA transfected cells, it should 
not affect the interpretation of the results shown below.  
     Fis1 was transfected on day 3 post siRNA transfection and the percentage of apoptosis was 
quantified with FACS on day 5. Although the down-regulation of Bap31 was detectable on 
day 2, the second transfection was performed on day 3 to allow cells to recover from the first 
transfection. The FACS analysis showed that Fis1 induced 36.4±6.7% (mean ± standard 
deviation) apoptosis in control siRNA transfected cells, whereas it was reduced to 19.7±2.1% 
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(46% reduction) in Bap31 siRNA transfected cells (Fig. 1-9 C). As a positive control, 
truncated Bid (tBid), which induces apoptosis independently of Bap31, was used. There was a 
slight increase of apoptosis (7%) in Bap31 siRNA transfected cells. This could be explained 
by the fact that the Bap31 siRNA transfected cells were more sensitive to apoptosis as 
indicated by the increased background apoptosis measured by β-gal transfection. The 
background apoptosis measured by β-gal transfection was 6.6±0.85 (siRNA control) and 
16.3±1.4 (siRNA Bap31). 
                        
 
 
 
Fig. 1-9 
Bap31 is required for Fis1-induced apoptosis 
(A) HeLa cells were transfected with siRNA against 
Bap31 (“si”) or control siRNA (“co”) and cells 
harvested from day1 (D1) to day5 (D5) post 
transfection. Cell lysates were separated and 
immunoblotted with a Bap31 antibody. 
(B) HeLa cells were treated with TNF 
(50ng/ml)+CHX (1μg/ml) overnight and cell lysates 
collected. Proteins were separated and immunoblotted 
with a Bap31 antibody. UT: untreated 
(C) Fis1 or tBid was transfected on day3 post siRNA 
transfection. The percentage of apoptosis measured by 
SubG1 DNA. FACS was performed after 48 hours 
(day5 post siRNA transfection). The transfection 
efficiency measured by GFP was 77.9±1.3 (siRNA 
control) and 60.6±1.7 (siRNA Bap31). Data represent 
the means±S.D. of three independent experiments.  
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      Although figure 1-9 shows that Bap31 is required for Fis1 to induce apoptosis, the level 
of its down-regulation was not complete and both the down-regulation and the Fis1 
expression relied on transient transfection. Thus, to exclude the possibility of artefacts, a cell 
line with stably downregulated Bap31 was produced (Fig. 1-10, western blot, see Result 
section “3.3 activation of procaspase-8 is Bap31 dependent” for more details). In this stable 
cell line, Fis1 was expressed and the level of apoptosis was measured as a depolarization of 
mitochondrial membrane potential (Fig. 1-10). As data indicated, control cell line (pLKO SC, 
no Bap31 downregulation) had 53.9±9.8% of cells with dissipated mitochondrial membrane 
potential whereas pLKO Bap31 (Bap31 downregulated cell line) cells had significantly 
reduced mitochondrial dysfunction (11.0±6.7%) with a p-value of 1.3x10
-3
.  
 
      
Fig. 1-10 
Bap31 downregulation makes cells refractory 
to Fis1-induced apoptosis 
A cell line with stable Bap31 knock-down 
(pLKO Bap31) or control cell line (pLKO SC) 
were transfected with the indicated genes and the 
percentage of cells showing dissipation of the 
mitochondrial membrane potential (ΔΨm) was 
measured 48 hours post-transfection using 
DiOC6 staining. The background measured by β-
gal transfection was 13.8±5.2 (pLKO SC) or 
20.2±7.4 (pLKO Bap31). The transfection 
efficiency measured by GFP was 80.6±7.4 
(pLKO SC) or 61.1±3.8 (pLKO Bap31). p-value 
between pLKO SC and pLKO Bap31 was 
1.3x10
-3
. Data are represented as means±S.D. 
n=3 (pLKO Bap31, Fis1 expression) or 4 
(others).  
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     In order to clarify the dependence of Fis1 for p20Bap31-induced apoptosis, endogenous 
Fis1 was down-regulated by short hairpin RNA (shRNA). Immunoblotting revealed that the 
endogenous Fis1 protein level was reduced on day 4 and 5 post shRNA transfection (Fig. 1-
11 A). Therefore, p20Bap31 was introduced on day 4 after shRNA transfection and the 
percentage of the cell population with subG1 DNA content was measured on day 5 (24 hours 
post p20Bap31 transfection) using FACS. It revealed that there was a slight increase in 
p20Bap31-induced apoptosis when Fis1 was down-regulated. But no statistical significance 
was observed (Fig. 1-11 B). Note that the endogenous Bap31 level was unchanged by 
transfection and p20Bap31 was only detectable upon transfection of its expression vector (Fig. 
1-11 B) 
              
 
 
 
 
Fig. 1-11 
Fis1 is not required for p20Bap31-induced apoptosis 
(A) HeLa cells were transfected with pSuper Fis1 and harvested on day 3 to day 5 
post transfection. pSuper vector-transfected cells were harvested on day 5. Cell 
lysates were separated and immunoblotted with an anti-Fis1 and anti-p38 antibody 
sequentially. p38 was used as a loading control. 
(B) On day4 post shRNA transfection, p20Bap31 was transfected and the percentage 
of apoptosis measured by subG1 DNA content analysed on day5 (24 hours post 
plasmid transfection). Data are presented as means±S.D. of three independent 
experiments. 
A 
B 
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     Hence, Fis1-induced apoptosis requires Bap31, however, the cleavage product of Bap31, 
p20Bap31, is not dependent on Fis1 to exert its pro-apoptotic effect. 
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2. Physical Interaction Between Fis1 and Bap31 
Summary 
     Physical interaction between mitochondria and the endoplasmic reticulum has been known 
for decades and some research data showed such inter-organeller association (Filippin et al 
2003, Goetz and Nabi 2006, Perktold et al 2007, Shore and Tata 1977b, Wang et al 2000b). It 
remains, however, unknown why such interaction should occur. Only for the past ten years, 
the physiological importance of such association was revealed including in apoptotic 
scenarios. Recently, several proteins were identified that facilitate the functional and/or 
physical interaction between the two cellular organelles; for example, PACS-2 and BIK have 
been shown to transmit signals for apoptosis from the ER to mitochondria (Simmen et al 
2005); Mitofusin 2 (de Brito and Scorrano 2008a) and Mmm1/Mdm10,12,34 were discovered 
to facilitate the physical association between mitochondria and the ER; and inositol 1,4,5-
trissphosphate (IP3) receptor and the voltage dependent anion channel (VDAC) connect these 
two organelles through glucose regulating protein 75 (GRP75, (Szabadkai et al 2006)). But no 
study showed both a functional and physical interaction.  
     In the previous section, it was shown that the mitochondrial fission protein Fis1 and the 
endoplasmic reticulum protein Bap31 functionally interact. Therefore, I sought to determine 
if these two proteins are also involved in physical interactions thus acting as an inter-
organelle scaffold. Immunostaining showed that Fis1 and Bap31 proteins are contiguous with 
each other. Moreover, the immunoprecipitation of endogenous Fis1 or Bap31 revealed a 
physical association between them, thereby between mitochondria and the ER. Further 
determination of the Fis1-Bap31 interaction showed that different deletion mutants of Bap31 
were still able to retain their interaction with Fis1. 
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2.1 Fis1 and Bap31 co-localize 
     To determine the localization of Fis1 and Bap31 under overexpression conditions, HeLa 
cells were transfected with Fis1-HA and YFP-mito (YFP tagged with a mitochondrial 
localization signal) or Bap31-myc and DsRed-ER (DsRed with a ER retention signal). The 
immunofluorescent images revealed that Fis1 and Bap31 are localized to mitochondria and to 
the ER, respectively as expected (Fig. 2-1 A,B). Also the cross section of a cell as represented 
by the fluorescent intensity plot overlapped with Fis1-HA and mitochondria, and likewise 
with Bap31-myc and the ER (Fig. 2-1 A,B right panels). Then Fis1-HA and Bap31-myc were 
co-expressed and the cells immunostained for the HA- and myc-epitope tags. Although it is 
not immediately apparent, figure 2-1 C shows that Fis1-HA and Bap31-myc are co-localized 
in some parts of the cell. The fluorescent intensity peaks of the signals are slightly out of 
phase. This further re-enforces that these two organelles are not overlapping but are 
juxtaposed to each other (Fig. 2-1 C, right panel).  
    I next attempted to test if it is possible to see a similar localization when all four expression 
vectors were transfected (Fis1-HA, Bap31-myc, YFP-mito and DsRed-ER). Immunostaining 
revealed that Fis1 localizes to mitochondria (Fig. 2-2 A); Bap31 localizes to the ER (Fig. 2-2 
B); and Fis1 and Bap31 co-localize (Fig. 2-2 C). Fluorescent intensity plots of a 
representative cross section shown on the right panels support this.  
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Fig. 2-1 
Fis1 co-localizes with Bap31 
HeLa cells were transfected with (A) YFP-mito (green) and Fis1-HA (counter stained with 
α-mouse Alexa Fluor 633, red), (B) DsRed-ER (red) and Bap31-myc (counter stained with 
α-rabbit Alexa Fluor 405, blue), and (C) Fis1-HA (counter stained with α-mouse Alexa 
Fluor 488, green) and Bap31-myc (counter stained with α-rabbit Alexa Fluor 594, red) and 
observed under a confocal microscope after immunostaining against HA and myc. 
Relative fluorescence intensity of a cross section is shown on right. Scale bars represent 
10µm. 
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Fig. 2-2 
Fis1 co-localizes with Bap31 in a single cell 
HeLa cells were transfected with YFP-mito, Fis1-HA, DsRed-ER and Bap31-myc and 
observed under the confocal microscope after immunostaining against HA and myc.  
Stainings for mitochondria and Fis1 (A), ER and Bap31 (B), and Fis1 and Bap31 (C) are 
shown. Fluorescent intensity plots of a cross section are presented on right. The combination 
of secondary antibodies were same as Fig. 2-1. Scale bar represents 10µm. 
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2.2 Fis1 and Bap31 physically interact 
     Having shown the spacial proximity between Fis1 and Bap31, the physical interaction 
between the two proteins was examined. Total cell extract was prepared from HeLa cells and 
the endogenous Fis1 or Bap31 proteins were immunoprecipitated (Fig. 2-3 “IP Fis1” and “IP 
Bap31”). The result revealed an interaction between endogenous Bap31 and Fis1 (Fig. 2-3).  
 
 
 
 
     Given the endogenous interaction between Fis1 and Bap31, I aimed to determine which 
domain of Bap31 is required for this interaction. There are five domains present in Bap31: 
three transmembrane domains (TM), one coiled-coil domain (CC) and one variant of death 
effector domain (vDED) as shown in the schematic diagram (Fig. 2-4). The potential domains 
for the protein-protein interaction are either the coiled-coil domain or the vDED domain. In 
order to identify the domains of interest, three mutants were produced (Fig. 2-4): 
Bap31ΔvDED (deletion mutant of Bap31 that lacks the vDED domain), p20Bap31 
(membrane anchored fragment after Bap31 cleavage by caspase) and Bap31ΔCC/vDED 
Fig. 2-3 
Endogenous Fis1 and Bap31 interact  
HeLa cells were washed, lysed and the endogenous proteins were immunoprecipitated 
(IP) either with Fis1 (left) or Bap31 (right) antibodies. The associated Bap31 or Fis1 
proteins were then detected by probing with Bap31 and Fis1 antibody sequentially and 
revealed by Western blot. Control IPs were carried out without antibodies.  
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(deletion mutant lacking CC and vDED domains). Figure 2-5 shows the protein expression of 
each mutant as well as full length wild type Bap31 (WT Bap31) in HEK293T cells.  
 
 
 
 
 
 
 
 
 
 
 
 
     Each deletion construct of Bap31 was co-expressed with a Fis1 expression vector in 
HEK293T cells and the total cell lysates were immunoprecipitated. First, either WT Bap31-
Fig. 2-4 
Schematic diagram showing different deletion mutants used 
Full length Bap31 (WT Bap31) is a 246 amino acids-long protein and possesses three 
transmembrane domains (TM, amino acid 7-27, 43-64 and 102-123), one coiled-coil domain 
(CC) and one variant of death effector domain (vDED, amino acid 175-229). The second 
diagramme represents the deletion mutant of vDED (Bap31ΔvDED). The third mutant, 
p20Bap31, is a membrane-anchored fragment after the cleavage of full length WT Bap31 by 
caspases. The last mutant lacks both CC and vDED domain (Bap31ΔCC/vDED).  
Note that the scissor marks represent the caspase cleavage sites (D164 and D238). 
 
Fig. 2-5 
Expression verification of different Bap31 mutants 
WT Bap31-Flag, Bap31ΔvDED-Flag, p20Bap31-myc and Bap31Δcc/vDED-Flag 
constructs were expressed in HEK293T cells and the total cell lysates were separated 
and probed with an α-Flag or α-myc antibody. 
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Flag or Bap31ΔvDED-Flag was expressed with Fis1-HA (Fig. 2-6 A). The total cell lysates 
were immunoprecipitated with α-HA or α-Flag antibody and the immunoprecipitates 
analysed on Western blot (Fig. 2-6 B,C). The data revealed that the Bap31ΔvDED mutant 
retained its ability to interact with Fis1. 
          
 
 
 
     I then determined if the cleavage product of Bap31, p20Bap31, is able to interact with Fis1. 
The mammalian expression vector coding for p20Bap31-myc was co-expressed with Fis1-HA 
in HEK293T cells. Full length Bap31 (WT Bap31-myc) was used as a positive control. Total 
cell lysates were subjected to immunoprecipitation using an α-myc antibody and the 
Fig. 2-6 
Bap31ΔvDED interacts with Fis1 
(A) Either WT Bap31-Flag or Bap31ΔvDED-Flag was co-transfected with Fis1-HA in 
HEK293T cells. Cell lysates were prepared 24 hours post-transfection. 
(B, C) The total cell lysates were collected 24 hours post-transfection and the equal amount 
of protein lysates were immunoprecipitated overnight with an α-HA (B) or α-Flag (C) 
antibody. The immunoprecipitates were analysed on Western blot using either α-Flag or α-
myc antibody. Control immunoprecipitations (IP) were carried out without addition of any 
antibody. 
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immunoprecipitates were analysed by immunoblotting (Fig. 2-7). As figure 2-7 indicates, 
p20Bap31 retained its ability to interact with Fis1. 
 
 
 
 
     I next sought to investigate if Fis1 can interact with smallest deletion mutant of Bap31, 
Bap31ΔCC/vDED. HEK293T cells were co-transfected with Fis1-HA and WT Bap31-Flag or 
Bap31ΔCC/vDED-Flag (Fig. 2-8, input). Total cell lysates were prepared and 
immunoprecipitated with α-HA (Fig. 2-8 left) or α-Flag (Fig. 2-8 right) antibody. As figure 2-
8 shows, the smallest mutant of Bap31 retained its interaction with Fis1. This result led us to 
consider the possibility that the transmembrane domains present in Bap31 is responsible for 
the Fis1 interaction or these deletion mutants transfected heterodimerize with WT Bap31, 
thus indirectly interacting with Fis1.  
     Since Bap31 may undergo homodimerization or heterodimerization between different 
mutants as dipiccted from above data, I first tested to see whether Bap31-Flag and Bap31-
Fig. 2-7 
Fis1 and p20Bap31 interact  
HEK293T cells were co-transfected with Fis1-HA and Bap31-myc or p20Bap31-myc 
(input). The total cell lysates were collected 24 hours post-transfection and equal amounts 
of protein lysates immunoprecipitated with α-myc antibody. Control 
immunoprecipitations (IP) were carried out without addition of any antibody. 
Immunoprecipitates were analysed on western blot using α-myc or α-HA antibody.  
** IgG light chain    * product of an alternative transcript 
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myc proteins can interact together. HEK293T cells were co-transfected with two Bap31 
constructs harboring different epitope tags and immunoprecipitated with an α-myc (Fig. 2-9 
left) or α-Flag (Fig. 2-9 right) antibody. It was found that Bap31 is indeed able to 
homodimerize in a healthy non-apoptotic condition.  
 
 
 
 
 
 
 
 
     
Fig. 2-8 
Fis1 and Bap31ΔCC/vDED interact 
HEK293T cells were co-transfected with Fis1-HA and Bap31-Flag or Bap31ΔCC/vDED-
Flag (input). Total cell lysates were collected 24 hours post-transfection and the equal 
amount of protein lysates immunoprecipitated with α-HA (left) or α-Flag (right) antibody.  
Control immunoprecipitations (IP) were carried out without addition of any antibody. 
Immunoprecipitates were analysed on western blot with the indicated antibodies. 
* product of an alternative transcript 
Fig. 2-9 
Bap31 homodimerizes 
HEK293T cells were co-transfected with Bap31-Flag and Bap31-myc expression 
constructs (input). Total cell lysates were collected 24 hours post-transfection and the 
equal amount of protein lysates immunoprecipitated with α-myc (left) or α-Flag (right) 
antibody. Control immunoprecipitations (IP) were carried out without addition of any 
antibody. Immunoprecipitates were analysed on western blot using either α-myc or α-Flag 
antibody. 
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     I then determined the potential of different Bap31 mutants interacting with full length 
Bap31. In figure 2-10, either WT Bap31-Flag or WT Bap31-myc was co-transfected with 
each Bap31 deletion mutants and immunoprecipitated with the indicated antibodies. It was 
found that WT Bap31 was able to heterodimerize strongly with all three mutants of Bap31 
(Bap31ΔvDED, p20Bap31 and Bap31Δcc/vDED, Fig. 2-10 top and bottom) apart from cells 
transfected with Bap31-Flag and p20Bap31-myc and immunoprecipitated against the Flag 
epitope (Fig. 2-10 bottom, second lane). Therefore, it is likely that the Fis1 interactions with 
different Bap31 deletion mutants are mediated by an indirect association through the 
endogenous full length Bap31 protein. This finding also insinuates that the TM of Bap31 is 
sufficient to provoke Bap31 dimerization.  
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Fig. 2-10 
WT Bap31 heterodimerizes with deletion mutants 
HEK293T cells were co-transfected with Bap31-Flag and mutants of Bap31 (input). Total 
cell lysates were collected 24 hours post-transfection and the equal amount of protein 
lysates immunoprecipitated with α-myc (top) or α-Flag (bottom) antibody. Control 
immunoprecipitations (IP) were carried out without addition of any antibody. 
Immunoprecipitates were analysed on western blot as indicated. 
* product of an alternative transcript 
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3. Procaspase-8 is Recruited to and Activated at the Fis1-Bap31 complex 
Summary 
     Caspases are the main initiators and the executioners of apoptosis (Alnemri et al 1996, 
Martin and Green 1995) and their activation is observed in most scenarios of apoptosis. The 
cascade of caspase-dependent caspase activation allows the effector caspases to be activated 
by initiator caspases. The activation of initiator caspases such as procaspase-8 or -9, however, 
requires different mechanisms of activation. Such processes involve the formation of protein 
complex that allow the proximity-induced dimerization of initiator caspases via the death 
effector domain (DED) of procaspase-8 or the caspase recruiting domain (CARD) present in 
procaspases-9. Several protein platforms have been described to activate initiator caspases, 
such as the apoptosome for procaspases-9; the PIDDosome (Tinel and Tschopp 2004) for 
procaspases-2; and the DISC and the Hip-1/Hippi complex (Gervais et al 2002) for 
procaspase-8 activation. Although these initiator caspases activating platforms exist, it is 
possible that cells harbour more of such complexes considering the diverse signals that can 
lead to the activation of caspases and the induction of apoptosis.  
     In this section, I describe another protein complex constituted by Fis1 and Bap31 that 
allows the recruitment and the activation of procaspase-8, which we name ARCosome. The 
involvement of caspase-8 indicated by the finding that Bap31 cleavage was alleviated when 
caspase-8 activity was inhibited. Further analysis revealed that procaspase-8 is recruited to 
the Fis1-Bap31 complex as an early event during the apoptosis mediated by exogenous 
signals. Moreover, stable knock-down of Bap31 greatly reduced the level of caspase-8 
activation, which also correlated to the reduced level of apoptosis. Use of deletion mutants of 
Bap31 described in the previous section revealed that the vDED in Bap31 is responsible for 
the recruitment of procaspase-8 to the ARCosome.  
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3.1 Caspase-8 cleaves Bap31-EYFP 
     The overexpression of Fis1 was shown to induce the cleavage of Bap31-EYFP in a 
caspase-dependent manner in section 1. It can, however, be criticised that overexpression of 
proteins may result in an artefact and not physiologically relevant. Thus, two exogenous 
apoptosis signals, actinomycin D and etoposide were used to assess whether they can induce 
the cleavage of Bap31-EYFP fusion protein. These drugs were selected as the apoptosis 
induced by them is dependent on Fis1 since knock-down of Fis1 alleviated the cell death 
signals mediated by these two drugs (Lee et al 2004). Figure 3-1 shows that the application of 
actinomycin D or etoposide in HeLa cells induced the cleavage of Bap31-EYFP. Moreover, 
the procaspase-8 protein level was concomitantly reduced in cells that displayed the cleavage 
of Bap31-EYFP, which indirectly indicates the activation of caspase-8. The amount of 
Bap31-EYFP cleavage also seems to correlate with the level of caspase-8 activation (compare 
Act.D 10μM and Eto100μM). 
                               
 
 
 
Fig. 3-1 
Exogenous signals induce the procession of Bap31-EYFP and procaspase-8 
HeLa cells were transfected with Bap31-EYFP and treated with actinomycin D (2 or 10µM, 5 hours) or 
etoposide (30 or 100µM, 30 hours). Total cell lysates were separated and probed with the indicated 
antibodies. GFP: positive control, NT: non-treated cells as a negative control. GAPDH was used as a loading 
control. Note that the data shown are from the same membrane with the same exposure time (within the 
same antibody). 
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     Given the involvement of caspase-8 in Bap31-EYFP cleavage, I used the inhibitor of 
caspase-8, zIETD-fmk, and analysed the procession of Bap31-EYFP upon drug treatment 
(Fig. 3-2). Treatment with etoposide induced ~60% of the fusion protein cleavage without the 
caspase-8 inhibitor, while it was reduced to ~30% in the presence of zIETD-fmk as 
determined by densitometry analysis (Fig. 3-2 A). The percentage was calculated by the 
lower band intensity (EYFP band) divided by the sum of the top and lower band intensities 
(Bap31-EYFP and EYFP). Similarly, actinomycin D treatment (10-20μM) without the 
presence of the inhibitor resulted in approximately 70% of Bap31 fusion protein cleavage, 
whereas it was reduced to around 35% in the presence of the caspase-8 inhibitor (Fig. 3-2 B). 
Collectively these data indicate the strong involvement of caspase-8 in Bap31 procession.  
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Fig. 3-2 
Application of caspase-8 inhibitor reduces the cleavage of Bap31-EYFP induced by exogenous 
chemicals  
HeLa cells were transfected with Bap31-EYFP and the caspase-8 inhibitor, zIETD-fmk (50µM), 
was added to the medium when the transfection reagent was removed after 5 hours. Following 
overnight protein expression, cells were treated with actinomycin D (2-20µM, 5 hours) or etoposide 
(30-200µM, 30 hours). Total cell lysates were separated and the procession of Bap31-EYFP was 
determined. GFP: positive control, NT: non-treated cells as a negative control. GAPDH was used as 
a loading control. Densitometry analysis was performed using ImageJ programme. The percentage 
dissociation was calculated by the intensity of the lower band divided by the sum of top and lower 
band intensities.  
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3.2 Procaspase-8 is recruited to Fis1-Bap31 complex  
     The long isoform of procaspase-8 (procaspase-8L) was previously shown to associate with 
Bap31 upon the expression of adenoviral proapoptotic E1A protein (Breckenridge et al 2002) 
and another paper described the presence of a variant of death effector domain (vDED) in 
Bap31 located in the C-terminus flanked by two caspase recognition sites (Fig. 3-3, 
(Breckenridge et al 2002, Ng et al 1997, Reed et al 2004)). Thus, I sought to determine if 
procaspase-8 can be recruited to the Fis1-Bap31 complex upon drug treatments that induce 
the cleavage of Bap31. In figure 3-4, HeLa cells were treated either with actinomycin D 
(ActD) or etoposide (Eto) and the endogenous Fis1 protein was immunoprecipitated (Fig. 3-4 
A). The data indicate that Fis1 was efficiently pulled down (Fig. 3-4 A, top panel) and it 
retained its interaction with Bap31 in all conditions (Fig. 3-4 A, middle panel). Furthermore, 
procaspase-8 was found to interact with the pre-existing Fis1-Bap31 complex only upon drug 
treatment (Fig. 3-4 A, bottom panel). In order to show that this recruitment occurs early 
during the apoptosis, the cleavage of the substrate of caspase-3, PARP, was determined by 
western blotting (Fig. 3-4 B). It showed that STS-treated cells presented the procession of 
PARP (as a positive control) while actinomycin D- or etoposide-treated cells did not. 
 
Fig. 3-3 
Schematic diagram showing the domains of Bap31 
Bap31 is a 246 amino acids-long protein containing three transmembrane domains (TM), one 
coiled-coil domain (CC) and one variant of death effector domain (vDED) flanked by two caspase 
recognition sites (D164 and D238). Coiled-coil domain and vDED is facing the cytosol. 
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     To further emphasize that this tripartite protein complex forms upon apoptotic stimuli, gel 
filtration/size-exclusion chromatography was performed. Figure 3-5A shows the fractionation 
of standard proteins (Fig. 3-5A top) and my sample fractions as depicted by UV absorbance 
(Fig. 3-5A bottom, threshold was set to 0.2). The SDS-PAGE separation of proteins revealed 
that caspase-8, Bap31 and Fis1 fractionate together upon treatment of the cells with 
actinomycin D (Fig. 3-5B, compare fraction number 40 in “non-treated” and “actinomycin D 
treated” samples). Moreover, the treatment of HeLa cells with both actinomycin D and 
etoposide enhanced the level of Bap31 homodimerization (Fig. 3-6). 
Fig. 3-4 
Procaspase-8 is recruited to Fis1-Bap31 complex early during apoptosis 
(A) HeLa cells were treated with actinomycin D (ActD, 10µM, 4 hours) or etoposide (Eto, 100µM, 
30 hours). Total cell lysates were prepared and immunoprecipitated with endogenous Fis1 antibody. 
Immunoprecipitates were analysed with the indicated antibodies.  
NT: non-treated cells as a negative control. Control IPs were performed without antibodies.  
(B) Using the same condition as a), cell lysates were subjected to SDS-PAGE and probed with a 
PARP antibody. Staurosporine was used as a positive control. GAPDH was employed as a loading 
control. 
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Fig. 3-5  
Caspase-8, Bap31 and Fis1 fractionate 
(A) A superose-12 gel-filtration/size-exclusion chromatography column was loaded with a mixture 
of five proteins, ferritin (440kDa), aldolase (158kDa), transferring (80kDa), ovalbumin (43kDa) and 
myoglobin (17kDa), and fractionated with a flow rate of 0.3ml/min. By spectrophotometer (UV 
absorbance), six distinctive peaks (first one is a contamination) were depicted corresponding to the 
size markers (top). Using exactly the same condition, cell lysates prepared was analysed (bottom). 
Fraction no. correspond to the numbers indicated in B). 
(B) Fraction 25 to 48 from cell lysates, either untreated or treated with actinomycin D (0.5μM, 23 
hrs), were separated on SDS-PAGE and probed for caspase-8, Bap31 and Fis1. Rough size 
estimations are indicated below the blot. 
B 
Fig. 3-6  
Drug treatment enhances the Bap31 homodimerization 
Bap31-Flag and Bap31-myc were co-transfected into HEK293T cells. Cells were treated with 
actinomycin D (0.2μM, 23hrs) or etoposide (100μM, 30hrs) 24 hours post-transfection. Cell lysates 
were then prepared and the equal amounts of protein, as determined by Bradford assay, were 
immunoprecipitated with α-Flag antibody. Immunoprecipitates were separated on an SDS-PAGE 
and probed with α-Flag and α-myc antibodies.  
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3.3 Activation of procaspase-8 is Bap31 dependent 
     To further analyse the importance of the Fis1-Bap31 complex, each component was stably 
downregulated with lentiviral shRNA transduction using the pLKO.puro vector. HeLa cells 
were transduced with viral particles that harbour shRNA sequences against control scramble, 
Fis1 or Bap31 (pLKO SC, pLKO Fis1 or pLKO Bap31), incubated for three days to allow the 
expression of shRNA, and selected with puromycin (5μg/ml). Figure 3-7A shows the 
efficiency of selection by puromycin. Non-transduced cells died within 24 hours of 
puromycin selection whereas transduced cells continued to grow normally (Fig. 3-7 A). The 
down-regulation of Fis1 or Bap31 was subsequently analysed by immunoblotting three days 
after the selection (Fig. 3-7 B).  
                                 
               
 
 
Fig. 3-7 
Production of stable Fis1 or Bap31 knock-down cell lines 
(A) Lentiviral shRNA vector, pLKO.puro, was used to subclone shRNA sequence against Fis1 or 
Bap31. HeLa cells were transduced on Day 0, grown for three days, and selected with puromycin 
(5µg/ml) for three days.  
(B) Cell lysates were collected after puromycin selection and subjected to SDS-PAGE to analyse 
the down-regulation. GAPDH was used as a loading control. 
  
A 
B 
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     Using these stable cell lines, the activation of caspase-8 was analysed upon treatment with 
actinomycin D or etoposide (Fig. 3-8). Application of actinomycin D in a range of 
concentrations resulted in 20-30% of caspase-8 activation over the background in pLKO 
scramble cells (Fig. 3-8 A, blue bars). On the other hand, pLKO Bap31 cells showed 
significantly reduced level of caspase-8 activation (Fig. 3-8 A, red bars) whereas, 
unexpectedly, pLKO Fis1 cells increased the caspase-8 activation (Fig. 3-8 A, green bars). 
Similarly, treatment with etoposide produced a dose-dependent caspase-8 activation in the 
control cell line (pLKO SC, Fig. 3-8 B). Cells with downregulated Bap31 (pLKO Bap31) did 
not completely abrogate the caspase-8 activity but had significantly reduced level of caspase-
8 activation when compared with pLKO SC cells (Fig. 3-8 B). Knock-down of Fis1, too, 
showed reduced caspase-8 activity in comparison with pLKO SC cells while actinomycin D 
treatment showed the opposite effect (Fig. 3-8 A,B). In order to assess the relevance of 
caspase-8 activation to apoptosis, the loss of the mitochondrial membrane potential was 
measured (Fig. 3-9). Both actinomycin D and etoposide treatment showed a correlation 
between caspase-8 activation and the level of apoptosis: cell death was reduced upon 
actinomycin D treatment in pLKO Bap31 cells while pLKO Fis1 cells revealed an increase 
(Fig. 3-9 A). Similarly, both pLKO Bap31 and pLKO Fis1 cells had lower level of apoptosis 
upon etoposide treatment (Fig. 3-9 B). The activation of caspase-8 and the dissipation of the 
mitochondrial membrane potential observed in pLKO Fis1 cells upon drug treatments were 
further supported when the Bap31-EYFP fusion construct was expressed and the cleavage 
was assessed upon exposure to actinomycin D or etoposide (Fig. 3-10). The procession of 
Bap31-EYFP upon etoposide application was lower when compared with cell transfected 
with a scramble construct (pLKO SC) whereas actinomycin D treatment resulted in a robust 
cleavage of Bap31-EYFP recapitulating the data observed in figure 3-8 and figure 3-9. One 
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may argue that the reduced level of caspase-8 activation and the mitochondrial dysfunction 
caused by exogenous signals in Bap31 knock-down cells emanate from the global alteration 
of ER stress responses. Thus to exclude such possibility, cell lysates from pLKO SC and 
pLKO Bap31 cells were prepared and probed for ER stress markers. Figure 3-11 shows that 
there was no difference in expression levels of those ER stress markers. 
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Fig. 3-8 
Bap31 is required for caspase-8 activation 
(A) Using cell lines with stable downregulation of Bap31 (pLKO Bap31) or Fis1 (pLKO Fis1), cells 
were treated with actinomycin D (0.2-5µM, 23 hours) and the activation of caspase-8 measured. 
pLKO SC: scramble shRNA. Background caspase-8 activation was 2.8±0.68 (pLKO SC), 5.4±3.8 
(pLKO Bap31) and 5.5±2.8 (pLKO Fis1). n=5 (pLKO SC non-treated) or 3 (all the rest).  
p-values with treatments were: 3.0x10
-2
, 1.8x10
-3
, 1.7x10
-3
 (pLKO SC v.s. pLKO Bap31, from 
0.2μM to 5 μM) or 2.0x10-2, 3.0x10-3, 1.5x10-3 (pLKO SC v.s. pLKO Fis1, from 0.2μM to 5 μM) 
(B) same as (A) but using etoposide (75-225µM, 30 hours). Background caspase-8 activation was 
2.8±0.68 (pLKO SC), 5.4±3.8 (pLKO Bap31) and 5.5±2.8 (pLKO Fis1). n=5 (pLKO SC non-
treated) or 3 (all the rest). p-values with treatments were: 1.1x10
-2
, 1.0x10
-2
, 6.2x10
-3
 (pLKO SC v.s. 
pLKOBap31, from  75μM to 225μM) or 4.5x10-5, 1.3x10-2, 2.0x-3 (pLKO SC v.s. pLKO Fis1, from  
75μM to 225μM) 
Histograms represent means±S.D. 
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Fig. 3-9 
Caspase-8 activity correlates with mitochondrial dysfunction 
(A) Using pLKO SC, Bap31 or Fis1 cell lines, cells were treated with actinomycin D (1µM, 23 
hours) and the dissipation of mitochondrial membrane potential (ΔΨm) was measured. Background 
DiOC6 positive cells were 3.4±2.3 (pLKO SC), 5.2±2.1 (pLKO Bap31) and 5.1±3.8 (pLKO Fis1). 
n=6 (non-treated) or 5 (1μM Act.D treated). p-values with treatments were: 1.3x10-2 (pLKO SC v.s. 
pLKO Bap31) or 0.13 (pLKO SC v.s. pLKO Fis1) 
(B) Same as a) but using etoposide (150µM, 30 hours). Background DiOC6 positive cells were 
3.4±2.3 (pLKO SC), 5.2±2.1 (pLKO Bap31) and 5.1±3.8 (pLKO Fis1). n=6 (non-treated) or 5 
(150μM etoposide treated). p-values with treatments were: 1.8x10-3 (pLKO SC v.s. pLKO Bap31) 
or 1.7x10
-5
 (pLKO SC v.s. pLKO Fis1). 
Histograms represent means±S.D. 
 
A B 
Fig. 3-10 
Bap31-EYFP cleavage correlates with the activation of caspase-8 
Bap31-EYFP fusion construct was expressed in pLKO SC or pLKO Fis1 cells. Cells were then 
treated with etoposide (100μM, 30hrs) or actinomycin D (0.2μM, 23hrs) 24 hours post-
transfection. Total cell lysates were collected and separated on SDS-PAGE. Cleavage of Bap31-
EYFP and the percentage cleavage were assessed as before (Fig. 3-2). Lysate from GFP-
transfected cells were used as a positive size control. UT: untreated  
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     Because knockdown of Bap31 or Fis1 exerted different effects on caspase-8 activation as 
well as the level of apoptosis measured by the loss of mitochondrial membrane potential 
(ΔΨm) upon drug treatments, cells with double knockdown of Bap31 and Fis1 were produced 
(pLKO Bap31/Fis1, Fig. 3-12 A). Using this cell line, the level of caspase-8 activation and 
the percentage cells with loss of mitochondrial membrane potential were measured upon 
actinomycin D or etoposide treatment (Fig. 3-12 B-E). The data indicate that double 
knockdown of Bap31 and Fis1 exhibited a similar trend as Fis1 single knock-down increased 
level of caspase-8 and mitochondrial depolarization with actinomycin D but reduced level of 
caspase-8 and mitochondrial dysfunction with etoposide in comparison to pLKO SC cells. 
Thus, it indicates that Fis1 knockdown is dominant in mediating this effect. 
 
  
Fig. 3-11 
Bap31 knock-down does not alter expression of 
ER stress markers 
Cell lysates from pLKO SC and pLKO Bap31 were 
prepared, separated on SDS-PAGE and probed for 
the indicated antibodies. 
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Fig. 3-12 
Double knock-down of Bap31 and Fis1 shows similar trend compared with pLKO Fis1 cells 
(A) Bap31 knock-down cells (pLKO Bap31) were transduced with viral shRNA particles against Fis1. 
Total cell lysates were prepared and separated to determine the down regulation of Bap31 and Fis1. 
GAPDH was used as a loading control.  
(B) pLKO Bap31/Fis1 cells were treated with actinomycin D with indicated concentration for 23 hrs 
and the activation of caspase-8 was determined. Background Caspase-8 positive cells were 3.6±1.0 
(pLKO SC) and 5.0±1.1 (pLKO Bap31/Fis1). n=4 (pLKO SC) or 5 (pLKO Bap31/Fis1). p= 8.3x10
-5
 
(pLKO SC v.s. pLKO Bap31/Fis1 with treatment) 
(C) pLKO Bap31/Fis1 cells were treated with actinomycin D with the indicated concentration for 23 
hrs and the dissipation of mitochondrial membrane potential was measured. Background DiOC6 
positive cells were 4.3±1.1 (pLKO SC) and 5.6±1.8 (pLKO Bap31/Fis1). n=5 (pLKO SC) or 4 (pLKO 
Bap31/Fis1). p= 9.5x10
-4
 (pLKO SC v.s. pLKO Bap31/Fis1 with treatment) 
(D) pLKO Bap31/Fis1 cells were treated with etoposide using indicated concentration for 30 hrs and 
the activation of caspase-8 was determined. Background Caspase-8 positive cells were 4.1±0.9 (pLKO 
SC) and 5.4±1.1 (pLKO Bap31/Fis1). n=4. p= 4.8x10
-4
 (pLKO SC v.s. pLKO Bap31/Fis1 with 
treatment) 
(E) pLKO Bap31/Fis1 cells were treated with etoposide using the indicated concentration for 30 hrs 
and the dissipation of mitochondrial membrane potential was measured. Background DiOC6 positive 
cells were 4.5±1.3 (pLKO SC) and 5.8±2.2 (pLKO Bap31/Fis1). n=3 (pLKO SC) or 3 (pLKO 
Bap31/Fis1). p= 1.9x10
-4
 (pLKO SC v.s. pLKO Bap31/Fis1 with treatment).  
Histograms represent means±S.D. 
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3.4 The vDED domain of Bap31 is responsible for procaspase-8 recruitment 
and its activation 
     As Bap31 was found to be a required component to activate caspase-8, a domain 
responsible for the recruitment of procaspase-8 was determined. The most likely candidate for 
such an interaction was the variant of death effector domain (vDED, amino acid 175-229) 
present in Bap31 (Fig. 3-13 A) since procaspase-8 possesses two DED domains for the 
homotypic interaction with other DED-containing proteins. A multiple sequence alignment 
revealed that the vDED present in Bap31 indeed possesses some degree of sequence 
homology to other known DED found in procaspase-8, procaspase-10, FADD or cFLIP (Fig. 
3-13 B) although, interestingly, vDED of Bap31 was phylogenetically closest to the second 
DED present in procaspase-10 (C10-DEDB, Fig. 3-13 C). To assess the importance of vDED 
domain in procaspase-8 recruitment, a deletion mutant of Bap31 that lacks vDED 
(Bap31ΔvDED) was produced (Fig, 2-4, 2-5, 3-13 A,D). 
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FADD-DED     FLVLLHSVSSSLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSMLLEQNDLEPGHTELL 
C10-DEDA     FREKLLIIDSNLGVQDVENLKFLCIGLVPNKKLEKSSSASDVFEHLLAEDLLSEEDPFFL 
C8-DEDA      FSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFL 
cFLIP-DEDB   YRVLMAEIGEDLDKSDVSSLIFLMKDYMGRGKISKEKSFLDLVVELEKLNLVAPDQLDLL 
C8-DEDB      YRVMLYQISEEVSRSELRSFKFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDIL 
cFLIP-DEDA   SAEVIHQVEEALDTDEKEMLLFLCRDVAIDVVPPNVRDLLDILRERGKLSVG------DL 
C10-DEDB     FRNLLYELSEGIDSENLKDMIFLLKDSLPKTEMTS----LSFLAFLEKQGKIDEDNLTCL 
Bap31-vDED   --------KLEEENRSLKADLQKLKDELASTKQKLEKAENEVLAMRKQSEGLTKEYDRLL 
                            .                         ..                * 
 
FADD-DED     RELLASLRRHDLLRRVDD 
C10-DEDA     AELLYIIRQKKLLQHLNC 
C8-DEDA      KELLFRINRLDLLITYLN 
cFLIP-DEDB   EKCLKNIHRIDLKTKIQK 
C8-DEDB      KRVCAQINKSLLKIIND- 
cFLIP-DEDA   AELLYRVRRFDLLKRILK 
C10-DEDB     EDLCKTVVPKLLRNIEK- 
Bap31-vDED   EE---------------- 
 
 
 
Fig. 3-13 
vDED of Bap31  
(A) Full length wild type Bap31 was tagged with a Flag 
epitope (WT Bap31-Flag, left). Using WT Bap31, a 
deletion mutant lacking vDED was produced 
(Bap31ΔvDED-Flag, right).  
(B) Multiple sequence alignment of DEDs present in 
FADD, procaspase-10 (C10), procaspase-8 (C8) and 
cFLIP, and the vDED of Bap31 are shown. The results 
showed that the vDED of Bap31 is 19% homologous to 
C8-DEDA, 17% to C8-DEDB, 20% to FADD, 17% to 
C10-A, 24% to C10-B, 15% to cFLIP-DEDA and 17% 
to cFLIP-DEDB. Note that “DEDA” is a first DED 
present in a protein and similarly “DEDB” is a second 
DED in a given protein. The sequence alignment was 
performed using ClustalW 1.81. 
(C) Phylogenetic tree of DEDs present in different 
proteins are shown.  
(D) WT Bap31-Flag and Bap31ΔvDED-Flag were 
expressed and immunoblotted against Flag, Bap31 and 
GAPDH.  
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     To investigate if this deletion mutant is able to recruit procaspase-8, HEK293T cells were 
transfected either with WT Bap31-Flag or Bap31ΔvDED-Flag and were subjected to 
actinomycin D or etoposide treatment. Total cell lysates were immunoprecipitated against 
endogenous caspase-8 and the association with WT Bap31-Flag or Bap31ΔvDED-Flag was 
assayed by immunoblotting against α-Flag antibody (Fig. 3-14). As figure 3-14 shows, 
neither WT Bap31-Flag nor Bap31ΔvDED-Flag interacted with procaspase-8 without 
apoptotic stimuli (Fig. 3-14, lane 1, 5, 9 and 13). However, the application of either 
actinomycin D or etoposide allowed WT Bap31-Flag to associate with procaspase-8 (Fig. 3-
14, lane 3 and 11). In contrast, Bap31ΔvDED-Flag was unable to interact with procaspase-8 
even upon drug application (Fig. 3-14, lane 7 and 15) indicating that it is the vDED (variant 
of death effector domain) that is responsible for the interaction between Bap31 and 
procaspase-8. 
 
 
  
 
 
Fig. 3-14 
vDED of Bap31 is responsible for the procaspase-8 recruitment 
HEK293T cells were transfected either with WT Bap31-Flag or Bap31ΔvDED-Flag (right panel, 
input). Following the expression of the genes for overnight, cells were treated with actinomycin D 
(0.2μM, 20 hours) or etoposide (100μM, 30 hours). The total cell lysates were subjected to 
immunoprecipitation against endogenous caspase-8. Immunoprecipitates were separated by SDS-
PAGE and analysed with α-Flag antibody.* product of an alternative transcript 
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     Having established the importance of Bap31 in procaspase-8 recruitment and its activation, 
I sought to investigate the requirement of Fis1 in the recruitment of this protease to the 
ARCosome. Figure 3-15 shows that the interaction between caspase-8 and Bap31 was 
diminished in the absence of Fis1 upon etoposide (21±16% of control cells) and actionomycin 
D (49±24% of control cells) treatment. Thus, although Bap31 is likely to interact with 
procasase-8, the presence of Fis1 is also needed for the efficient recruitment.  
  
 
 
 
 
 
 
 
Fig. 3-15 
Knock-down of Fis1 suppresses the efficient procaspase-8 recruitment to Bap31 
pLKO SC, pLKO Fis1 and pLKO Bap31 cells were either treated with etoposide (100µM, 30hrs, 
top) or actinomycin D (0.5µM, 23hrs, bottom). Total cell lysates were prepared and equal amounts 
of protein subjected to immunoprecipitation against caspase-8. Immunoprecipitates were 
subsequently separated by SDS-PAGE and probed for caspase-8 and Bap31. Left band are scramble 
cells without any treatment. Control immunoprecipitations were carried out without any antibodies. 
Numbers shown below each blot represent the percentage caspase8-Bap31 interaction with respect 
to pLKO SC cells treated with drug as depicted by the densitometry analysis. Percentages are 
shown as means±S.D. of three independent experiments. 
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4. The Cytosolic Calcium Concentration Increases Upon Activation of 
Bap31 
Summary 
     Calcium is a well-known intracellular secondary messenger in the cell but it is also an 
important ion that controls the signalling pathways of apoptosis. Temporal elevation of 
cytosolic calcium is recognized to play a pivotal role during apoptosis and some evidence 
suggest that they originate from the endoplasmic reticulum (Baffy et al 1993, Breckenridge et 
al 2003, Ducret et al 2003, Kaiser and Edelman 1977, Kaiser and Edelman 1978).  
     Since the previous sections have revealed that Fis1 and Bap31 interact both physically and 
functionally, and recruit procaspase-8 for its association, a more detailed study of the pathway 
down-stream of ARCosome activation was conducted. Here I show that Fis1 overexpression 
and the cleavage of Bap31 results in cytosolic calcium elevation and the released calcium was 
shown to originate from the ER. Additionally, inhibition of Bap31 cleavage by zVAD-fmk 
significantly reduced such increase of cytosolic calcium induced by Fis1 and further 
experiments allowed to conclude that this calcium elevation was mediated by the production 
of p20Bap31, the pro-apoptotic fragment of Bap31. However, the cytosolic calcium is not a 
prerequisite for the cleavage of Bap31. Furthermore, stable knock-down of Bap31 or Fis1 
(pLKO Bap31 and pLKO Fis1) allowed to investigate the requirement of the ARCosome for 
the calcium release induced by exogenous signals such as actinomycin D or etoposide. 
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4.1 Fis1 overexpression results in cytosolic calcium increase 
     Previously, cytosolic calcium increase was observed during p20Bap31-induced apoptosis 
(Breckenridge et al 2003). Since the expression of Fis1 leads to the cleavage of Bap31 to 
produce p20Bap31, the cytosolic calcium concentration was measured upon Fis1 expression 
using p20Bap31 as a positive control (Fig. 4-1). The data indicated that Fis1 expression 
results in a significant increase (~15% increase over control) of cytosolic calcium already on 
day1 (27 hours post-transfection) and to a more robust increase (~25% increase over control) 
on day2 (48 hours post-transfection). p20Bap31 transfected cells showed a much higher 
increase (~75% increase over control) on both day1 and day2 as p20Bap31 is a factor down-
stream of Fis1-induced apoptosis. 
 
 
 
Fig. 4-1 
Fis1 overexpression results in cytosolic 
calcium increase 
HeLa cells were transfected with the 
indicated genes and harvested at 27 (day1) 
or 48 (day2) hours post-transfection. Cells 
were then incubated with the Fluo-4/AM 
dye to detect the cytosolic calcium. The 
cytosolic calcium level was then analysed 
using FACS. The mean fluorescent 
intensity of β-gal control transfected cells 
were set to 100% and the relative cytosolic 
calcium increase by Fis1 or p20Bap31 
transfection was calculated. Data are 
presented as means±S.D. n=8,8,7,9,8,7 
(from the left)  
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4.2 Calcium released by Fis1 originates from the ER 
     I then postulated that the increased cytosolic calcium concentration was either due to the 
influx of calcium from the extracellular environment since the culture medium contains 
1.8mM calcium whereas cytosolic calcium concentration is usually ~100nM (Hajnoczky et al 
2003) or the calcium was released from the ER as seen in many apoptotic conditions (Baffy et 
al 1993, Breckenridge et al 2003, Ducret et al 2003, Kaiser and Edelman 1977, Kaiser and 
Edelman 1978). Because it was not possible to measure the ER calcium concentration directly, 
ER was stimulated by thapsigargin, a sercoplasmic endoplasmic reticulum calcium ATPase 
(SERCA) inhibitor, to induce the release of calcium and the increase of cytosolic calcium was 
then measured to indicate the ER calcium content. For this, I used two known intracellular 
cytosolic calcium chealators, Fura-2 conjugated with acetoxymethylester (AM) and Fluo-
4/AM. Fura-2/AM is a ratiometric dye, which is excited simultaneously at 340nm and 380nm, 
and the emission is detected at 510nm. The ratio of two fluorescent intensities (F340nm/F380nm) 
indicates the relative calcium concentration in the cytosol. On the other hand, the Fluo-4/AM 
dye emits only little fluorescence when unbound to calcium, but it emits a ~6 fold higher 
fluorescence upon calcium binding. Typical data obtained with Fura-2/AM and Fluo-4/AM 
are shown in figure 4-2 A,B. Upon Fis1 overexpression, the ER calcium content decreased to 
~50% after 20 hours when measured with Fura-2/AM compared with the β-gal control-
transfected cells (Fig. 4-3). Although the data were not in complete accordance with Fura-
2/AM data (Fig. 4-3), Fluo-4/AM showed a similar tendency. The ER calcium content was 
decreased by 15% and 20% from the control after 27 and 48 hours post Fis1 transfection (Fig. 
4-4), which corresponds well with the increased cytosolic calcium concentration observed in 
Fig. 4-1, which was increased by 15% and 25% upon Fis1 transfection after 27 and 48 hours 
post-transfection, respectively. 
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Fig. 4-2 
Typical result of Fura-2/AM and Fluo-4/AM experiment 
(A) Fura-2/AM loaded cells were excited at 340nm and 380nm simultaneously and 
emitted at 510nm, which was detected by FLUOstar OPTIMA. At the beginning, both 
F340nm and F380nm have similar fluorescent intensities. However, after the addition of 
thapsigargin (Tg), fluorescent intensity of F340nm increases and F380nm decreases resulting 
in a higher F340nm/F380nm ratio, which is an indication of a higher cytosolic calcium 
concentration.  
(B) Fluo-4/AM loaded cells were analysed using FACS. After 30 seconds of baseline 
fluorescent measurement, thapsigargin (Tg) was added to the cells. The difference 
between a peak fluorescent intensity and the baseline fluorescence was considered as the 
ER calcium content.  
Fig. 4-3 
Fis1 overexpression results in the decrease of the ER calcium content 
(A) A representitive F340nm/F380nm ratio plot from β-gal- and Fis1- transfected cells is shown.  
(B) The quantitative analysis of a) in triplicate is shown. Note that only one sample was 
analysed for the control. a.u.: arbitrary unit 
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     I then asked if the increased cytosolic calcium is linked to the cleavage of Bap31. Cells 
were transfected with Fis1 in a presence or the absence of zVAD-fmk, which inhibits the 
cleavage of Bap31 (Fig. 1-5), and the cytosolic calcium concentration was measured (Fig. 4-
5). The data revealed that the application of zVAD-fmk significantly reduced the cytosolic 
calcium increase induced by Fis1 overexpression (Fig. 4-5, second and third bar). However, 
although not statistically significant, the application of zVAD-fmk did not completely inhibit 
the cytosolic calcium increase induced by Fis1 overexpression (Fig. 4-5, first and third bar). 
Fig. 4-4 
ER calcium is released upon Fis1 
expression 
HeLa cells were transfected with the 
indicated genes and the ER calcium content 
was measured after addition of thapsigargin 
to Fluo-4/AM loaded cells after base line 
cytosolic calcium measurement after 30 
seconds. The mean fluorescent intensity 
measurements of β-gal control transfected 
cells were set to 100% and the relative ER 
calcium content in Fis1 or p20Bap31 
transfected cells were calculated. Data are 
presented as means±S.D. n=6,6,3,4,6,6 
(from the left)  
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Fig. 4-5 
Application of zVAD-fmk reduces the cytosolic 
calcium increase induced by Fis1 
HeLa cells were transfected with Fis1 in the presence 
(+zVAD) or absence (-zVAD) of zVAD-fmk (50µM). 
The cytosolic calcium concentration was measured 
after 24 hours of transfection using the Fluo-4/AM 
dye. Note that β-gal-transfected cells were kept  
without zVAD. The mean fluorescent intensity 
measurements of Fis1 transfected cells without zVAD 
(middle bar) were set to 100% and the relative 
cytosolic calcium level was calculated. Data are 
presented as means±S.D. n=5,5,3 (from the left) 
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4.3 Cytosolic calcium increase is required for Fis1-induced apoptosis but not 
for the cleavage of Bap31 
     As involvement of calcium in apoptosis is well established and as a similar cytosolic 
calcium increase is also observed in this study, I then determined if such an elevation is 
required for the induction of apoptosis. For this, cells were incubated in two medium 
formulations as previously described (Alirol et al 2006): one with 1.8mM calcium 
concentration corresponding to normal DMEM, and a 0.1mM calcium concentration, a 18-
fold reduction from normal DMEM. The cytosolic calcium concentration was measured after 
incubating cells with the two different medium formulations for 48 hours. The results showed 
that the reduction of the extracellular calcium concentration concomitantly reduced the 
cytosolic calcium concentration (Fig. 4-6 A). I then transfected cells in the two medium 
formulations with the indicated genes and the percentage of subG1 population was measured 
(Fig. 4-6 B). Both the transfection efficiency measured by GFP transfection (71.0±3.1% in 
normal DMEM and 70.0±0.54% in reduced calcium medium) and the background apoptosis 
measured with β-gal transfection (8.5±1.2% in normal DMEM and 7.4±0.6% in reduced 
calcium medium) were unaffected by the modulation of the extracellular calcium 
concentration (Fig. 4-6 B). The result showed that all pro-apoptotic genes tested induced high 
level of apoptosis in normal DMEM after 48 hours. However, all the genes tested had greatly 
reduced level of apoptosis (approximately 50% reduction) when incubated with the reduced 
calcium medium (Fig. 4-6 B). 
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Fig. 4-6 
Cytosolic calcium is required for Fis1-induced apoptosis  
(A) HeLa cells were cultured in DMEM containing either 1.8mM or 0.1mM calcium for two 
days. Cells were then harvested and stained for intracellular calcium ions. Arbitrary fluorescent 
intensities are shown. Data are presented as means±S.D. n=3 p=1.6x10
-2
 
(B) HeLa cells were transfected with the indicated genes in the two medium formulations. Post 
48 hours transfection, cells were harvested and the percentage of the cell population with subG1 
DNA content was measured using FACS. Data are presented as means±S.D. n=6 (for Bax 
transfection) or 3 (all the rest). p-values were 1.6x10
-4 
(for Fis1), 1.1x10
-3 
(for p20Bap31) and 
3.3x10
-3
 (for Bax). 
A 
B 
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     Having shown that calcium is required for Fis1-induced apoptosis, I then sought to study 
at what stage the calcium is required. From the published data, it was likely that the calcium 
release from the ER is linked to the mitochondrial dysfunction (see later section). But first, I 
tried to determine if calcium is involved in the cleavage of the Bap31. Cells were incubated in 
two calcium media (1.8mM or 0.1mM) and co-transfected with Bap31-EYFP and β-gal, Fis1, 
Bax or p20Bap31. The cleavage of Bap31-EYFP was determined as before after 24 and 30 
hours post-transfection (Fig. 4-7). The immunoblot showed that there was no difference in 
procession of this fusion protein induced by Fis1 indicating that calcium elevation is not 
involved in Bap31 cleavage. Also no cleavage was observed in Bax-transfected cells, 
reproducing the data shown before. As expected p20Bap31 transfection likewise did not 
cause any procession of Bap31-EYFP. 
 
 
 
 
 
Fig. 4-7 
Cleavage of Bap31-EYFP is unaffected by the extracellular calcium concentration 
HeLa cells were incubated with 1.8 or 0.1mM extracellular calcium concentration and transfected 
as indicated. Cells were then harvested after 24 hours (left blot) or 30 hours (right blot), their 
lysates separated and immunoblotted as before. p38 was used as a loading control. 
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     I then addressed if the cleavage of endogenous Bap31 was affected by the calcium 
concentration. Figure 4-8 shows that the procession of the endogenous Bap31 was unchanged 
in medium with reduced calcium and also when the intracellular calcium was complexed by 
BAPTA-AM (Fig. 4-8, compare lane 2 and 5, and lane 3 and 6). This indicated that the 
requirement of calcium is somewhere downstream of Fis1-induced Bap31 cleavage. 
  
 
 
 
 
 
 
 
 
 
 
Fig. 4-8 
Cleavage of endogenous Bap31-EYFP is unaffected by the calcium modulation 
HeLa cells were transfected either with β-gal or Fis1 and harvested after 27 hours post-transfection. 
Cells in lane 1 and 4 were incubated with normal 1.8mM DMEM, lane 2 and 5 were incubated with 
0.1mM DMEM and lane 3 and 6 were incubated with normal DMEM but with BAPTA-AM, an 
intracellular calcium chealator. The cleavage of endogenous Bap31 was determined by 
immunoblotting. p38 was used as a loading control. 
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4.4 Cytosolic calcium increase is dependent on ARCosome activation 
     To further determine the requirement of Bap31 in the calcium release, pLKO Bap31 
(stable knock-down of Bap31, Fig. 3-5) was employed. Having confirmed that the baseline 
calcium concentrations between pLKO SC and pLKO Bap31 cells are similar (Fig. 4-9 A), 
both cell lines were transfected with β-gal or Fis1 expression vectors and the cytosolic 
calcium concentrations measured (Fig. 4-9 B). Transfecting Fis1 into pLKO SC cells resulted 
in a 40% increase of the cytosolic calcium concentration over background whereas only a 
minor increase of ~15% was observed upon Fis1 expression in pLKO Bap31 cells. This 
emphasizes the requirement of Bap31 in the calcium release induced by Fis1 overexpression.  
     I then sought to determine if the drug-induced cytosolic calcium could be compromised by 
the downregulation of Bap31 or Fis1. As figure 4-10 shows, stable knock-down of Bap31 or 
Fis1 reduced the level of cytosolic calcium mediated by the exogenous signals.  
     I further investigated the requirement of the p20Bap31 fragment production upon Fis1 
expression in the cytosolic calcium increase. To address this, a site-directed mutagenesis was 
performed on the mammalian expression vector coding for a caspase cleavage-resistant 
Bap31 (crBap31), which harbours two mutations D164A and D238A, to introduce six silent 
mutations (crBap31-mut) so that the lentiviral shRNAs expressed in pLKO Bap31 cells is 
unable to recognize (Fig. 4-11 A). The expression of this vector was confirmed in both pLKO 
SC and pLKO Bap31 cell lines while endogenous Bap31 was still downregulated in pLKO 
Bap31 cells (Fig. 4-11 B). The co-transfection of this mutant (crBap31-mut) with Fis1 into 
pLKO SC or pLKO Bap31 cells revealed that the level of cytosolic calcium increase observed 
in pLKO SC cells was abolished in pLKO Bap31 cells (Fig. 4-11 B).  
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Fig. 4-9 
Bap31 downregulation diminishes the Fis1-induced [Ca
2+
]c increase 
(A) The baseline calcium concentration of pLKO SC and pLKO Bap31 cells were measured using 
Fluo-4/AM. n=9 
(B) β-gal or Fis1 were transfected into pLKO SC or pLKO Bap31 cells and the cytosolic calcium 
concentration measured 48 hours post-transfection. n=3. Data are presented as means±S.D. Note that 
in order to show a greater effect, 0.4μg of DNA was used instead of 0.2μg as normally used. 
Fig. 4-10 
Bap31 or Fis1 downregulation diminishes the drug-induced [Ca
2+
]c increase 
(A) pLKO SC, Bap31 or Fis1 cells were treated with actinomycin D (0.2-2μM) for 6 hours 
and the cytosolic calcium was measured. n=4,3,4,3,4,3,3,4,3 (from left). p-values were 0.31 
(0.2µM), 0.053 (1µM), and 0.17 (2µM) for pLKO SC v.s. pLKO Bap31; and 0.091 (0.2µM), 
0.012 (1µM), and 0.056 (2µM) for pLKO SC v.s. pLKO Fis1. 
(B) Same as (A) but using etoposide (1-7μM) for 20 hours. n=5,5,5,4,5,5,3,5,5 (from left) p-
values were 0.33 (1µM), 0.03 (2µM), and 0.03 (7µM) for pLKO SC v.s. pLKO Bap31; and 
0.35 (1µM), 0.046 (2µM), and 0.00094 (7µM) for pLKO SC v.s. pLKO Fis1. 
Data are presented as means±S.D. 
A B 
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Fig. 4-11 
Production of p20Bap31 is necessary for the increase of [Ca
2+
]c mediated by Fis1 
(A) Six silent mutations (indicated in red) were introduced to an expression vector coding 
for a caspase cleavage-resistant Bap31 (crBap31) by site-directed mutagenesis so that the 
shRNAs produced in pLKO Bap31 cells cannot downregulate crBap31. 
(B) The mutant of caspase cleavage-resistant Bap31 (crBap31-mut) was co-expressed either 
with β-gal or Fis1 in pLKO SC or with pLKO Bap31 cells. The level of cytosolic calcium 
was measured using Fluo-4/AM dye and analysed by FACS. The mean measurements of β-
gal transfected cells in pLKO SC was set to 100% and the relative cytosolic calcium levels 
in other samples were measured. Note that 0.4µg of DNA was used instead of 0.2µg to 
show a greater effect. Histogram shows means±S.D. n=6 and p-value between pLKO SC 
and pLKO Bap31 upon Fis1 transfection was 2.5x10
-3
 
B 
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5. Mitochondrial Dysfunction Occurs Downstream of ARCosome 
Activation 
Summary 
     The canonical function of mitochondria is to produce ATP for cellular energy, however, 
the importance of mitochondria in various aspects of cellular homeostasis has emerged in the 
past ten years. One such aspect is the involvement in apoptosis. Mitochondria contain several 
important factors of apoptosis, such as cytochrome c and apoptosis inducing factor. Release 
of these molecules can initiate apoptosis and this release is mediated by the rupture of the 
outer mitochondrial membrane (OMM). The exact mechanism of how OMM becomes 
permeable to such molecules has not been fully elucidated. However, one mechanism is the 
opening of the permeability transition pore (PTP). The opening of PTP can be initiated by 
increased calcium concentration in mitochondria, which is seen in some scenarios of 
apoptosis.  
     Here I investigate the involvement of mitochondria down-stream of the ARCosome 
activation. It was found that the calcium concentration in mitochondria was significantly 
increased upon Fis1 transfection and led to the dissipation of the mitochondrial membrane 
potential. Furthermore, the loss of mitochondrial membrane potential was inhibited by the 
specific inhibitor of PTP, bongkrekic acid. Moreover, the extent of mitochondrial dysfunction 
was alleviated in Fis1-transfected cells when Bap31 was stably knocked-down, supporting 
that the activation of mitochondria for cell death execution happens after the activation of the 
ARCosome. I also show that the activation of caspase-8 occurs prior to the dysregulation of 
mitochondria and the presence of caspase-8 is required for the activation of mitochondria for 
cell death induction. 
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5.1 Mitochondrial calcium concentration is elevated upon Fis1 transfection 
     In the previous section I presented data that Fis1 or p20Bap31 expression result in 
cytosolic calcium increase (Fig. 4-1). I then thought to determine if the released cytosolic 
calcium could be taken up by mitochondria upon apoptosis induction. To measure the level of 
mitochondrial calcium, Rhod-2/AM dye, which binds to calcium ions in mitochondria (Fig. 5-
1 A), was used. In HeLa cells, Fis1 or p20Bap31 were transfected and the mitochondrial 
calcium level was measured after 27 and 48 hours (Fig. 5-1 B). As the data show, no 
statistically significant increase of calcium in mitochondria was observed after 27 hours of 
transfection, whereas a robust increase of this ion was detected 48 hours post-transfection 
suggesting that the released cytosolic calcium mediated by Fis1 or p20Bap31 was taken up by 
mitochondria (Fig. 5-1 B).  
     I then investigated the dysfunction of mitochondria as measured by the loss of the 
mitochondrial membrane potential (ΔΨm) since this is regarded as one of the features of 
apoptotic cells. Using the same condition as in figure 5-1B, cells were measured for the 
dissipation of the mitochondrial membrane potential (Fig. 5-2 A). As it is shown on the 
histogram, the loss of membrane potential was closely related to the calcium increase in 
mitochondria (Fig. 5-1 B); no dissipation of membrane potential was observed after 24 hours 
but a significant increase was observed after 48 hours (Fig. 5-2 A). To further define the 
mechanism of this result, I incubated the cells with the PT-pore inhibitor bongkrekic acid 
(BA) and measured ΔΨm, which showed that the inhibition of the PTP, although not 
completely, still significantly reduced the mitochondrial dysfunction (Fig. 5-2 B). 
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Fig. 5-1 
Mitochondrial calcium is increased upon Fis1 
overexpression 
(A) HeLa cells were transfected with YFP-mito 
and stained with Rhod-2/AM dye 24 hours post-
transfection. Live cell images were acquired using 
confocal microscopy. Scale bars indicate 10μm.  
(B) β-gal, Fis1 or p20Bap31 were expressed in 
HeLa cells and the relative mitochondrial calcium 
increase was measured with Rhod-2/AM dye using 
FACS. The mean fluorescent intensities of β-gal 
transfected cells were set to 100% on day1 (27 
hours post-transfection) and day2 (48 hours post-
transfection), subsequently the relative 
mitochondrial calcium content was calculated for 
Fis1- and p20Bap31-transfected cells. Data are 
represented as means±S.D. n=5 
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Fig. 5-2 
Fis1 induces the loss of the mitochondrial membrane potential via the the PT-pore 
(A) HeLa cells were transfected with β-gal, Fis1 or p20Bap31 and the dissipation of the 
mitochondrial membrane potential was measured 24 and 48 hours post-transfection with DiOC6 
staining of the cells. Data are acquired using FACS. n=4 
(B) HeLa cells were transfected with β-gal, Fis1 or p20Bap31 and treated with the PT-pore 
inhibitor, bongkrekic acid (50μM). The dissipation of mitochondrial membrane potential was 
measured 48 hours post-transfection. Data are represented as means±S.D. n=4 
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5.2 Activation of the ARCosome occurs prior to mitochondrial dysfunction 
     To establish the order of events leading to mitochondrial deregulation, Fis1 was expressed 
in pLKO Bap31 cells and ΔΨm was measured 48 hours after transfection. As figure 5-3A 
shows the stable knock-down of Bap31 was resistant to Fis1-induced mitochondrial 
permeabilisation. In order to prove the requirement of p20Bap31 for mitochondrial 
dysfunction, crBap31-mut (a mutant that cannot be downregulated by shRNAs expressed in 
the cell, refer to Fig. 4-11 A) was co-expressed with Fis1 in pLKO SC or pLKO Bap31 cells. 
The results showed that the cleavage product of Bap31 (p20Bap31) is necessary for the 
mitochondrial dysfunction (Fig. 5-3 B).  
 
 
 
 
Fig. 5-3 
p20Bap31 production is required for the mitochondrial dysfunction 
(A) pLKO SC or pLKO Bap31 cells were transfected with β-gal or Fis1 and the dissipation of 
the mitochondrial membrane potential measured 48 hours post-transfection. n=4,4,4,3 
(B) pLKO SC or pLKO Bap31 cells were co-transfected with crBap31-mut and β-gal or Fis1, 
and the dissipation of the mitochondrial membrane potential measured 48 hours post-
transfection. n=3  
Data are represented as means±S.D. 
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     Collectively, these data indicate that the cleavage product of Bap31, p20Bap31, is 
responsible for the increase of cytoplasmic calcium level (Fig. 4-11) and the dissipation of the 
mitochondrial membrane potential (Fig. 5-3 B). I then asked if the activation of caspase-8 
induced by drug treatment or Fis1 expression takes place prior to mitochondrial dysfunction 
as the release of cytochrome c and down-stream activation of effector caspases can result in 
global caspases activation. In figure 5-4, HeLa cells were either treated with exogenous 
signals (etoposide or actinomycin D) or transfected with Fis1 in the presence or the absence 
of bongkrekic acid and the level of caspase-8 activation was measured (Fig. 5-4 A-C). As the 
histogram shows, activation of caspase-8 was unchanged in all the conditions tested 
suggesting that the activation of caspase-8 happens prior to mitochondrial deregulation.  
 
 
 
 
 
Fig. 5-4 
Caspase-8 activation happens prior to mitochondrial dysfunction 
(A) HeLa cells were treated with etoposide (100μM) with or without the presence of bongkrekic 
acid (BA, 50μM). The activation of caspase-8 was measured after 30 hours. n=3, p=0.77 
(B) HeLa cells were treated with actinomycin D (0.5μM) with or without the presence of BA 
(50μM). The activation of caspase-8 was measured after 23 hours. n=3, p=0.79 
(C) HeLa cells were transfected with Fis1 and incubated with or without BA (50μM). The 
activation of caspase-8 was measured after 48 hours. n=3, p=0.29 
Data is represented as means±S.D. 
215 | P a g e  
 
     The endogenous caspase-8 was stably down-regulated (pLKO Casp.8, Fig. 5-5 A) with 
lentiviral shRNA particles to study the necessity of this protease in Fis1-induced 
mitochondrial dysregulation. The expression vector for Fis1 was transfected into pLKO 
Casp.8 cells and the activation of Bax, which is linked to the mitochondrial dysfunction, and 
the loss of the mitochondrial membrane potential was measured (Fig. 5-5 B,C). The results 
revealed that both the activation of Bax and the dissipation of the mitochondrial membrane 
potential was reduced in the absence of caspase-8 indicating that the formation and the 
activation of the ARCosome is necessary to induce the down-stream effects of p20Bap31 
production mediated by Fis1. 
 
 
 
 
 
 
Fig. 5-5 
Caspase-8 is required for the mitochondrial dysfunction induced by Fis1 
(A) Endogenous caspase-8 was down-regulated with lentiviral shRNA particles. SC: scramble 
(B) Control cell line (pLKO SC) or the caspase-8 knock-down (pLKO Casp.8) cells were 
transfected with β-gal or Fis1 and the activation of Bax was measured 48 hours post-transfection. 
n=5,4,4,4 (from the left) and p=0.015 (between pLKO SC and pLKO Bap31 upon Fis1 
expression) 
(C) Control cell line (pLKO SC) or the caspase-8 knock-down (pLKO Casp.8) cells were 
transfected with β-gal or Fis1 and the ΔΨm was measured 48 hours post-transfection. n=4 and 
p=6.0x10
-5
 (between pLKO SC and pLKO Bap31 upon Fis1 expression) 
Data is represented as means±S.D. 
216 | P a g e  
 
6. Mitochondrial Fission Is Not Required for Fis1-Induced Apoptosis 
Summary 
     Recent studies have strongly indicated the connection between mitochondrial morphology 
changes and the control of cell death. The direct connection between these two processes has 
yet to be established; nevertheless, numerous reports have been published to support that 
increased mitochondrial fusion has a cytoprotective effect whereas increased mitochondrial 
fission makes cells more susceptible to cell death (Jahani-Asl et al 2007, Knott and Bossy-
Wetzel 2008, Lee et al 2004, Sugioka et al 2004).  
     In the previous sections, I have concentrated on the signalling pathway of Fis1-induced 
apoptosis without addressing its function as a mitochondrial fission factor. Thus, here I 
determined the role of mitochondrial fission and the connection to apoptosis induced by the 
bi-functional protein Fis1. Mitochondrial morphology of Fis1 knock-down cells exhibited 
rather tubular morphology as expected. Furthermore, expression of Fis1 induced 
mitochondrial fission and such morphology remained even upon the application of zVAD-
fmk, which inhibited the procession of Bap31. It indicates the pathway emanated from Fis1 
that mediates Bap31 cleavage and the induction of apoptosis, and the pathway leading to 
mitochondrial fission are separable. Further support of this idea  came from an experiment 
that revealed that mitochondrial morphology did not change upon etoposide treatment, which 
induced Bap31 procession and the Bap31 procession was not inhibited when the fission 
inhibitor, Mdivi-1, was applied. 
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6.1 Fis1 protein levels determines mitochondrial morphology 
     To first set up an appropriate parameter to determine the mitochondrial morphology in 
HeLa cells, Fis1 was either overexpressed or down-regulated and the mitochondrial structure 
was determined by confocal microscopy. The expression of Fis1 was found to induce 
extensive mitochondrial fission resulting in the production of punctuate structure. Likewise 
downregulation of Fis1 led to mitochondrial fusion causing mitochondrial elongation (Fig. 6-
1 A-C) as previously described elsewhere (Lee et al 2004, Stojanovski et al 2004).  
     The apoptosis signalling emanated from Fis1 first targets Bap31 to induce its cleavage and 
produces the pro-apoptotic p20Bap31 (Fig. 1-3), which can be inhibited by a pan-caspase 
inhibitor (Fig. 1-5). Since the ectopic expression of p20Bap31 was previously reported to 
induce mitochondrial fission (Breckenridge et al 2003), I attempted to inhibit the production 
of p20Bap31 upon Fis1 expression with zVAD-fmk, which inhibits the apoptosis signal by 
Fis1, and determined the mitochondrial structure. As figure 6-2 shows, the expression of a 
control vector had no effect on the mitochondrial phenotype (Fig. 6-2 A) whereas expression 
of Fis1 led to extensive mitochondrial fragmentation (Fig. 6-2 B). Moreover, Fis1 expression 
induced pronounced mitochondrial fission even upon the application of pan-caspase inhibitor, 
zVAD-fmk (Fig. 6-2 C) indicating that the mitochondrial fission induced by Fis1 is separable 
from its ability to induce apoptosis.  
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Fig. 6-1 
Mitochondrial morphology is regulated by Fis1 
(A) HeLa cells were transfected with a mammalian expression vector coding for Fis1 and the 
mitochondrial morphology was analysed 24 hours post-transfection with TMRE.  
O/E: over expression 
(B) A control cell line (pLKO SC) transduced with lentiviral particles was stained with TMRE 
and the mitochondrial structure was determined.  
(C) A cell line with stable down-regulation of Fis1 (pLKO Fis1) was stained with TMRE and the 
mitochondrial morphology was determined with TMRE. 
All the pictures were taken using a Laser Scanning Confocal Microscopy. 
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Fig. 6-2 
Fis1-induced fission does not require caspase activation 
HeLa cells were transfected with β-gal (A) or Fis1 (B,C) and either mock treated (A,B) or treated 
with zVAD-fmk (C). Mitochondrial morphology was analysed upon TMRE staining and the 
images were captured using laser scanning confocal microscopy. Three representative panels are 
shown. 
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     In order to determine the possibility that Fis1-induced fragmentation occurring prior to the 
procession of Bap31, HeLa cells were treated with etoposide under a condition in which the 
procession of Bap31 was detectable (Fig. 3-1) and the morphology of mitochondria was 
determined (Fig. 6-3). As figure 6-3 shows, both mock treated and etoposide-treated cells 
showed normal morphology of mitochondria suggesting that mitochondrial fragmentation is 
not required for the induction of Bap31 cleavage. 
 
 
 
 
 
Fig. 6-3 
Mitochondrial fission is not required for Bap31 cleavage 
HeLa cells were mock treated with DMSO (A) or with 100µM etoposide for 30 hours (B). 
Mitochondrial morphology was subsequently analysed upon TMRE staining and the images 
were captured using laser scanning confocal microscopy Three representative panels are shown. 
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     Collectively, inhibition of apoptosis mediated by Fis1 does not inhibit the ability of Fis1 to 
induce mitochondrial fission. I then sought to determine if suppressing mitochondrial fission 
can verify this observation. Cassidy-Stone and colleagues have recently identified a small 
chemical inhibitor of Drp1, Mdivi-1 (for “mitochondrial division inhibitor-1”), that prevents 
mitochondrial division and Bax-mediated mitochondrial membrane permeabilisation 
(Cassidy-Stone et al 2008). By employing this chemical, the procession of Bap31 mediated 
by Fis1 was assayed. Figure 6-4 shows that the co-expression of Bap31-EYFP with β-gal in 
the presence or absence of Mdivi-1 did not cause any alteration in the cleavage of this fusion 
protein. On the contrary, expression of Bap31-EYFP with Fis1 resulted in cleavage of this 
protein as observed before (Fig 1-3). Furthermore, application of Mdivi-1 to Bap31-EYFP 
and Fis1 co-transfected cells also showed a prominent cleavage of this fusion protein 
indicating that inhibiting mitochondrial fission cannot repress Fis1-mediated Bap31 cleavage.  
 
 
 
 
 
Fig. 6-4 
Mdivi-1 cannot inhibit Fis1-induced 
Bap31 cleavage 
HeLa cells were transfected as 
indicated and treated with Mdivi-1 (0, 
5 or 10µM). Cell lysates were 
collected 30 hours post-transfection, 
separated by SDS-PAGE and 
immunobloted. Lysates from GFP 
transfected cells were used as a size 
indicator. GAPDH was used as a 
loading control. 
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Discussion 
1. Summary of the study 
     In this study I demonstrated that the association between the mitochondrial fission factor 
Fis1 and the integral ER membrane protein Bap31 is responsible for the transfer of an 
apoptosis signal from the mitochondria to the ER. The Fis1-Bap31 interaction is detectable in 
normal, non-apoptotic cells indicating that it constitutes a preformed scaffold complex along 
which the cell death signal can be quickly transferred (Fig. D step1). The cleavage and the 
activation of Bap31 suggest that it is a genuine signalling complex and not only a structural 
component in the cell that merely tethers these two organelles. Furthermore, the generic 
canonical procaspase-8 isoform is recruited to the Fis1-Bap31 complex to form the 
ARCosome when various apoptogenic signals, such as chemical cell death inducers, are 
applied (Fig. D step2). Consistent with the proximity-induced dimerization model (Fig. 6), 
Bap31 is able to increase its dimerization upon reception of the cell death signal (Fig. D 
step2), which allows the procession of procaspase-8 into the mature capase-8 (Fig. D step3). 
Activated caspase-8 then cleaves Bap31 to produce the membrane embedded p20Bap31 (Fig. 
D step4) and result in the calcium release from the ER (Fig. D step5). The released calcium 
ions are quickly taken up by neighbouring, juxtaposed mitochondria (Fig. D step6) and leads 
to apoptosis induction via PT-pore opening and the dissipation of the mitochondrial 
membrane potential (Fig. D step7). 
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2. Functional Interaction between Fis1 and Bap31 in Apoptosis 
     The function of mitochondria was once thought to be solely the production of cellular 
energy in the form of ATP. This notion was changed by the identification of factors that 
connect mitochondrial morphology and other cellular pathways such as the induction of cell 
death (Abdelwahid et al 2007, Fannjiang et al 2004, Frank et al 2001, Goyal et al 2007, 
Jagasia et al 2005). It was observed that cells with increased mitochondrial fission are more 
susceptible to cell death and conversely, cells with reduced mitochondrial fission are more 
resistant to apoptogenic stimuli. Furthermore, recent studies indicate that the profusion factor 
mitofusin (Mfn) is involved in the mitochondrial quality control system known as mitophagy 
(Gegg et al 2010, Ziviani and Whitworth 2010). One of the proteins identified in a high-
throughput screening performed in the lab for apoptosis inducers was Fis1 (Albayrak and 
Grimm 2003, Albayrak et al 2003, Grimm and Kachel 2002, Kachel et al 2006). Among 
many mitochondrial fission and fusion factors, Fis1 is the only factor that can cause apoptosis 
upon overexpression. Since the identification of this factor, numerous studies have been 
conducted to understand the mechanism of Fis1-induced apoptosis (Alirol et al 2006, James 
et al 2003, Lee et al 2004, Parone et al 2006). One of our central questions was to delineate if 
mitochondrial fission is sufficient and/or necessary to mediate apoptosis or if Fis1 activates a 
pathway, other than mitochondrial fission, for cell death induction. We indeed hypothesized 
that Fis1 mediates another pathway that leads to apoptosis since, firstly, although the 
expression of Drp1 in C. elegans can induce apoptosis, expression in mammalian cells does 
not induce apoptosis (Jagasia et al 2005). Similarly, no report indicated the spontaneous 
induction of cell death when mitochondrial fusion factors are downregulated. Likewise, 
knocking out fusion factor Mfn in mice is not embryonic lethal. Moreover, Alirol et al 
showed that Fis1 mutant with a point mutation (K148R) retained its ability to induce 
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mitochondrial fission whereas the induction of apoptosis was inhibited (Alirol et al 2006). 
Furthermore, they reported that Fis1-induced apoptosis requires the ER signalling gateway 
for the cell death induction (Alirol et al 2006). 
     Bap31 was selected for a Fis1 target candidate since Alirol et al reported the involvement 
of the ER in Fis1-mediated apoptosis (Alirol et al 2006). One may ask why we did not focus 
on BH3-only proteins, which first perceive the pro-apoptotic stimuli, or other ER proteins 
involved in apoptosis but instead selected Bap31 as a Fis1 target. One reason is that two 
proteins, adenoviral E1A and BH3-only protein CHMP5/Spike (another pro-apoptotic factor 
identified in the screen), have been known to target Bap31 for the apoptosis induction (Mund 
et al 2003, Nguyen et al 1998). Additionally, with the established function of Bap31 in 
mediating apoptosis upon cleavage to produce p20Bap31 (Breckenridge et al 2003), we 
hypothesized that Bap31 as a Fis1 target. 
     To first establish that Fis1 and Bap31 function in a linear pathway leading to cell death 
with Bap31 being downstream of Fis1, endogenous Bap31 was knocked down. Expression of 
Fis1 in Bap31 downregulated cells led to a reduced apoptosis (Fig. 1-9 and 1-10). Moreover, 
as predicted, Fis1 expression led to the cleavage of endogenous Bap31 and of the GFP fusion 
protein of Bap31 (Fig.1-3 and 1-4) in a caspase-dependent manner (Fig. 1-5), which is in line 
with other reports indicating that Bap31 is a known substrate of several different caspases 
(Granville et al 1998). Two caspases, caspase-3 and -8, were likewise found to be activated 
upon Fis1 expression (Fig. 1-6 and 1-7). Controversially, however, I found that activation of 
these caspases was only detectable after 48 hours post-transfection while the cleavage of 
Bap31 was detectable after 24 hours (Fig. 1-3 and 1-7). It is known that the tetrapeptide 
inhibitors (zIETD-fmk or zLETD-fmk) used to measure caspase-8 activation (Fig. 1-6, 3-8, 3-
12 and 5-4) and to measure Bap31 cleavage induced by chemical apoptosis inducers (Fig. 3-
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2) is only partly specific at nanomolar concentrations and not sensitive unless high level of 
this protease is activated in the cell (McStay et al 2008). Therefore, a small amount of 
possibly very localized activation of caspase-8 after 24 hours may have remained 
undetectable with this method. However, to support the involvement of caspase-8, I later 
showed that procaspase-8 is recruited to the Fis1-Bap31 complex (Fig. 3-4); the activation of 
procaspase-8 is Bap31-dependent (Fig. 3-8); and the induction of apoptosis mediated by Fis1 
requires the presence of caspase-8 (Fig. 5-5). Thus, I am confident that the cleavage of Bap31 
is regulated by caspase-8, which is in accordance with other publications that indicated 
caspase-8 as the physiological mediator of Bap31 cleavage (Breckenridge et al 2002, 
Breckenridge et al 2003, Granville et al 1998, Mund et al 2003, Ng et al 1997, Ng and Shore 
1998). It is, however, desirable to develop more sensitive assay methods to detect the 
activation of these caspases at earlier time points. 
     I also showed that the expression of p20Bap31 resulted in Bax activation and its 
localization was found to be at the periphery of mitochondria (Fig. 1-8) as predicted since 
p20Bap31 is a downstream factor of Fis1 expression and Fis1-induced apoptosis is known to 
be dependent on Bax (Alirol et al 2006, Lee et al 2004). Moreover, Fis1-induced Bax 
activation is dependent on caspase-8 (Fig. 5-5), which is also in line with the finding that 
Bap31 cleavage is mediated by caspase-8. Furthermore, p20Bap31-induced apoptosis was 
independent of Fis1 (Fig. 1-11).  
     Overall, the data presented were in line with the publication by Scorrano and colleagues 
where Fis1-induced apoptosis requires the ER signalling gateway for apoptosis (Alirol et al 
2006). Moreover, the signal emanated from Fis1 is Bap31-dependent whereas p20Bap31-
induced apoptosis is Fis1-independent. Thus these indicate the strong unidirectional 
functional crosstalk between Fis1 and Bap31 where Bap31 is located downstream of Fis1 
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signaling pathway. This observation also shows that this signalling pathway is unidirectional: 
originated from mitochondria to the ER. 
     It should, however, be noted that Fis1 is also known to regulate the biogenesis of 
peroxisomes (Delille and Schrader 2008, Kobayashi et al 2007, Koch et al 2005, Nagotu et al 
2008, Schrader 2006). Thus, to obtain additional evidence that Fis1 and Bap31 tethers 
mitochondria to the ER, organelle fractionation should be performed.  
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3. Formation of the ARCosome and Involvement in Apoptosis 
     There are currently three known platforms that can activate caspase-8. The most 
intensively studied complex is a DISC complex, which is located on the plasma membrane to 
form a multiprotein complex (Fig. 10). The factor that enables the recruitment of caspase-8 in 
this complex is FADD, which contains the death effector domain (Fig. 12). Another known 
platform is Hip/Hippi complex, where both Hip and Hippi possess variant of DEDs and their 
dimerization mediates the activation of procaspase-8 (Gervais et al 2002). Although a detailed 
mechanism is unknown, unligated integrin is capable of activating caspase-8 (Stupack et al 
2001). My data indicated that the generic procaspase-8 isoform is recruited to a preformed 
Fis1/Bap31 complex, which we named ARCosome, when various apoptosis-inducing 
chemicals such as etoposide and actinomycin D are applied (Fig. 3-4). The association of 
Bap31 with the overexpressed canonical procaspase-8 and the specific isoform of procaspase-
8L that comprises 59 additional N-terminal amino acids has previously been shown for 
apoptosis induced by the adenoviral E1A protein (Breckenridge et al 2002, Ng et al 1997). 
Furthermore, Chandra et al. have reported that active caspase-3, -9 and -8 were accumulated 
in the membrane-enriched fraction upon etoposide treatment in various cell lines (Chandra 
and Tang 2003, Chandra et al 2004). They also suggest that etoposide-induced apoptosis 
progresses along two pathways. One mechanism signals to the BH3-only proteins and the 
other results in caspase-8 activation in a FADD/TRADD-dependent manner that mediates the 
cleavage of Bap31 to induce apoptosis. The data presented in this thesis is in line with the 
idea that active caspase-8 is enriched in the membrane fraction since the ARCosome is 
formed at the interface between the membranes of mitochondria and the ER (Iwasawa et al 
2011). We do not, however, know if the ARCosome-dependent procaspase-8 activation by 
etoposide requires FADD or TRADD. Chandra and colleagues argue that in many situations 
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drug-induced caspase-8 activation is primarily a positive feedback amplification mechanism 
after activation of caspase-9 in the apoptosome (Fig. 10). This statement is indeed appreciable 
because most chemotherapeutic drugs initiate the activation of p53 to promote the expression 
of proapoptotic BH-3 proteins, Noxa and Puma, which results in the activation of the 
mitochondria-dependent apoptosis pathway leading to the activation of caspase-9. However, I 
do not believe the activation of caspase-8 is merely a secondary effect given the 
identifications of several intracellular caspase8-activating complexes that mediate apoptosis 
(Gervais et al 2002, Iwasawa et al 2011, Stupack et al 2001). I anticipate that they came to 
such a conclusion because it was unknown at the time that Bap31 contains a death-effector-
domain, a domain required for caspase-8 association. Thus, it led them to connect FADD or 
TRADD which are well documented adaptor proteins for caspase-8 in the DISC complex. In 
my study, I show that the variant of DED present in Bap31 (Ng et al 1997, Reed et al 2004) is 
responsible for the recruitment (Fig. 3-14) and the activation of procaspase-8 (Fig. 3-8) and, 
moreover, that this process occurs prior to the activation of caspase-3 during etoposide-
induced apoptosis (Fig. 3-4). Therefore, besides the DISC complex, the Hip/Hippi complex 
and unligated integrins, the Fis1-Bap31 complex (the ARCosome) represents another 
platform for procaspase-8 activation (Iwasawa et al 2011), which is likely to be independent 
of FADD/TRADD.  
     In agreement with the “induced proximity dimerization” model for caspase activation (Fig. 
6), Bap31 underwent homooligomerization upon application of apoptogenic stimuli (Fig. 2-9 
and 3-6), which subsequently activated caspase-8 (Fig. 3-6).  In contrast, it is perplexing that 
Fis1 knock-down cells became sensitive to actinomycin D treatment but not to etoposide 
while Bap31 downregulation conferred resistance to both drugs (Fig. 3-8 and 3-9). In fact, 
knocking down Fis1 leads to different observations depending on different experimental 
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settings. Lee et al reported that ablation of Fis1 makes cells resistant to various apoptogenic 
chemicals, including actinomycin D and etoposide (Lee et al 2004), whereas Parone et al did 
not see any protective effect by actinomycin D (Parone et al 2006). It would have been less 
confusing if they and we used different cell line, however, all the experiments were done in 
HeLa cells. Technique-wise, Lee et al used the number of apoptotic nuclei stained by Hoechst 
dye as an output method to determine apoptotic cells (Lee et al 2004). On the contrary, 
Martinou and colleagues looked for the activation of caspase-3 by measuring the 
externalisation of phosphatidyl serine (Parone et al 2006). I used the activation of caspase-8 
and the dissipation of the mitochondrial membrane potentials (Fig. 3-8 and 3-9). With the 
model presented (Fig. D), the most likely course of events happening is the activation of 
caspase-8, the loss of mitochondrial membrane potential leading to the activation of effector 
caspases. Thus, I assume that the differences arose due to the analysis of different steps of 
apoptotic processes or the conditions employed (dose of drugs and duration of treatment). It is 
desirable to study several other cell lines to determine which effect(s) is occurring in general. 
     In summary, though there are rooms for further investigations, it is already evident that 
each component of the ARCosome is necessary to transmit proapoptotic stimuli to cause 
downstream effects of either Fis1- or chemical- mediated apoptosis (Table 9).  
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Table 9  Ablation of ARCosome components and its cellular effects 
Gene Cellular Effects Ref 
Fis1 K/D 
↓ Caspase-8 activation by etoposide Fig. 3-8 
↓ Cleavage of Bap31-EYFP by etoposide Fig. 3-10 
↓ Recruitment of procaspase-8 to Fis1/Bap31 complex by drugs Fig. 3-15 
↓ Increase of [Ca2+]c by drugs Fig. 4-10 
↓ Loss of ΔΨm by etoposide Fig. 3-9 
Bap31 K/D 
↓ Fis1-induced apoptosis (measured by SubG1 population) Fig. 1-9 
↓ Increase of [Ca2+]c by Fis1 Fig. 4-9 
↓ Loss of ΔΨm by Fis1 Fig. 1-10 
↓ Caspase-8 activation by etoposide or actinomycin D Fig. 3-8 
↓ Loss of ΔΨm by etoposide or actinomycin D Fig. 3-9 
↓ Recruitment of procaspase-8 to Fis1/Bap31 complex by drugs Fig. 3-15 
↓ Increase of [Ca2+]c by drugs Fig. 4-10 
Caspase-8 
K/D 
↓ Bax activation by Fis1 Fig. 5-5 
↓ ΔΨm by Fis1 Fig. 5-5 
K/D: knock-down 
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4. Interface between Mitochondria and the ER in Apoptosis 
     It has been established for decades that membranes of mitochondria and the ER are at 
close proximity as detected by electron micrograph (Franke and Kartenbeck 1971, Montisano 
et al 1982, Morre et al 1971) and Perkins et al. reported that some contact sites are as close as 
15nm (Perkins et al 1997). Furthermore, subcellular fractionations of the ER fractions 
copurify with mitochondria (Lewis and Tata 1973, Shore and Tata 1977a) and the ER-derived 
mitochondria-associated membrane fractions are suggested to be implicated in the 
phospholipid transfer between the organelles (Achleitner et al 1999, Shiao et al 1998, Vance 
1990). Yet only recently factors that allow such inter-organelle tethering were identified. 
Some proteins such as Mfn2, Mmm1/Mdm10 and autocrine motility factor receptor are 
merely a structural component for this interaction (de Brito and Scorrano 2008b, Wang et al 
2000a). In this study, I report that two components of the ARCosome, mitochondria-localized 
Fis1 and the ER-localized Bap31, are interacting endogenously without any apoptotic 
stimulation as revealed by immunostaining (Fig. 2-1 and 2-2) and by co-immunoprecipitation 
studies (Fig. 2-3).  
      The physical interaction between mitochondria and the ER is not only for a structural 
tethering but this association is also important to create a close interface for functional 
interaction between these two organelles. Such spacial proximity is especially important for 
the calcium homeostasis in the cells. The interaction between IP3R and VDAC, for example, 
seems to enhance the quick transfer of Ca
2+
 from the ER to mitochondria (Szabadkai et al 
2006) and PACS-2 and Bik have been shown to transmit signals for apoptosis from the ER to 
mitochondria (Chinnadurai et al 2008, Simmen et al 2005). Here I also show that the 
formation of the ARCosome and the subsequent production of p20Bap31 are involved in the 
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calcium release from the ER and the execution of apoptosis (Fig. 4-1, 4-4, 5-1 and 5-2).        
     Our data allow order the temporal succession of the apoptosis signalling events initiated 
by Fis1 and reveal how the signal that is transmitted from mitochondria to the ER by the 
ARCosome is ferried back to the organelle of its origin. On day 1 I could observe only two 
features of this pathway: Bap31 cleavage (Fig. 1-3) and Ca
2+
 release from the ER (Fig. 4-4) 
resulting in the increase of [Ca
2+
]c (Fig. 4-1). On the second day more downstream processes 
such as the uptake of calcium into mitochondria (Fig. 5-1), the dissipation of the 
mitochondrial membrane potential (Fig. 5-2), and the cleavage of procaspase-3 and PARP 
(Fig. 1-7) were detected. Frieden et al observed a similar change in Ca
2+
 homeostasis upon 
ectopic Fis1 expression (Frieden et al 2004). This supports that the cleavage of Bap31 is a 
very early event in the apoptosis signalling caused by Fis1. Thus, Fis1 can activate a 
signalling pathway that, rather than directly impacting on mitochondria and initiating 
mitochondrial fission for apoptosis, progresses from mitochondria to the ER through the 
interaction of Fis1 with Bap31, its cleavage and finally the release of Ca
2+
, which then feeds 
back to mitochondria. To further support this, Fis1-induced apoptosis was significantly 
reduced when Bap31 was down-regulated (Fig. 1-9 and 1-10) whereas knockdown of Fis1 
did not inhibit p20Bap31 mediated apoptosis (Fig. 1-11). Moreover, as shown by 
Breckenridge et al., the production or the expression of the p20Bap31 fragment is necessary 
and sufficient to cause cytosolic calcium increase (Fig. 4-5, 4-9, 4-10 and 4-11 (Breckenridge 
et al 2003)). In support of this, the cleavage of Bap31 occurs without the cytosolic calcium 
elevation (Fig. 4-7 and 4-8).  
     The released calcium ions upon Fis1 expression seem to be taken up by mitochondria as 
reported by others (Fig. 5-1 (Csordas et al 1999, Rizzuto et al 1993, Rizzuto et al 1994, 
Rutter et al 1996, Scorrano et al 2003)). Although a transient elevation of [Ca
2+
]m acts as a 
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prosurvival mechanism (Bathori et al 2006, Gincel et al 2001, Rapizzi et al 2002), 
persistently high calcium concentration within this organelle results in cell demise. The well-
known mechanism through which cells die in such a situation is via PTP opening leading to 
mitochondrial membrane permeabilisation (Pinton et al 2001a, Szalai et al 1999). Indeed, the 
application of the PTP inhibitor bongkrekic acid alleviated Fis1-induced apoptosis (Fig. 5-2). 
The integration of the ER with its numerous apoptosis regulators and calcium-binding 
proteins (Groenendyk et al 2004, Orrenius et al 2003) into this signalling circuit could allow 
incorporate additional layers of signal regulation. This scenario would ensure that input from 
both organelles, the mitochondria and the ER, are processed and converge on the 
executioners for apoptosis. While activated Bap31 in the form of p20Bap31 does not rely on 
Fis1 for apoptosis signalling (Fig. 1-11), we cannot exclude that in some cases the 
ARCosome also functions to convey signals from the ER to mitochondria. 
     This study reveals a crucial role of Ca
2+
 released from the ER in the downstream 
signalling of the ARCosome. This Ca
2+
 could function as an amplifier for cell death in this 
signalling circuit that is able to reach many mitochondria in close proximity to the ER to 
engage them for apoptosis induction. In fact, high resolution imaging of the mitochondrial 
network estimated that 5-20% of all mitochondria are in close contact with the 
ER/mitochondria interface (Rizzuto et al 1998) and a recent report even suggested that all 
mitochondria can be manipulated to associate with the ER upon drug stimulation (Csordas et 
al 2010) thus facilitating the efficient take-up of calcium in the micro-domains of high 
calcium levels. Ca
2+
 release from the ER is a general mediator in many cell death scenarios 
(Gogvadze et al 2004) including those initiated by caspase-8 (Wozniak et al 2006). Hence, 
since our data indicate that its cytosolic increase is a direct consequence of the activation of 
mitochondrial fission factors, the activation of Bap31 could tie in two generally observed 
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features of apoptosis, calcium release from the ER and mitochondrial fission factor activation. 
The amplification of the apoptosis signal by Ca
2+
 could constitute an important aspect of 
ARCosome activation as only a minority of the Bap31 and Fis1 proteins in the cell are 
engaged in this complex as we detected them in co-immunoprecipitations but not when we 
examined whole cell lysates by gel-filtration assay (Fig. 3-4 and 3-5).  
     Furthermore, Wang et al. reported elevation of free cytosolic calcium concentrations over 
the physiological levels enforces the close association between mitochondria and the ER, 
whereas [Ca
2+
]c of less than 100nM (below physiological level) favours the dissociation of 
these two organelles. This would mean that the production of p20Bap31 should further 
strengthen the association between mitochondria and the ER. It is indeed shown here that 
Fis1 is capable of interacting with cleaved Bap31, p20Bap31 (Fig. 2-7). However, we have 
not yet investigated if the production of p20Bap31 and the subsequent calcium release 
enhances the interaction between these two organelles. On a different perspective, however, 
this report could explain why cell death induced by Fis1, p20Bap31, and Bax were reduced 
when cytosolic calcium concentration was decreased (Fig. 4-6). Perhaps the consequent loose 
association between mitochondria and the ER, due to a reduced cytosolic calcium 
concentration, does not impact on the calcium release from the ER but on its efficient uptake 
into mitochondria. Additionally, lowered [Ca
2+
]c can increase the calcium buffering capacity 
of stimuli that lead to the cytosolic calcium elevation induced by the ectopic expression of 
Fis1, p20Bap31, and Bax. Likewise, apoptosis inducers that require prompt transfer of Ca
2+
 
from the ER to mitochondria are incapable of inducing apoptosis under such conditions. In 
support of this idea, Alirol et al. have shown that Fis1-induced apoptosis is inhibited by 
cytosolic calcium reduction whereas tBid-induced apoptosis, which directly impacts on 
mitochondria for apoptosis induction, remained unaffected (Alirol et al 2006). 
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     One conundrum is the presence of the caspase-8 substrate Bap31 within the caspase-8-
activating complex ARCosome. For all known such platforms (DISC complex, Hip/Hippi 
complex and unligated integrins) their constituents are not substrates of caspase-8. It would 
make sense for cells to activate caspases at the highest level in order to execute cells but the 
presence of Bap31 and its cleavage by activated caspase-8 will certainly reduce the amount of 
caspase-8 to be activated in the ARCosome. This may explain why only a small amount of 
caspase-8 was activated upon Fis1-expression (Fig. 1-6). Furthermore, perhaps due to the 
production of barely sufficient amounts of active caspase-8 to execute cell death, cells initiate 
the release of calcium ions from the ER that mediates the persistent opening of the PTP 
resulting in an amplification loop for efficient apoptosis execution.  
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5. Mitochondrial Fission and Apoptosis 
     It is currently being discussed in the filed of apoptosis whether mitochondrial fission is 
required for apoptosis induction or whether it constitutes a cellular feature that merely 
accompanies the cell death process (Sheridan et al 2008, Tanaka and Youle 2008). The 
procession of Bap31 makes the signalling pathway of the ARCosome dependent on caspases, 
while the fission of mitochondria seems independent of Bap31 procession (Fig. 1-5 and 6-2). 
Hence, the signalling circuit for apoptosis emanating from Fis1 is not required for fission of 
mitochondria. Moreover, etoposide treatment did not show any appreciable mitochondrial 
fission at a time point when Bap31 was already cleaved (Fig. 6-3). Conversely, the 
application of the mitochondrial fission inhibitor Mdivi-1 did not inhibit the procession of 
Bap31 (Fig. 6-4).  
     The failure to observe any change in fission when caspases - and by extension the 
activation of caspase-8 in the ARCosome - were inhibited (Fig. 6-2) suggests that the 
signalling pathway described here is independent of mitochondrial fission. It is known that 
the Fis1-mediated apoptosis can be repressed by Bcl-XL without compromising its effect on 
fission (James et al 2003). This is also supported by the finding on the kinetics of 
mitochondrial fission compared with Bap31 cleavage (Fig. 1-3, 3-1, 6-2, 6-3 and 6.4). 
Furthermore, the co-expression of Fis1 and the dominant negative form of Drp1, Drp1K38A, 
which inhibits mitochondrial fission, does not suppress Fis1-induced apoptosis although the 
release of cytochrome c from mitochondria was observed to be repressed (Lee et al 2004). 
This data, however, should be considered carefully. Our data demonstrate that the expression 
of Fis1 leads to the dissipation of the mitochondrial membrane potential (Fig. 5-2), which we 
assume will result in the release of cytochrome c. This raises the possibility that Fis1 
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mediates apoptosis in a mitochondrial-dependent (though fission-independent) manner but 
there could be another mechanism to execute apoptosis independently of mitochondria. One 
possibility could be the activation of other caspases, for example caspase-2, within the 
ARCosome, which could convey apoptosis signals resulting in the activation of downstream 
caspases or perhaps the activated caspase-8 mediates the activation of effector caspases 
without initiating the feedback loop to mitochondria. 
     Hence, it seems that fission factors such as Fis1 are a bifunctional proteins involved in 
apoptosis signalling and fission independently of each other, a notion that is also supported by 
several other studies (Alirol et al 2006, James et al 2003, Lee et al 2004, Sheridan et al 2008, 
Tanaka and Youle 2008). It should, however, noted that Fis1-induced apoptosis does not 
require mitochondrial fission, the expression of p20Bap31 nevertheless induce mitochondrial 
fission (Breckenridge et al 2003). This event was shown to be inhibited by reducing the ER 
calcium content by thapsigargin; by the expression of Bcl-2; by chelating cytosolic calcium 
by BAPTA; by inhibiting mitochondrial calcium uptake by Ru360 and by the expression of 
Drp1K38A (Breckenridge et al 2003). Thus mitochondrial fission observed in many scenarios 
of apoptosis, I believe, is a secondary effect of upstream signaling events and, though it may 
enhance, is not required for the execution of cell death. 
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6. Future Prospects 
     In this study, I presented the identification of a novel caspase-8 activating platform and the 
mechanism of Fis1-induced apoptosis through various molecular, cellular and biochemical 
approaches. However, these findings raise interesting questions and some of the data 
presented here should be followed up. One such experiment is figure 2-1 and 2-2, in which 
the co-localization of Fis1 and Bap31 was shown by confocal microscopy. To obtain more 
conclusive data, other proteins localized to the ER and mitochondria could be investigated. 
For example, it would be interesting if the amount of co-localization between Fis1 
(mitochondria marker) and Bap31 (ER marker) is higher than the co-localization between 
Mfn2 (mitochondria marker) and Bap31 (ER marker) or IP3R (ER marker) and Fis1 
(mitochondria marker). Other assay techniques could include the use of the FRET effect: Fis1 
tagged with CFP and Bap31 tagged with YFP, or vice versa, to compare and investigate the 
level of the FRET effect between other, unrelated proteins localized to either mitochondria or 
the ER. A more comprehensive method would be to employ mass spectrometry after 
immunoprecipitating either Fis1 and/or Bap31 and then detect which proteins are associated 
with the components of the ARCosome. 
     Based on my results I believe that Fis1, Bap31 and procaspase-8 constitute central factors 
in the ARCosome. However, the exact nature and the components of the ARCosome are yet 
to be determined. From this study several additional questions arise. For example, how can 
the pre-existing Fis1-Bap31 complex activate procaspase-8, which is localized in the cytosol, 
only upon apoptotic stimulation? Perhaps there is an adaptor protein that is hindering the 
exposure of the vDED domain of Bap31 thereby inhibiting the activation of caspase-8 in 
healthy cells just like SODD (silencer of death domain) in the TNF receptor complex (Fig. 
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10). The application of pro-apoptotic stimuli may then dislocate such adaptor proteins 
allowing the exposure of the vDED domain and facilitating the association and 
oligomerization of Bap31 and procaspases-9, which results in the production of mature 
caspase-8. As some anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and Bcl-XL, are 
reported to interact with Bap31 (Mund et al 2003, Ng et al 1997, Ng and Shore 1998), it is 
possible that these factors are acting as competitive inhibitors in healthy cells. Nevertheless, a 
more detailed analysis of the ARCosome should be performed. Rather than performing a 
targeted approach, as mentioned above performing a mass spectrometry with and without 
drug treatment and immunoprecipitate proteins using α-Fis1 and/or α-Bap31 antibodies could 
be informative. This should give more insights to understand as to how this caspase-8 
activating complex is regulated.  
     It is shown here that the Fis1-Bap31 complex recruits procaspase-8 to form a caspase-
activating-complex, the ARCosome, upon apoptogenic stimulation. It is yet unclear how Fis1 
is able to independently function as an interacting partner of Bap31 and as a pro-fission factor. 
One possibility is that the domain of Fis1 that interacts with Bap31 then cannot recruit Drp1 
to induce mitochondrial fission, thus Bap31 is acting as an antagonist. The cleavage of Bap31, 
however, produces p20Bap31 resulting in the release of the Fis1-Bap31 interaction enabling 
Drp1 to be recruited to Fis1 leading to mitochondrial fission. This would fit with the previous 
reports indicating that the expression of p20Bap31 induces mitochondrial fission 
(Breckenridge et al 2003). This idea, however, does not support the data where p20Bap31 
was still capable of interacting with Fis1 (Fig. 2-7) unless this interaction is an artefact. In 
fact, this interaction may not occur at a physiological level due to the nature of the 
experimental procedure used, namely the co-immunoprecipitation of lysed cells. It is possible 
that the association between p20Bap31 and Fis1 is indirect. Figure 2-10 shows that every 
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construct produced (full length Bap31, Bap31ΔvDED, p20Bap31 and Bap31Δcc/vDED) were 
able to interact with each other. This raises the possibility that the interaction between 
p20Bap31 and Fis1 was in fact an indirect association such that p20Bap31 interacts with full 
length Bap31 and the full length Bap31 associates with Fis1. To determine this, in vitro 
binding assay of purified proteins could be performed (given that no adaptor proteins are 
required for Fis1-Bap31 interaction). 
     Overall, it is necessary to perform more research to attach additional physiological 
relevance to this complex. Since the downregulation of Bap31 seems to confer resistance to 
multiple apoptotic stimuli, examining tissues of chemotherapy resistant patients might 
identify Bap31 as a biomarker for treatment sensitivity. Similarly, using the Bap31 knockout 
mice or producing an overexpressing animal model to  examine their resistance to different 
compounds at an organismal level may also yield further information on this complex.  
     Our candidate approach to hypothesize that Bap31 is a Fis1 target proved to be correct. 
However, there exist several BH3-only proteins that regulate apoptosis at the ER. For 
example, Bim, one of BH3-only proteins known to be involved in the ER stress-mediated 
apoptosis (Puthalakath et al 2007), may play a role in Fis1 induced apoptosis since I did not 
examine the relevance of ER stress responses upon Fis1 expression. Thus ER stress markers 
upon Fis1 expression should be studied to examine the possibility that ER stress is involved. 
Also, another BH-3 only protein, Bik, is known to primarily localize to the ER to regulate 
mitochondrial pathways of apoptosis by mobilizing calcium from the ER to the mitochondria 
(Chinnadurai et al 2008). Therefore, this factor could also be a potential target of Fis1-
induced apoptosis or drug mediated cell demise.  
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     Lastly, many of the experiments performed were done at a specific time points. These 
results enabled us to constitute a pathway of Fis1- or drug-mediated apoptosis. It would, 
however, be more informative and definitive if we could monitor the progression of apoptosis 
over a course of time by combining different techniques. One approach I propose will be to 
employ a live cell imaging system (Appendix 1). Using this method, it is possible to focus on 
a single cell where all the FACS or western blot data presented in this thesis are pool of cells. 
For example, transfect calcium FRET construct that measures different compartment of a cell 
(Appendix 1) then treat with a drug and add a dye that specifically binds to active caspase-3/7 
or caspase-8, or mitochondria. This method will allow to measure the exact point of events 
happening within a single cell. 
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Apendix 1: Calcium Monitoring using FRET technique 
     The FRET constructs used were YC3.6cyt (Nagai et al 2004), D1ER (Palmer et al 2004), 
YC2mit (Arnaudeau et al 2001), and all the constructs were kind gifts of Dr. Nicolas 
Demaurex (University of Geneva). 
     Although the constructs were used and verified in papers mentioned above, they were 
nevertheless first tested to confirm the validity in my system. HeLa cells were transfected 
with each construct in a 10cm dish or 6-well plate, split after 24 hours into 6cm dishes, and 
analysed 48 hours post-transfection. On the day of analysis, cells were excited only for CFP 
(405nm) and the emission was measured for CFP (442-515nm) and YFP (518-632nm). The 
ratio of YFP fluorescent intensity and CFP fluorescent intensity (YFP/CFP) was used to 
analyse the FRET effect. At certain time points during the acquisition, either histamine or 
thapsigargin was added to induce the release of calcium. 
     Figure A1-1 (A-C) show that YC3.6cyt, D1ER, and YC2mit localize to the cytosol, ER, and 
mitochondria, respectively.  
     A typical set of data for the YC3.6cyt is shown in figure 4-2. The basal fluorescent 
intensities of CFP and YFP were measured (Fig. A1-1A) then the cells were stimulated with 
histamine, which induced a rapid transient reduction of both CFP and YFP. After a few 
seconds post histamine challenge, CFP fluorescent intensity gradually returned to the basal 
level (Fig. A1-2A left) whereas YFP fluorescent intensity was quickly elevated above the 
baseline (Fig. A1-2A right) resulting in an increased FRET ratio (Fig. A1-2B). The 
differences were clearly visible on pseudo-coloured FRET ratio images (Fig. A1-2C). 
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Fig. A1-1 
Localization of different FRET constructs 
HeLa cells were transfected with YC3.6 cytosolic, D1ER, or YC2 mitochondria FRET constructs 
and the sub-cellular localization was determined by immunofluorescent assay. 
(A) YC3.6cyt construct was transfected and immunostained with phalloidin conjugated with Alexa 
Fluor 633. 
(B) D1ER construct was co-transfected with DsRed-ER. 
Scale bar indicates 10µm 
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Fig. A1-2  
Cytosolic calcium increases upon addition of histamine 
HeLa cells were transfected with YC3.6 cytosolic FRET construct and the FRET effect was 
determined using an excitation laser at 405nm and emission filters for CFP and YFP. At the 
indicated time points, histamine (100µM) was added to induce the calcium release. 
(A) The fluorescent intensity changes of CFP (left) and YFP (right) are shown 
(B) The FRET ratio measured as a fluorescent intensity from YFP divided by fluorescent intensity 
of CFP is shown. 
(C) The representative pseudo-coloured images of FRET ratio are shown. The left panel shows the 
basal level of FRET effect, middle panel shows the reduction of FRET ratio after the addition of 
histamine, and right panel shows the maximum FRET ratio after the addition of histamine. 
A 
B 
C 
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     To further analyse the construct, cells were transfected with YC3.6cyt and challenged with 
thapsigargin (Fig. A1-3). A similar observation was made compared with histamine, and the 
cells with different expression levels of the construct showed a similar surge of calcium 
increase. As expected, background (without any transfected cells) had no change in the FRET 
ratio.  
 
 
 
 
 
 
 
Fig. A1-3 
Addition of thapsigargin results in increased cytosolic calcium level 
HeLa cells were transfected with YC3.6cyt and analysed as in figure A1-2 except that thapsigargin 
(10µM) was used instead of histamine. The centre image represents the field of acquisition and the 
left bottom picture indicates the FRET ratio of an entire field. Two cells expressing different levels 
of the YC3.6cyt construct were selected and their FRET ratio were determined and found to have 
similar kinetics. The top right panel shows the background FRET ratio. 
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     In order to have a negative control, cells transfected with YC3.6cyt were incubated with 
dantrolene (100µM) and/or 2-APB (2-aminoethoxydiphenylborate, 100µM) three hours prior 
to the analysis, an antagonist of the ryanodine receptor and the inositol 1,4,5-trisphosphate 
receptor, respectively. Figure A1-4 shows that the application of these drugs reduced the 
surge of calcium increase in the cytosol induced by histamine. Without any drug treatment, 
addition of histamine resulted in 95% increase in the FRET ratio (Fig. A1-4A), whereas it 
was reduced to 35% with both dantrolene and 2-APB treatment, 28% with dantrolene and 
12% with 2-APB (Fig. A1-4B-D). On the other hand, pre-treatment with nifedipine (100µM), 
an inhibitor of L-type calcium channel at the plasma membrane, had much less effect on 
calcium release into the cytosol upon histamine challenge (Fig. A1-4E). 
 
 
A 
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E 
Fig. A1-4 
Addition of ER calcium receptor antagonist(s) reduces the cytosolic calcium release induced 
by histamine 
HeLa cells were transfected with YC3.6cyt and analysed as in figure A1 -2. Three hours prior to the 
analysis, cells were treated with (A) DMSO, (B) 2-APB and dantrolene, (C) 2-APB, (D) dantrolene, 
and (E) nifedipine. Pseudo-coloured calcium image ratio together with images of different time 
points during the analysis are shown. 
D 
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     I then attempted to analyse the D1ER FRET construct. The same approach was taken to 
test the construct. HeLa cells were transfected with D1ER and challenged by histamine or by 
thapsigargin after baseline FRET ratio measurement. Figure A1-5A shows that the FRET 
ratio in the ER drops immediately after addition of histamine, however, the ER calcium is 
quickly restored in 10 seconds. Similar observation was made when a single cell was 
analysed (Fig. A-5B). Since histamine evoked only a very transient reduction of ER calcium, 
I indirectly stimulated the release of calcium from the ER by inhibiting the uptake of calcium 
into the ER by thapsigargin, and an inhibitor of SERCA. As expected, addition of 
thapsigargin resulted in a quick reduction of FRET ratio and the ratio was kept decreasing 
gradually (Fig. A1-6). This indicates that the calcium is continuously released to the cytosol 
from the ER whereas the re-uptake of calcium back into the ER was inhibited by thapsigargin. 
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Fig. A1-5 
Calcium release from the ER induced by histamine is quickly restored 
HeLa cells were transfected with D1ER and challenged by histamine to induce the release of 
calcium. 
(A) The FRET ratio of an entire field is indicated. Images below represent the baseline FRET (left), 
immediately after the addition of histamine (middle panel) and after the addition of histamine (right 
panel). 
(B) Bottom left and bottom right shows the FRET ratio of single cells. The right top shows the 
background FRET image. 
 
B 
A 
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     The YC2mit FRET construct was tested next. HeLa cells were transfected and the calcium 
release was stimulated with histamine. Figure A1-7A shows that the stimulation with 
histamine resulted in identical increase of calcium as observed in YC3.6cyt reduction of FRET 
ratio immediately after addition of histamine then the robust FRET ratio increase and the 
FRET ratio then gradually decreases. Same characteristics were also seen when a single cell 
was analysed (Fig. A1-7B).  
Fig.A1-6 
Calcium release from the ER induced by thapsigargin 
HeLa cells were transfected with D1ER and challenged by thapsigargin to induce the release of 
calcium from the ER. The FRET ratio and the representative images of different time points during 
analysis are shown. Addition of thapsigargin resulted in an immediate reduction of the FRET ratio, 
which came back slightly and then kept decreased over a time.   
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Fig. A1-7 
Increase of mitochondrial calcium by histamine challenge 
HeLa cells were transfected with YC2 mit and challenged by histamine. 
(A) FRET ratio of an entire field is indicated. Images below represent the baseline FRET (left 
panel), immediately after the addition of histamine (middle panel) and after the addition of 
histamine (right panel). 
(B) Bottom left and bottom right panel show the FRET ratio of single cells. The right top panel 
shows the background FRET image. 
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Appendix 2: Analysis of correct insert orientation 
 
 
 
 
 
 
 
 
 
 
 
Fig. A2 
Analysis of correct insert orientation 
The use of StrataClone mammalian expression vector system allows the quick addition of 
an epitope tag to the gene of interest. IHowever, it cannot control the orientation of 
atheinsert. Thus, although the C-terminus of the gene should be juxtaposed to the Flag tag, 
it is possible to get a construct with the N-terminus of the gene next to the Flag tag. Thus, it 
is required to assess if the gene of interest is inserted in the correct orientation. To 
determine this, restriction enzyme digestions were performed as indicated above. 
(A) For full length Bap31-Flag, the resulting vectors were digested with DraI or XhoI. The 
correct orientation should give 351bp, whereas the incorrect orientation will result in the 
production of a 426bp fragment.  
(B) For Bap31 ΔvDED-Flag, the resulting vectors were digested with DraI or XhoI. The 
correct orientation should give 224bp whereas the incorrect orientation will result in the 
production of a 426bp fragment.  
(C) For Bap31 ΔCC/vDED-Flag, resulting vectors were digested with DraI or XhoI. The 
correct orientation should give 308bp whereas the incorrect orientation will result in the 
production of a 176bp fragment.  
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Appendix 3: Cloning of shRNA into Lentiviral pLKO.puro vector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. A3 
Cloning of shRNA into Lentiviral pLKO.puro vector 
(A) pLKO.puro TRC cloning vector was purchased from AddGene. The vector contains 
RRE (Rev responsive element), the U6 promoter to drive the transcription of shRNA, cPPT 
(central polypurine tract, improves transduction efficiency), the hPGK promoter (human 
phosphoglycerate kinase) to drive the expression of the puromycin resistant cassette franked 
by 5’LTR and 3’LTR (left). The vector was digested with AgeI and EcoRI restriction 
endonuclease. The annealed primers were then ligated with the vector backbone to produce 
pLKO.puro vector with shRNA (right). 
(B) The primer contains an AgeI compatible end on its sense strand (CCGG) followed by 
either G or C. Thus, AgeI restriction site (A↓CCGGT) is destroyed upon successful cloning 
(top). However, when vectors are re-ligated, the AgeI site remains intact (bottom). 
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